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Arabidopsis (1020) STVGSSCVYVMRRPDKRLYEGQTDDLEGRRAHRAKEGEQGSSELYLNVQ 
Common Bean (1036) SVWGSSSVYWFTEDKKLYVGETDDLEGRVRRHRIKEGMDEASELYFIVE 
Soybean (1040) SVVGSSSVYVMFREDKKLYVGETDDLEGRVRRHREKEGMHEASELYELVE 
Rice (1037) STVGRSSYWIRRDSKLYEGQTDDLVGRSAHRSKEGMODASILYILVE 
Tomato (1040) STEGASSVYMLREDKKLYWGSTDDLEGRVRAHRLKEGMENASELYELVS 
Consensus (1051) STVGSSSVYVM RPDKKLYVGOTDDLEGRVRAHRLKEGM DASFLYFLVP 
O 15 O 
Arabidopsis (1070) GKSMACQLEELLINQLHEQGSSIANADGKHRNFGTSSSLSTSDVVSIL 
Common Bean (1086) GKSACQFESLLINQLSSQGEQLSNMADGKHRNFGTSNEYA- - - - - - - - - 
Soybean (1090) GKSACQFESLLINQLSGQGEQLSNADGKHRNFGTSNCYT- - - - - - - - - 
Rice (1087) GKSACQIELLINQLPLKGEKLINKADGKHRNFGISLSPGEAIAA- - - - 
Tomato (1090) GKSACQEEELLINQLPNHGFQLNWADGKHRNFG - - - - - - - - - - - - - - - 
Consensus (1101) GKSIACQLETLLINQL OGFOLSNIADGKHRNFGTS L 
Arabidopsis SEQ ID NO: 3 
Common Bean SEQ ID NO: 47 
Soybean SEQ ID NO : 31 
Rice SEQ ID NO: 22 
Tomato SEQ ID NO: 40 
Consensus SEO ID NO: 65 
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IMPLEMENTATION OF A MITOCHONDRIAL 
MUTATOR 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
0001. This application claims priority under 35 U.S.C. 
$119 from U.S. Application Ser. No. 60/456,318, filed Mar. 
20, 2003, which is incorporated herein in its entirety by 
reference. 
GOVERNMENT LICENSE RIGHTS 
0002 The U.S. Government has a paid-up license in this 
invention and the right in limited circumstances to require 
the patent owner to license others on reasonable terms as 
provided for by the terms of the contracts awarded by the 
National Science Foundation and the Department of Energy. 
TECHNICAL FIELD 
0003. This invention relates to using molecular and evo 
lutionary techniques to identify polynucleotide and polypep 
tide Sequences corresponding to commercially relevant traits 
in domesticated plants. 
BACKGROUND OF THE INVENTION 
0004. The plant mitochondrial genome is retained in a 
multipartite Structure that arises by a process of repeat 
mediated homologous recombination. Low frequency 
ectopic recombination also occurs, often producing 
Sequence chimeras, aberrant open reading frames, and novel 
Subgenomic DNA molecules. This genomic plasticity may 
distinguish the plant mitochondrion from mammalian and 
fungal types. In plants, relative copy number of recombina 
tion-derived subgenomic DNA molecules within mitochon 
dria is controlled by nuclear genes, and a genomic shifting 
proceSS can result in their differential copy number Suppres 
Sion to near-undetectable levels. We have cloned a nuclear 
gene that regulates mitochondrial SubStoichoimetric shifting 
in Arabidopsis. The CHM gene was shown to encode a 
protein related to the MutS protein of E. coli that is involved 
in mismatch repair and DNA recombination. We postulate 
that the process of SubStoichiometric shifting in plants may 
be a consequence of ectopic recombination Suppression or 
replication Stalling at ectopic recombination Sites to effect 
molecule-Specific copy number modulation. 
0005 Argument for the mitochondrion as a central regu 
lator of cellular functions has become increasingly perSua 
Sive in the past Several years, as information expands 
detailing cell metabolic functions (Golden & Melov, (2001) 
Mech. Aging Dev. 122, 1577-1589; Naviaux (2000) Eur. 
J.Ped. 159, 5219-5226), programmed cell death (Ravagnan, 
et al. (2002)1 Cell. Physiol. 192,131-137), and intracellular 
signaling (Epstein et al. (2001) Molec. Biol. Cell. 12,297 
308). The disclosures of Golden & Melov, Naviaux, and all 
other patents and publications referred to herein, are incor 
porated herein in their entirety by reference. In higher plants, 
mitochondrial functions and behavior have clearly been 
influenced by the plant cells unique context. Co-evolution 
of mitochondria and chloroplasts has permitted economy of 
function via protein dual-targeting (Small, et al. (1998) Plant 
Molec. Biol. 38,265-277, Peeters & Small (2001) Biochim. 
BiophyS. Acta 1541, 54-63), genome capacity and coding 
have been altered (Knoop & Brennicke (2002) Crit. Rev. 
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Plant Sci. 21,111-126), and the mitochondrial genomes of 
plants have acquired Structural and maintenance features 
distinct from their animal counterparts. 
0006 The plant mitochondrial genome appears to be 
organized as a collection of Small circular and large, circu 
larly-permuted linear molecules (Oldenburg & Bendich 
(2001) Molec. Biol. 310, 549-562; Backert, et al. (1997) 
Trend Plant Sci. 2, 477-483), not unlike what has been 
postulated for yeast (Maleszka, et al. (1991) EMBO J. 10, 
3923-3929; Lecrenier & Foury (2000) Gene 246,37-48). 
DNA replication may be conducted by a rolling circle 
mechanism, and experimental difficulties identifying repli 
cation origins have led to the Suggestion of recombination 
mediated replication initiation (Backert & Borner (2000) 
Curr. Genet. 37, 304-314). In fact, a distinct feature of plant 
mitochondrial genome organization is the prominent role of 
recombination. 
0007 High frequency inter- and intra-molecular recom 
bination is detected within the higher plant mitochondrial 
genome at large repeated Sequences that can be readily 
identified by physical mapping (Fauron, et al. (1995) Trends 
Genet. 11, 228-235). Their presence in direct orientation 
permits the Subdivision of the genome into a collection of 
molecules, each containing only a portion of the genetic 
information. More intriguing, however, is the common 
observation in plants of intragenic ectopic recombination 
events that can occur at Sites containing as few as Seven 
nucleotides of homology (Andre, et al. (1992) Trends Genet. 
8, 128-132). Ectopic recombination results in expressed 
gene chimeras that cause cytoplasmic male Sterility, plant 
variegation and other aberrant phenotypes (Mackenzie & 
Mcintosh (1999) Plant Cell 11, 571-585; Sakamoto, et al. 
(1996) Plant Cell 8, 1377-1390). 
0008. A phenomenon rendering the plant mitochondrial 
genome unusually variable in Structure is termed Substo 
ichiometric shifting. First reported in maize (Small, et al. 
(1987) EMBO J. 6, 865-869) as the stable presence of 
Subgenomic mitochondrial DNA molecules within the 
genome at near-undetectable levels, the process appears to 
be highly dynamic. Mitochondrial genomic shifting involves 
rapid and dramatic changes in relative copy number of 
portions of the mitochondrial genome over one generation's 
time (Janska, et al. (1998) Plant Cell 10,1163-1180). These 
Substoichiometric forms have been estimated at levels as 
low as one copy per every 100-200 cells (Arrieta-Montiel, et 
al. (2001) Genetics 158, 851-864). Generally the rapid 
shifting proceSS involves only a Single Subgenomic DNA 
molecule, often containing recombination-derived chimeric 
Sequences, and the process is apparently reversible (Janska, 
et al., ibid., Kanazawa, et al. (1994) Genetics 138,865-870). 
Genomic shifting can alter plant phenotype because the 
process activates or Silences mitochondrial Sequences 
located on the shifted molecule. Observed phenotypic 
changes have included plant tissue culture properties 
(Kanazawa, et al., ibid.), leaf variegation and distortion 
(Sakamoto, et al., ibid.), and spontaneous reversion to fer 
tility in cytoplasmic male Sterile crop plants (Janska, et al., 
ibid., Smith, et al. (1991) Theor. Appl. Genet. 81,793-798). 
It has been postulated that SubStoichiometric shifting may 
have evolved to permit the Species to create and retain 
mitochondrial genetic variation in a Silenced but retrievable 
form (Small, et al. (1989) Cell 58, 69-76). 
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0009 Mitochondrial Substoichiometric shifting has been 
shown in at least two cases to be under nuclear gene control, 
involving the Fr gene in Phaseolus vulgaris (Mackenzie & 
Chase (1990) Plant Cell 2,905-912) and the CHM gene in 
Arabidopsis (Martinez-Zapater, et al. (1992) Plant Cell 4, 
889-899; Redei (1973) Mut. Res. 18,149-162). Mutation of 
the nuclear CHM gene results in a green-white leaf varie 
gation that, in Subsequent generations, displays maternal 
inheritance (Redei, ibid.). The appearance of the variegation 
phenotype is accompanied by a Specific rearrangement 
(Martinez-Zapater, et al., ibid.) that includes amplification of 
a mitochondrial DNA molecule encoding a chimeric 
Sequence (Sakamoto, et al., ibid.). Genetic analysis Suggests 
that the wildtype form of CHM actively suppresses copy 
number of the Subgenomic molecule carrying the chimeric 
Sequence. LOSS of proper function of the CHM gene, char 
acterized by two available EMS-derived mutant alleles 
chm1-1, chm1-2 (Redei, ibid.) and a tissue culture-derived 
mutant allele chm1-3 (Martinez-Zapater, et al., ibid.), results 
in rapid and Specific copy number amplification of the 
Subgenomic molecule, producing the consequent leaf varie 
gation. It is not clear whether the copy number amplification 
or Suppression of a Single Subgenomic molecule occurs by 
differential replication or a recombination mechanism. 
SUMMARY OF THE INVENTION 
0.010 The present invention provides an isolated nucleic 
acid molecule Selected from the group consisting of a 
nucleic acid molecule comprising a nucleic acid sequence 
selected from the group consisting of SEQID NO:1, SEQID 
NO:6, SEQ ID. NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ 
ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, 
SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID 
NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID. NO:32, 
SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:37, SEQ ID 
NO:38, SEQ ID NO:41, SEQ ID NO:43, and SEQ ID 
NO:45; a nucleic acid molecule comprising at least a portion 
of any of these nucleic acid molecules, a complement of a 
any of these nucleic acid molecules, and a nucleic acid 
molecule comprising an allelic variant of a nucleic acid 
molecule comprising any of these nucleic acid Sequences. 
0011. In some embodiments, the nucleic acid molecule is 
a plant nucleic acid molecule, a nucleic acid molecule 
Selected from the group consisting of Arabadopsis, Oryza, 
Glycine, Hordeum, Zea, Medicago, Allium, Citrus, Solanum, 
Sorghum, Saccharum, Nicotiana, LycopersicOn, Triticum, 
Zinnia, and Phaseolus nucleic acid molecules, a nucleic acid 
molecule Selected from the group consisting of a nucleic 
acid molecule comprising a nucleic acid Sequence that 
encodes a protein having an amino acid Sequence Selected 
from the group consisting of SEQ ID NO:3, SEQ ID NO:7, 
SEQ ID NO.:9, SEQ ID NO.12, SEQ ID NO.:15, SEQ ID 
NO:17, SEQ ID NO.19, SEQ ID NO.:22,SEQ ID NO.:24, 
SEQ ID NO.:26, SEQ ID NO.:31, SEQ ID NO:33, SEQ ID 
NO.:35, SEQ ID NO.:40, SEQ ID NO.:42, SEQ ID NO:44, 
SEQ ID NO:47, and SEQ ID NO:65; and a nucleic acid 
molecule comprising an allelic variant of a nucleic acid 
molecule encoding a protein having any of Said amino acid 
Sequences. 
0012. The present invention also provides an isolated 
MSH1 protein. In some embodiment, the protein is encoded 
by a plant MSH1 nucleic acid molecule that hybridizes to the 
complement of a nucleic acid molecule having a nucleic acid 
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sequence SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, 
SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID 
NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, 
SEQ ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID 
NO:28, SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, 
SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID 
NO:41, SEQ ID NO:43, or SEQ ID NO:45 under stringent 
hybridization conditions. In Some embodiments, the protein 
is SEQ ID NO:3, SEQ ID NO:7, SEQ ID NO.:9, SEQ ID 
NO.:12, SEQ ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19, 
SEQ ID NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID 
NO.:31,SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40, 
SEQ ID NO.:42, SEQ ID NO:44, SEQ ID NO:47 or SEQ ID 
NO:65, or a protein comprising at least a portion of an amino 
acid Sequence Selected from the group consisting of SEQ ID 
NO:3, SEQID NO:7, SEQ ID NO.:9, SEQID NO.12, SEQ 
ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19, SEQ ID 
NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID NO.:31, 
SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40, SEQ ID 
NO.:42, SEQ ID NO:44, SEQ ID NO.47 and SEQ ID 
NO:65. 
0013 The present invention also provides a method to 
identify a compound capable of inhibiting MSH1 activity of 
a plant, Said method comprising: contacting an isolated plant 
MSH1 nucleic acid molecule selected from the group con 
sisting of SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, 
SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID 
NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, 
SEO ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID 
NO:28, SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, 
SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID 
NO:41, SEQ ID NO:43, and SEQ ID NO:45 with a putative 
inhibitory compound which, in the absence of Said com 
pound, said plant MSH1 nucleic acid molecule has the 
activity of Suppressing ectopic recombination; and deter 
mining if Said putative inhibitory compound inhibits Said 
activity. In Some embodiments, the putative inhibitory com 
pound is a RNA molecule suspected of having RNAi activ 
ity. The invention also provides compounds identified by the 
method 
0014 Further provided is a method for identification of 
plant mutants arising from mitochondrial ectopic recombi 
nation comprising providing a plant, Suppressing expression 
of an MSH1-homologous gene in the plant, and detecting an 
aberrant phenotype, 
0015 whereby a plant mutant is identified. In some 
embodiments, the Suppression is effected by a com 
pound identified by the above-described method. In 
Some embodiments, the aberrant phenotype is cyto 
plasmic male Sterility. The invention also provides 
plant mutants identified by the method of claim 12. 
BRIEF DESCRIPTION OF THE FIGURES 
0016 FIG. 1. Positional cloning of the CHM candidate 
locus. The use of molecular markers permitted the estab 
lishment of a genetic map (A) and identification of the 
intervening overlapping bacterial artificial chromosome 
clones for physical mapping (B) All physical mapping 
information was derived from the Arabidopsis Genome 
Initiative (50). High resolution mapping with three markers 
permitted delimitation of the locus to a 80-kb interval 
contained within a single bacterial artificial chromosome 
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clone (C) A gene candidate was identified within the interval 
based on predicted mitochondrial targeting features. The 
candidate CHM locus contains 22 exons (D) with two 
MutS-like conserved intervals denoted by red lines. Analysis 
of two EMS-derived mutants, chm1-1 and chm1-2, and one 
tissue culture-derived mutant chm1-3, as well as two TDNA 
insertion mutations (T1 and T2), provided definitive evi 
dence of CHM identity (E). The numbers in parentheses in 
(A) correspond to the number of recombinants identified 
between the marker and the gene. 
0017 FIG. 2. Alignment of AtMSH1 with MutS and 
MutS homologs. The amino acid Sequence alignment was 
performed using the ClustalW Software and includes the 
MutS sequence from E. coli, MSH1 from Saccharomyces 
cerevisiae, and AtMSH6 and CHM (AtMSH1) from Arabi 
dopsis. (A) Alignment of the region of the DNA-binding 
domain that encompasses the conserved motif for mismatch 
recognition and DNA binding. (B) Alignment of a portion of 
the ATPase domain. The characteristic motifs for this 
domain are indicated by red lines. M1-Walker motif, 
M2-ST motif, M3–DE motif (Walker B motif); M4–TH 
motif (Obmolova, et al. (2000) Nature 407,703-710; Lam 
ers, et al. (2000) Nature, 407, 711-717). The asterisks (*) 
indicate residues that are identical and the arrow indicates 
the Site of amino acid Substitution in mutant chur1-3. 
0018 FIG. 3. Alignment of MSH proteings. 
DETAILED DESCRIPTION OF THE 
INVENTION 
0019. The present invention provides a plant nuclear gene 
and corresponding gene product, in Arabidopsis thaliana 
that influences mitochondrial genome organization. The 
gene is designated AtMSH1, and it is believed to SuppreSS 
ectopic (illegitimate) recombination of the mitochondrial 
genome. The present invention provides for isolated MSH1 
proteins, isolated MSH1 nucleic acid molecules, antibodies 
directed against MSH1 proteins and other inhibitors of 
MSH1 activity. As used herein, the terms isolated MSH1 
proteins and isolated MSH1 nucleic acid molecules refers to 
MSH1 proteins and esterase nucleic acid molecules derived 
from plants and, as Such, can be obtained from their natural 
Source or can be produced using, for example, recombinant 
nucleic acid technology or chemical Synthesis. The term 
“plant” refers to an individual living plant or population of 
Same, a species, Subspecies, variety, cultivar or Strain. In 
Some preferred embodiments, the domesticated organism is 
a plant Selected from the group consisting of maize, wheat, 
rice, Sorghum, tomato or potato, or any other domesticated 
plant of commercial interest. A "plant' is any plant at any 
Stage of development, including a Seed plant. Also included 
in the present invention is the use of these proteins, nucleic 
acid molecules, antibodies and inhibitors to generate trans 
genic plants, and mutant plants, as well as in other applica 
tions, Such as those disclosed below. 
0020. The present invention is the result of studies inves 
tigating the unusual plant phenomenon of mitochondrial 
Subtoichiometric shifting and the role of the nuclear gene 
CHM. This gene, located on chromosome III, was shown to 
encode a protein that is targeted to mitochondria and that has 
homology to a yeast mitochondrial MutS protein. A Sum 
mary of this investigation is provided in the EXAMPLES 
Section. 
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0021 MSH1 proteins and nucleic acid molecules of the 
present invention have utility because they represent novel 
targets for modulation which would effect mitochondrial 
ectopic recombination. The products and processes of the 
present invention are advantageous because they enable the 
express and inhibition of processes that involve MSH1. 
While not being bound by theory, it is believed these newly 
discovered proteins have contributed adaptive advantage by 
a strategy that may be unique to the Plant Kingdom. 
0022 A. MSH1 Polypeptides 
0023. One embodiment of the present invention is an 
isolated plant MSH1 polypeptide. As used herein, an MSH1 
polypeptide, in one embodiment, is a polypeptide that is 
related to (i.e., bears structural Similarity to) the A. thaliana 
polypeptide of about 1118 amino acids and having the 
sequence depicted in FIG. 3 (SEQ ID NO:3). The original 
identification of Such a polypeptide is detailed in the 
Examples. 
0024. A preferred MSH1 polypeptide is encoded by a 
polynucleotide that hybridizes under Stringent hybridization 
conditions to a gene encoding an MSH1 polypeptide (i.e., an 
A. thaliana gene). It is to be noted that the term “a” or “an” 
entity refers to one or more of that entity; for example, a 
gene refers to one or more genes or at least one gene. AS 
such, the terms “a” (or “an”), “one or more” and “at least 
one' can be used interchangeably herein. It is also to be 
noted that the terms “comprising,”“including,” and “having 
can be used interchangeably. 
0025 AS used herein, stringent hybridization conditions 
refer to standard hybridization conditions under which poly 
nucleotides, including oligonucleotides, are used to identify 
molecules having similar nucleic acid Sequences. Such stan 
dard conditions are disclosed, for example, in Sambrook et 
al., MOLECULAR CLONING: A LABORATORY 
MANUAL, Cold Spring Harbor Labs Press, 1989. Examples 
of Such conditions are provided in the Examples Section of 
the present application. 
0026. As used herein, an A. thaliana AtMSH1 gene 
includes all nucleic acid Sequences related to a natural A. 
thaliana AtMSH1 gene Such as regulatory regions that 
control production of the A. thaliana AtMSH1 polypeptide 
encoded by that gene (such as, but not limited to, transcrip 
tion, translation or post-translation control regions) as well 
as the coding region itself. In one embodiment, an A. 
thaliana AtMSH1 gene includes the nucleic acid Sequence 
SEQ ID NO:1. Nucleic acid sequence SEQ ID NO:X 
represents the deduced sequence of a cDNA (complemen 
tary DNA) polynucleotide, the production of which is dis 
closed in the Examples. It should be noted that Since nucleic 
acid Sequencing technology is not entirely error-free, SEQ 
ID NO:1 (as well as other sequences presented herein), at 
best, represents an apparent nucleic acid Sequence of the 
polynucleotide encoding an A. thaliana AtMSH1 polypep 
tide of the present invention. 
0027. In another embodiment, an A. thaliana AtMSH1 
gene can be an allelic variant that includes a similar but not 
identical sequence to SEQ ID NO:1. During higher plant 
evolution, natural allelic variation for the MSH1 locus likely 
revealed the adaptive advantage that arises from Sporadic 
copy number modulation of mitochondrial genomic Vari 
ants. Some of these variants, when amplified, condition male 
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Sterility that could facilitate advantageous outcrossing activ 
ity in natural populations (Arrieta-Montiel, et al., ibid.). An 
allelic variant of an A. thaliana AtMSH1 gene including 
SEQ ID NO: 1 is a locus (or loci) in the genome whose 
activity is concerned with the same biochemical or devel 
opmental processes, and/or a gene that that occurs at essen 
tially the same locus as the gene including SEQ ID NO:1, 
but which, due to natural variations caused by, for example, 
mutation or recombination, has a similar but not identical 
Sequence. Because genomes can undergo rearrangement, the 
physical arrangement of alleles is not always the same. 
Allelic variants typically encode polypeptides having Simi 
lar activity to that of the polypeptide encoded by the gene to 
which they are being compared. Allelic variants can also 
comprise alterations in the 5' or 3' untranslated regions of the 
gene (e.g., in regulatory control regions). Allelic variants are 
well known to those skilled in the art and would be expected 
to be found within a given cultivar or Strain Since the 
genome is diploid and/or among a population comprising 
two or more cultivars or Strains. 
0028. According to the present invention, an isolated, or 
biologically pure, polypeptide, is a polypeptide that has been 
removed from its natural milieu. AS Such, "isolated” and 
“biologically pure” do not necessarily reflect the extent to 
which the polypeptide has been purified. An isolated MSH1 
polypeptide of the present invention can be obtained from its 
natural Source, can be produced using recombinant DNA 
technology or can be produced by chemical Synthesis. An 
MSH1 polypeptide of the present invention may be identi 
fied by its ability to perform the function of natural MSH1 
in a functional assay. By “natural MSH1 polypeptide,” it is 
meant the full length MSH1 polypeptide of A. thaliana. The 
phrase “capable of performing the function of a natural 
MSH1 in a functional assay” means that the polypeptide has 
at least about 10% of the activity of the natural polypeptide 
in the functional assay. In other embodiments, the MSH1 
polypeptide has at least about 20% of the activity of the 
natural polypeptide in the functional assay. In other embodi 
ments, the MSH1 polypeptide has at least about 30% of the 
activity of the natural polypeptide in the functional assay. In 
other embodiments, the MSH1 polypeptide has at least 
about 40% of the activity of the natural polypeptide in the 
functional assay. In other embodiments, the MSH1 polypep 
tide has at least about 50% of the activity of the natural 
polypeptide in the functional assay. In other embodiments, 
the polypeptide has at least about 60% of the activity of the 
natural polypeptide in the functional assay. In other embodi 
ments, the polypeptide has at least about 70% of the activity 
of the natural polypeptide in the functional assay. In other 
embodiments, the polypeptide has at least about 80% of the 
activity of the natural polypeptide in the functional assay. In 
Still other embodiments, the polypeptide has at least about 
90% of the activity of the natural polypeptide in the func 
tional assay. Examples of functional assays are detailed 
elsewhere in this specification. 
0029. As used herein, an isolated plant MSH1 polypep 
tide can be a full-length polypeptide or any homologue of 
Such a polypeptide. Examples of MSH1 homologues include 
MSH1 polypeptides in which amino acids have been deleted 
(e.g., a truncated version of the polypeptide, Such as a 
peptide), inserted, inverted, Substituted and/or derivatized (e.g., by glycosylation, phosphorylation, acetylation, myri 
Stylation, prenylation, palmitoylation, amidation and/or 
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addition of glycerophosphatidyl inositol) Such that the 
homolog has natural MSH1 activity. 
0030. In one embodiment, when the homologue is admin 
istered to an animal as an immunogen, using techniques 
known to those skilled in the art, the animal will produce a 
humoral and/or cellular immune response against at least 
one epitope of a natural MSH1 polypeptide. MSH1 homo 
logues can also be Selected by their ability to perform the 
function of MSH1 in a functional assay. 
0031 Plant MSH1 polypeptide homologues can be the 
result of natural allelic variation or natural mutation. MSH1 
polypeptide homologues of the present invention can also be 
produced using techniques known in the art including, but 
not limited to, direct modifications to the polypeptide or 
modifications to the gene encoding the polypeptide using, 
for example, classic or recombinant DNA techniques to 
effect random or targeted mutagenesis. 
0032. In accordance with the present invention, a mime 
tope refers to any compound that is able to mimic the ability 
of an isolated plant MSH1 polypeptide of the present 
invention to perform the function of an MSH1 polypeptide 
of the present invention in a functional assay. Examples of 
mimetopes include, but are not limited to, anti-idiotypic 
antibodies or fragments thereof, that include at least one 
binding Site that mimics one or more epitopes of an isolated 
polypeptide of the present invention; non-polypeptideaceous 
immunogenic portions of an isolated polypeptide (e.g., 
carbohydrate structures); and synthetic or natural organic 
molecules, including nucleic acids, that have a structure 
Similar to at least one epitope of an isolated polypeptide of 
the present invention. Such mimetopes can be designed 
using computer-generated Structures of polypeptides of the 
present invention. Mimetopes can also be obtained by gen 
erating random Samples of molecules, Such as oligonucle 
otides, peptides or other organic molecules, and Screening 
Such Samples by affinity chromatography techniques using 
the corresponding binding partner. 
0033. The minimal size of an MSH1 polypeptide homo 
logue of the present invention is a size Sufficient to be 
encoded by a polynucleotide capable of forming a stable 
hybrid with the complementary Sequence of a polynucle 
otide encoding the corresponding natural polypeptide. AS 
Such, the size of the polynucleotide encoding Such a 
polypeptide homologue is dependent on nucleic acid com 
position and percent homology between the polynucleotide 
and complementary Sequence as well as upon hybridization 
conditions per Se (e.g., temperature, Salt concentration, and 
formamide concentration). It should also be noted that the 
extent of homology required to form a stable hybrid can vary 
depending on whether the homologous Sequences are inter 
spersed throughout the polynucleotides or are clustered (i.e., 
localized) in distinct regions on the polynucleotides. The 
minimal Size of Such polynucleotides is typically at least 
about 12 to about 15 nucleotides in length if the polynucle 
otides are GC-rich and at least about 15 to about 17 bases in 
length if they are AT-rich. Preferably, the polynucleotide is 
at least 12 bases in length. 
0034. As such, the minimal size of a polynucleotide used 
to encode an MSH1 polypeptide homologue of the present 
invention is from about 12 to about 18 nucleotides in length. 
There is no limit, other than a practical limit, on the maximal 
Size of Such a polynucleotide in that the polynucleotide can 
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include a portion of a gene, an entire gene, or multiple genes, 
or portions thereof. Similarly, the minimal size of an MSH1 
polypeptide homologue of the present invention is from 
about 4 to about 6 amino acids in length, with preferred sizes 
depending on whether a full-length, fusion, multivalent, or 
functional portions of Such polypeptides are desired. Pref 
erably, the polypeptide is at least 30 bases in length. 
0035) Any plant MSH1 polypeptide is a suitable polypep 
tide of the present invention. Suitable plants from which to 
isolate MSH1 polypeptides (including isolation of the natu 
ral polypeptide or production of the polypeptide by recom 
binant or synthetic techniques) include maize, wheat, barley, 
rye, millet, chickpea, lentil, flax, olive, fig almond, pistachio, 
walnut, beet, parSnip, citrus fruits, including, but not limited 
to, Orange, lemon, lime, grapefruit, tangerine, minneola, and 
tangelo, Sweet potato, bean, pea, chicory, lettuce, cabbage, 
cauliflower, broccoli, turnip, radish, Spinach, asparagus, 
onion, garlic, pepper, celery, Squash, pumpkin, hemp, Zuc 
chini, apple, pear, quince, melon, plum, cherry, peach, 
nectarine, apricot, Strawberry, grape, raspberry, blackberry, 
pineapple, avocado, papaya, mango, banana, Soybean, 
tomato, Sorghum, Sugarcane, Sugarbeet, Sunflower, rapeseed, 
clover, tobacco, carrot, cotton, alfalfa, rice, potato, eggplant, 
cucumber, Arabidopsis, and Woody plants Such as conifer 
ous and deciduous trees, with Soybean, tomato, potato, rice, 
wheat, and barley being preferred. 
0036) A preferred plant MSH1 polypeptide of the present 
invention is a compound that when expressed or modulated 
in a plant, is capable of Suppressing ectopic recombination 
of the mitochondrial genome. 
0037. One embodiment of the present invention is a 
fusion polypeptide that includes an MSH1 polypeptide 
containing domain attached to a fusion Segment. Inclusion 
of a fusion segment as part of a MSH1 polypeptide of the 
present invention can enhance the polypeptide's Stability 
during production, Storage and/or use. Depending on the 
Segment's characteristics, a fusion Segment can also act as 
an immunopotentiator to enhance the immune response 
mounted by an animal immunized with an MSH1 polypep 
tide containing Such a fusion Segment. Furthermore, a fusion 
Segment can function as a tool to Simplify purification of an 
MSH1 polypeptide, such as to enable purification of the 
resultant fusion polypeptide using affinity chromatography. 
A Suitable fusion Segment can be a domain of any size that 
has the desired function (e.g., imparts increased Stability, 
imparts increased immunogenicity to a polypeptide, and/or 
Simplifies purification of a polypeptide). It is within the 
Scope of the present invention to use one or more fusion 
Segments. Fusion Segments can be joined to amino and/or 
carboxyl termini of the MSH1-containing domain of the 
polypeptide. Linkages between fusion Segments and MSH1 
containing domains of fusion polypeptides can be Suscep 
tible to cleavage in order to enable Straightforward recovery 
of the MSH1-containing domains of such polypeptides. 
Fusion polypeptides are preferably produced by culturing a 
recombinant cell transformed with a fusion polynucleotide 
that encodes a polypeptide including the fusion Segment 
attached to either the carboxyl and/or amino terminal end of 
a MSH1-containing domain. 
0.038 Exemplary fusion segments for use in the present 
invention include a glutathione binding domain; a metal 
binding domain, Such as a poly-histidine Segment capable of 
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binding to a divalent metalion; an immunoglobulin binding 
domain, such as Polypeptide A, Polypeptide G, T cell, B cell, 
Fc receptor or complement polypeptide antibody-binding 
domains, a Sugar binding domain Such as a maltose binding 
domain from a maltose binding polypeptide; and/or a “tag” 
domain (e.g., at least a portion off-galactosidase, a Strep tag 
peptide, other domains that can be purified using compounds 
that bind to the domain, Such as monoclonal antibodies). 
Other fusion Segments Suitable for use in the invention 
include metal binding domains, Such as a poly-histidine 
Segment; a maltose binding domain; a Strep tag peptide. 
0039) Preferred plant MSH1 polypeptides of the present 
invention are Arabadopsis MSH1 polypeptides, soybean 
MSH1 polypeptides, tomato MSH1 polypeptides, rice 
MSH1 polypeptides, and common bean MSH1 polypep 
tides. Other preferred plant MSH polypeptides include corn 
MSH1 polypeptides, wheat MSH1 polypeptides, Sugar cane 
MSH1 polypeptides, medicago MSH1 polypeptides, onion 
MSH1 polypeptides, orange MSH1 polypeptides, Zinnia 
MSH1 polypeptides, tobacco MSH1 polypeptides, and bar 
leyMSH1 polypeptides. 
0040. One preferred A. thaliana AtMSH1 polypeptide of 
the present invention is a polypeptide encoded by an A. 
thaliana polynucleotide that hybridizes under Stringent 
hybridization conditions with complements of polynucle 
otides represented by SEQ ID NO:1. Such an AtMSH1 
polypeptide is encoded by a polynucleotide that hybridizes 
under Stringent hybridization conditions with a polynucle 
otide having nucleic acid sequence SEQ ID NO:1. 
0041. Inspection of AtMSH1 genomic nucleic acid 
Sequences indicates that the genes comprise Several regions, 
including an ATP-binding domain, comprised of four well 
conserved motifs designated M1-M4 (Obimolova, et al., 
ibid.; FIG. 2B), and a DNA binding domain (aa 129-206) 
containing the aromatic doublet (FY) motif. 
0042 Translation of SEQ ID NO:1 suggests that the A. 
thaliana AtMSH1 polynucleotide includes an open reading 
frame. The reading frame encodes an A. thaliana AtMSH1 
polypeptide of about 1118 amino acids, the deduced amino 
acid sequence of which is represented herein as SEQ ID 
NO:3, assuming an open reading frame having an initiation 
(start) codon Spanning from about nucleotide 124 through 
about nucleotide 126 of SEQ ID NO:1 and a termination 
(stop) codon Spanning from about nucleotide 3478 through 
about nucleotide 3480 of SEO ID NO:1. 
0043. Similarly, translation of SEQ ID NO:20 suggests 
that the Oryza sativa MSH1 polynucleotide includes an open 
reading frame. The reading frame encodes an Oryza Sativa 
MSH polypeptide of about 1132 amino acids, the deduced 
amino acid Sequence of which is represented herein as SEQ 
ID NO:22, assuming an open reading frame having an 
initiation (start) codon Spanning from about nucleotide 1 
through about nucleotide 3 of SEQ ID NO:22 and a termi 
nation (Stop) codon Spanning from about nucleotide 3394 
through about nucleotide 3396 of SEQ ID NO:20. 
0044 Similarly, translation of SEQ ID NO:29 suggests 
that the Glycine max MSH1 polynucleotide includes an open 
reading frame. The reading frame encodes an Glycine max 
MSH polypeptide of about 1130 amino acids, the deduced 
amino acid Sequence of which is represented herein as SEQ 
ID NO:31, assuming an open reading frame having an 
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initiation (start) codon Spanning from about nucleotide 1 
through about nucleotide 3 of SEQ ID NO:29 and a termi 
nation (stop) codon Spanning from about nucleotide 3391 
through about nucleotide 3393 of SEQ ID NO:20. 
0045 Similarly, translation of SEQ ID NO:38 suggests 
that the Lycopersicon esculentum MSH1 polynucleotide 
includes an open reading frame. The reading frame encodes 
an Lycopersicon esculentum MSH polypeptide of about 
1124 amino acids, the deduced amino acid Sequence of 
which is represented herein as SEQ ID NO:40, assuming an 
open reading frame having an initiation (start) codon Span 
ning from about nucleotide 1 through about nucleotide 3 of 
SEQ ID NO:38 and a termination (stop) codon spanning 
from about nucleotide 3369 through about nucleotide 3371 
of SEO ID NO:20. 
0046) Similarly, translation of SEQ ID NO:45 suggests 
that the Phaseolus vulgaris MSH1 polynucleotide includes 
an open reading frame. The reading frame encodes an 
Phaseolus vulgaris MSH polypeptide of about 1126 amino 
acids, the deduced amino acid Sequence of which is repre 
sented herein as SEQ ID NO:47, assuming an open reading 
frame having an initiation (start) codon Spanning from about 
nucleotide 1 through about nucleotide 3 of SEQ ID NO:45 
and a termination (stop) codon spanning from about nucle 
otide 3379 through about nucleotide 3381 of SEQ ID 
NO:2O. 
0047. Additional EST sequences having at least 60% 
sequence identity to a portion of SEQ ID NO.1 or a 
complement of SEQ ID NO:1 have been found. These 
include MSH1 polynucleotides from corn (SEQ ID NO:11), 
potato (SEQ ID NO:18), wheat (SEQ ID NO:41), sugar cane 
(SEQ ID NO:32 and SEQ ID NO:34), medicago (SEQ ID 
NO:13), onion (SEQ ID NO:14), orange (SEQ ID NO:16), 
zinnia (SEQ ID NO:43), tobacco (SEQ ID NO:36), and 
barley (SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10). 
Polypeptides encoded by the foregoing nucleic acid mol 
ecules can be deduced using methods well known in the art. 
In general, the polynucleotide or its complement is aligned 
with the Arabidopsis AtMSH1 polynucleotide, a reading 
frame is determined, and the resulting polypeptide Sequence 
is translasted. Polypeptides encoded by the foregoing 
nucleic acid molecules or their complements include corn 
(SEQ ID NO:12), potato (SEQ ID NO:19), wheat (SEQ ID 
NO:42), sugar cane (SEQ ID NO:33 and SEQ ID NO:35), 
onion (SEQ ID NO:15), orange (SEQ ID NO:17), Zinnia 
(SEQ ID NO:44), and barley (SEQ ID NO:7, SEQ ID 
NO:9), and consensus (SEQ ID NO:65). 
0.048 Comparison of the various A. thaliana, soybean, 
corn, tomato, potato, rice, wheat, common bean, Sugar cane, 
medicago, onion, orange, Zinnia, tobacco, and barley MSH1 
nucleic acid Sequences and amino acid Sequences described 
herein indicates that these species of plants possess similar 
MSH1 genes and polypeptides. The nucleotide Sequences of 
the coding region of MSH1 from the various plants have 
>60% sequence identity when compared to each other, 
which makes clear that they are homologous. 
0049 Finding this degree of identity between soybean, 
corn, tomato, potato, rice, wheat, common bean, Sugar cane, 
medicago, onion, orange, Zinnia, tobacco, and barley MSH1 
nucleic acid Sequences and amino acid Sequences Supports 
the ability to obtain any plant MSH1 polypeptide and 
polynucleotide given the polypeptide and nucleic acid 
Sequences disclosed herein. 
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0050. These plant MSH1 polypeptides, and the poly 
nucleotides that encode them, represent novel compounds 
with utility in ectopic recombination of the mitochondrial 
genome. 
0051) Preferred plant MSH1 polypeptides of the present 
invention include polypeptides comprising amino acid 
Sequences that are at least about 30%, preferably at least 
about 50%, more preferably at least about 75% and even 
more preferably at least about 90% identical to one or more 
of the amino acid Sequences disclosed herein for A. thaliana 
AtMSH1 polypeptides of the present invention. More pre 
ferred plant MSH1 polypeptides of the present invention 
include: polypeptides encoded by at least a portion of SEQ 
ID NO.1, SEQ ID NO.:20, SEQ ID NO.:29, SEQ ID 
NO.:38 and/or SEO ID NO:45 and, as Such, have amino acid 
sequences that include at least a portion of SEQ ID NO:3, 
SEQ ID NO.:22, SEQ ID NO.:31, SEQ ID NO.:40 and/or 
SEQ ID NO:47; polypeptides encoded by at least a portion 
of SEQ ID NO:1, SEQ ID NO.:20, SEQ ID NO.:29, SEQ ID 
NO.:38 and/or SEO ID NO:45 and, as Such, have amino acid 
sequences that include at least a portion of SEQ ID NO:3, 
SEQ ID NO.:22, SEQ ID NO.:31, SEQ ID NO.:40 and/or 
SEQ ID NO:47. Also preferred are polypeptides that have 
amino acid Sequences that include at least a portion of SEQ 
ID NO:7, SEQ ID NO.:9, SEQ ID NO.12, SEQ ID NO.:15, 
SEQ ID NO:17, SEQ ID NO.:19, SEQ ID NO.:24, SEQ ID 
NO.:26, SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:42, 
and/or SEQID NO:44; and polypeptides encoded by at least 
a portion of SEQ ID NO:6, SEQ ID NO.:8, SEQ ID NO.:10, 
SEQ ID NO.:11, SEQ ID NO:13, SEQ ID NO.:14, SEQ ID 
NO.:16, SEQ ID NO.:18, SEQ ID NO:23, SEQ ID NO.:25, 
SEQ ID NO.:26, SEQ ID NO.:27, SEQ ID NO.:28, SEQ ID 
NO.:30, SEQ ID NO:32, SEQ ID NO.:34, SEQ ID NO.:36, 
SEQ ID NO.:37, SEQ ID NO.:41, and/or SEQ ID NO:43, or 
a complement of any of the foregoing SEQID NO:s. As used 
herein, “at least a portion' of a polynucleotide or polypep 
tide means a portion having the minimal size characteristics 
of Such Sequences, as described above, or any larger frag 
ment of the full length molecule, up to and including the full 
length molecule. For example, a portion of a polynucleotide 
may be 12 nucleotides, 13 nucleotides, 14 nucleotides, 15 
nucleotides, and So on, going up to the full length poly 
nucleotide. Similarly, a portion of a polypeptide may be 4 
amino acids, 5 amino acids, 6 amino acids, 7 amino acids, 
and So on, going up to the full length polypeptide. The length 
of the portion to be used will depend on the particular 
application. AS discussed above, a portion of a polynucle 
otide useful as hybridization probe may be as short as 12 
nucleotides. A portion of a polypeptide useful as an epitope 
may be as short as 4 amino acids. A portion of a polypeptide 
that performs the function of the full-length polypeptide 
would generally be longer than 4 amino acids. 
0.052 Particularly preferred plant MSH1 polypeptides of 
the present invention are polypeptides that include SEQ ID 
NO:3, SEQID NO:7, SEQ ID NO.:9, SEQID NO.12, SEQ 
ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19, SEQ ID 
NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID NO.:31, 
SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40, SEQ ID 
NO.:42, SEQ ID NO:44, SEQ ID NO:47 and/or SEQ ID 
NO:65 (including, but not limited to the encoded polypep 
tides, full-length polypeptides, processed polypeptides, 
fusion polypeptides and multivalent polypeptides thereof) as 
well as polypeptides that are truncated homologues of 
polypeptides that include at least portions of the aforemen 
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tioned SEQ ID NOS. Examples of methods to produce such 
polypeptides are disclosed herein, including in the Examples 
Section. 
0053 Plant MSH1 polypeptides may have DNA binding 
and ATPase activities. Identification of the chm1-3 mutation 
as a cysteine-tyrosine substitution within the predicted ATP 
binding domain does Suggest the importance of this region 
to protein function. Substitution of the bulkier tyrosine 
would likely create distortion in the region, affecting ATP 
binding or hydrolysis. 
0.054 Mismatch repair components appear to be involved 
in not only the binding and excision of nucleotide mis 
matches during the replication process, but also Suppression 
of ectopic recombination (Harfe & Jinks-Robertson (2000) 
Annu. Rev. Genet. 34, 359-399; Chen & Jinks-Robertson 
(1999) Genetics 151,1299-1313). Investigation of the mito 
chondrial SubStoichometric shifting phenomenon Suggests 
two alternative models for the influence of MSH1. It is 
conceivable that the MSH1 gene has shared or relinquished 
its mismatch repair function, Such that its primary role in the 
plant mitochondrial genome is to regulate non-homologous 
recombination. Disruption of MSH1 could, thus, result in 
the enhancement of intra-molecular ectopic recombination 
activity detected as apparent amplification of novel mito 
chondrial DNA forms. A possible weakness in this model 
arises in reports that Several plant Systems with mitochon 
drial DNA molecules susceptible to shifting appear to be 
derived from a DNA exchange that involved at least one 
molecular form no longer present in high copy number. 
Some also appeared to contain unique Sequences. Therefore, 
the shifted molecules were thought to replicate autono 
mously (Andre, et al., ibid; Kanazawa, et al., ibid.; , Janska 
& Mackenzie (1993) Genetics 135,869-879). 
0055) If mitochondrial DNA molecules that undergo 
shifting are, in fact, replicated autonomously, an alternative 
model for molecule-Specific SubStoichiometric shifting 
might apply. The Arabidopsis MSH1 product likely partici 
pates as a component of the DNA replication apparatus. 
Mitochondrial DNA molecules Subject to copy number 
shifting may have originated by earlier ectopic recombina 
tion events during the evolution of the lineage. In this case, 
the resulting chimeric Sites might Serve to trigger a proceSS 
of site-specific replication stalling by the MSH1 protein 
during vegetative growth. 
0056 Both models assume that the replicative form of the 
mitochondrial genome within meristematic (undifferenti 
ated) tissues differs from that of vegetative (Somatic). 
Hence, Stoichiometric shifting events in vegetative tissues 
do not condition irreversible loSS of the Suppressed genetic 
information. Presumably, the complete mitochondrial 
genetic complement is retained within the transmitting (mer 
istematic) tissues (Arrieta-Montiel, et al., Janska & Mack 
enzie, ibid.). 
0057 B. MSH1 Polynucleotides 
0.058. One embodiment of the present invention is an 
isolated plant polynucleotide that hybridizes under Stringent 
hybridization conditions with an A. thaliana AtMSH1 gene. 
The identifying characteristics of Such genes are heretofore 
described. A polynucleotide of the present invention can 
include an isolated natural plant MSH1 gene or a homologue 
thereof, the latter of which is described in more detail below. 
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A polynucleotide of the present invention can include one or 
more regulatory regions, full-length or partial coding 
regions, or combinations thereof. The minimal size of a 
polynucleotide of the present invention is the minimal size 
that can form a stable hybrid with one of the aforementioned 
genes under Stringent hybridization conditions. Suitable and 
preferred plants are disclosed above. 
0059. In accordance with the present invention, an iso 
lated polynucleotide is a polynucleotide that has been 
removed from its natural milieu (i.e., that has been Subject 
to human manipulation). AS Such, "isolated” does not reflect 
the extent to which the polynucleotide has been purified. An 
isolated polynucleotide can include DNA, RNA, or deriva 
tives of either DNA or RNA. 
0060 An isolated plant MSH1 polynucleotide of the 
present invention can be obtained from its natural Source 
either as an entire (i.e., complete) gene or a portion thereof 
capable of forming a stable hybrid with that gene. An 
isolated plant MSH1 polynucleotide can also be produced 
using recombinant DNA technology (e.g., polymerase chain 
reaction (PCR) amplification, cloning) or chemical Synthe 
sis. Isolated plant MSH1 polynucleotides include natural 
polynucleotides and homologues thereof, including, but not 
limited to, natural allelic variants and modified polynucle 
otides in which nucleotides have been inserted, deleted, 
Substituted, and/or inverted in Such a manner that Such 
modifications do not substantially interfere with the poly 
nucleotide's ability to encode an MSH1 polypeptide of the 
present invention or to form stable hybrids under Stringent 
conditions with natural gene isolates. 
0061 A plant MSH1 polynucleotide homologue can be 
produced using a number of methods known to those skilled 
in the art (See, for example, Sambrook et al., ibid.). For 
example, polynucleotides can be modified using a variety of 
techniques including, but not limited to, classic mutagenesis 
techniques and recombinant DNA techniques, Such as Site 
directed mutagenesis, chemical treatment of a polynucle 
otide to induce mutations, restriction enzyme cleavage of a 
nucleic acid fragment, ligation of nucleic acid fragments, 
polymerase chain reaction (PCR) amplification and/or 
mutagenesis of Selected regions of a nucleic acid Sequence, 
Synthesis of oligonucleotide mixtures and ligation of mix 
ture groups to “build” a mixture of polynucleotides and 
combinations thereof. Polynucleotide homologues can be 
Selected from a mixture of modified nucleic acids by Screen 
ing for the function of the polypeptide encoded by the 
nucleic acid (e.g., ability to elicit an immune response 
against at least one epitope of an MSH1 polypeptide, ability 
to Suppress ectopic recombination in a transgenic plant 
containing an MSH1 gene and/or by hybridization with an A. 
thaliana AtMSH1 gene. 
0062) An isolated polynucleotide of the present invention 
can include a nucleic acid Sequence that encodes at least one 
plant MSH1 polypeptide of the present invention, examples 
of Such polypeptides being disclosed herein. Although the 
phrase “polynucleotide’ primarily refers to the physical 
polynucleotide and the phrase “nucleic acid Sequence' pri 
marily refers to the Sequence of nucleotides on the poly 
nucleotide, the two phrases can be used interchangeably, 
especially with respect to a polynucleotide, or a nucleic acid 
Sequence, being capable of encoding an MSH1 polypeptide. 
As heretofore disclosed, plant MSH1 polypeptides of the 
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present invention include, but are not limited to, polypep 
tides having full-length plant MSH1 coding regions, 
polypeptides having partial plant MSH1 coding regions, 
fusion polypeptides, multivalent protective polypeptides and 
combinations thereof. 
0.063 At least certain polynucleotides of the present 
invention encode polypeptides that Selectively bind to 
immune Serum derived from an animal that has been immu 
nized with an MSH1 polypeptide from which the polynucle 
otide was isolated. 
0064. A preferred polynucleotide of the present inven 
tion, when Suppressed in a Suitable plant, is capable of 
generating economically useful mutant plants. AS will be 
disclosed in more detail below, Such a polynucleotide can be, 
or encode, an antisense RNA, a molecule capable of triple 
helix formation, a ribozyme, or other nucleic acid-based 
compound. 
0065 One embodiment of the present invention is a plant 
MSH1 polynucleotide that hybridizes under stringent 
hybridization conditions to an MSH1 polynucleotide of the 
present invention, or to a homologue of such an MSH1 
polynucleotide, or to the complement of Such a polynucle 
otide. A polynucleotide complement of any nucleic acid 
Sequence of the present invention refers to the nucleic acid 
Sequence of the polynucleotide that is complementary to 
(i.e., can form a complete double helix with) the Strand for 
which the Sequence is cited. It is to be noted that a double 
Stranded nucleic acid molecule of the present invention for 
which a nucleic acid Sequence has been determined for one 
strand, that is represented by a SEQ ID NO, also comprises 
a complementary Strand having a Sequence that is a comple 
ment of that SEQ ID NO. As such, polynucleotides of the 
present invention, which can be either double-Stranded or 
Single-Stranded, include those polynucleotides that form 
stable hybrids under stringent hybridization conditions with 
either a given SEQ ID NO denoted herein and/or with the 
complement of that SEQ ID NO, which may or may not be 
denoted herein. Methods to deduce a complementary 
Sequences are known to those skilled in the art. Preferred is 
an MSH1 polynucleotide that includes a nucleic acid 
Sequence having at least about 60 percent, at least about 65 
percent, preferably at least about 70 percent, more prefer 
ably at least about 75 percent, more preferably at least about 
80 percent, more preferably at least about 85 percent, more 
preferably at least about 90 percent and even more prefer 
ably at least about 95 percent homology with the corre 
sponding region(s) of the nucleic acid sequence encoding at 
least a portion of an MSH1 polypeptide. Particularly pre 
ferred is an MSH1 polynucleotide capable of encoding at 
least a portion of an MSH1 polypeptide that naturally is 
present in plants. 
0.066 Particularly preferred MSH1 polynucleotides of 
the present invention hybridize under Stringent hybridization 
conditions with at least one of the following polynucle 
otides: SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ 
ID NO:10, SEQID NO:11, SEQID NO:13, SEQID NO:14, 
SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, SEQ ID 
NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:28, 
SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, SEQ ID 
NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:41, 
SEQ ID NO:43, and/or SEQ ID NO:45, or to a homologue 
or complement of Such polynucleotide. 
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0067. A preferred polynucleotide of the present invention 
includes at least a portion of nucleic acid Sequence SEQ ID 
NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ ID NO:10, SEQ 
ID NO:11, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, 
SEQ ID NO:18, SEQ ID NO:21, SEQ ID NO:23, SEQ ID 
NO:25, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, 
SEQ ID. NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID 
NO:37, SEQ ID NO:38, SEQ ID NO:41, SEQ ID NO:43, 
and/or SEQ ID NO:45 that is capable of hybridizing (i.e., 
that hybridizes under Stringent hybridization conditions) to 
an A. thaliana AtMSH1 gene of the present invention, as 
well as a polynucleotide that is an allelic variant of any of 
those polynucleotides. Such preferred polynucleotides can 
include nucleotides in addition to those included in the SEQ 
ID NOS, Such as, but not limited to, a full-length gene, a 
full-length coding region, a polynucleotide encoding a 
fusion polypeptide, and/or a polynucleotide encoding a 
multivalent protective compound. 
0068 The present invention also includes polynucle 
otides encoding a polypeptide including at least a portion of 
SEQ ID NO:3, polynucleotides encoding a polypeptide 
having at least a portion of SEQ ID NO:7, polynucleotides 
encoding a polypeptide having at least a portion of SEQ ID 
NO:9, polynucleotides encoding a polypeptide having at 
least a portion of SEQ ID NO:12, polynucleotides encoding 
a polypeptide having at least a portion of SEQ ID NO:15, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:17, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:19, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:22, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:24, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:26, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:31, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:33, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:35, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:40, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:42, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:42, polynucleotides encoding a 
polypeptide having at least a portion of SEQ ID NO:44, 
polynucleotides encoding a polypeptide having at least a 
portion of SEQ ID NO:47, and/or polynucleotides encoding 
a polypeptide having at least a portion of SEQ ID NO:65, 
including polynucleotides that have been modified to 
accommodate codon usage properties of the cells in which 
Such polynucleotides are to be expressed. 
0069. Knowing the nucleic acid sequences of certain 
plant MSH1 polynucleotides of the present invention allows 
one skilled in the art to, for example, (a) make copies of 
those polynucleotides, (b) obtain polynucleotides including 
at least a portion of Such polynucleotides (e.g., polynucle 
otides including full-length genes, full-length coding 
regions, regulatory control Sequences, truncated coding 
regions), and (c) obtain MSH1 polynucleotides for other 
plants. Such polynucleotides can be obtained in a variety of 
ways including Screening appropriate expression libraries 
with antibodies of the present invention; traditional cloning 
techniques using oligonucleotide probes of the present 
invention to screen appropriate libraries or DNA; and PCR 
amplification of appropriate libraries or DNA using oligo 
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nucleotide primers of the present invention. Preferred librar 
ies to Screen or from which to amplify polynucleotides 
include libraries such as genomic DNA libraries, BAC 
libraries, YAC libraries, cDNA libraries prepared from iso 
lated plant tissues, including, but not limited to, Stems, 
reproductive Structures/tissues, leaves, roots, and tillers, and 
libraries constructed from pooled cDNAs from any or all of 
the tissues listed above. In the case of rice, BAC libraries, 
available from Clemson University, are preferred. Similarly, 
preferred DNA sources to screen or from which to amplify 
polynucleotides include plant genomic DNA. Techniques to 
clone and amplify genes are disclosed, for example, in 
Sambrook et al., ibid. and in Galun & Breiman, TRANS 
GENIC PLANTS, Imperial College Press, 1997. 
0070 The present invention also includes polynucle 
otides that are oligonucleotides capable of hybridizing, 
under Stringent hybridization conditions, with complemen 
tary regions of other, preferably longer, polynucleotides of 
the present invention Such as those comprising plant MSH1 
genes or other plant MSH1 polynucleotides. Oligonucle 
otides of the present invention can be RNA, DNA, or 
derivatives of either. The minimal Size of Such oligonucle 
otides is the size required to form a stable hybrid between a 
given oligonucleotide and the complementary Sequence on 
another polynucleotide of the present invention. Minimal 
Size characteristics are disclosed herein. The size of the 
oligonucleotide must also be Sufficient for the use of the 
oligonucleotide in accordance with the present invention. 
Oligonucleotides of the present invention can be used in a 
variety of applications including, but not limited to, as 
probes to identify additional polynucleotides, as primers to 
amplify or extend polynucleotides, as targets for expression 
analysis, as candidates for targeted mutagenesis and/or 
recovery, or in agricultural applications to alter MSH1 
polypeptide production or activity. Such agricultural appli 
cations include the use of Such oligonucleotides in, for 
example, antisense-, triplex formation-, ribozyme- and/or 
RNA drug-based technologies. The present invention, there 
fore, includes Such oligonucleotides and methods in a plant 
by use of one or more of Such technologies. 
0071. The predicted features of the candidate CHM 
encoded protein denoted MSH1 Suggest that the gene 
encodes the mitochondrial MSH1 counterpart in higher 
plants. MSH1 encodes a mitochondrial mismatch repair 
protein in yeast, though its counterpart in animals has not yet 
been identified. The CHM candidate sequence showed 
strongest homology with the Arabidopsis nuclear MSH6 
Sequence (FIG. 2), consistent with Suggestions that nuclear 
mismatch repair components likely derived from a progeni 
tor to MSH1 (Culligan, et al. (2000) Nucl. Acids Res. 28, 
463-471). 
0.072 Although the predicted CHM candidate protein 
displayed Several features Suggesting its involvement in 
mismatch repair, lines containing mutations in the locus 
showed no evidence of mitochondrial point mutation accu 
mulation. The primary effect within the mitochondrion 
appeared to be the reproducible SubStoichiometric shifting 
phenomenon. This assumption is based on the observation of 
identical mitochondrial DNA restriction fragments arising 
upon SubStoichiometric shifting in all chm mutants when 
tested repeatedly (Sakamoto, et al., ibid., Martinez-Zapater, 
et al., ibid., this report). Moreover, no evidence of progres 
Sive decline in plant growth features has been observed over 
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time. The chm1-1 and chm1-2 mutants, reported in the 
1970's (Redei, ibid.), appear identical to one another in 
phenotype and mitochondrial DNA configuration. Although 
detailed Sequence analysis would be required to estimate the 
incidence of mismatch accumulation in the chm mutants, 
one would anticipate a random pattern of mitochondrial 
DNA polymorphism and progressive phenotypic decline in 
chm mutants were the mismatch accumulation rate 
enhanced. 
0073 Mutation of the MSH1 locus in yeast results in 
rapid accumulation of mitochondrial genomic rearrange 
ments leading to disruption of mitochondrial function. Inter 
estingly, a reproducible pattern of DNA restriction fragment 
polymorphism was reported in Some of the petit mutants 
arising in yeast MSH1 mutant strains (Reenan & Kolodner). 
This observation may be indication that mshl-associated 
mitochondrial genomic rearrangements are Similar in plants 
and fungi. Alignment between the yeast MSH1 protein and 
the Arabidopsis CHM (MSH1) candidate shows only 17% 
amino acid identity overall, with ca. 28% identity within the 
predicted functional domains for ATP and DNA binding, but 
with well conserved motifs (FIG. 2). The yeast MSH1 
protein has been shown to have both DNA mismatch binding 
and ATPase activity (Chi & Kolodner (1994) J Biol. Chem. 
269,29984-29992; Chi & Kolodner. (1994) J. Biol. Chem. 
269,29993–29997). 
0074 C. Recombinant Molecules 
0075. The present invention also includes a recombinant 
vector, which includes at least one plant MSH1 polynucle 
otide of the present invention, inserted into any vector 
capable of delivering the polynucleotide into a host cell. 
Such a vector contains heterologous nucleic acid Sequences, 
that is nucleic acid Sequences that are not naturally found 
adjacent to polynucleotides of the present invention and that 
preferably are derived from a Species other than the Species 
from which the polynucleotide(s) are derived. AS used 
herein, a derived polynucleotide is one that is identical or 
Similar in Sequence to a polynucleotide or portion of a 
polynucleotide, but can contain modifications, Such as modi 
fied bases, backbone modifications, nucleotide changes, and 
the like. The vector can be either RNA or DNA, either 
prokaryotic or eukaryotic, and typically is a virus or a 
plasmid. Recombinant vectors can be used in the cloning, 
Sequencing, and/or otherwise manipulating of plant MSH1 
polynucleotides of the present invention. One type of recom 
binant vector, referred to herein as a recombinant molecule 
and described in more detail below, can be used in the 
expression of polynucleotides of the present invention. 
Preferred recombinant vectors are capable of replicating in 
the transformed cell. 
0076 Suitable and preferred polynucleotides to include 
in recombinant vectors of the present invention are as 
disclosed herein for suitable and preferred plant MSH1 
polynucleotides per se. Particularly preferred polynucle 
otides to include in recombinant vectors, and particularly in 
recombinant molecules, of the present invention include 
SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ ID 
NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:14, 
SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, SEQ ID 
NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:28, 
SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, SEQ ID 
NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:41, 
SEQ ID NO:43, and/or SEQ ID NO:45. 
US 2004/0210962 A1 
0077. Isolated plant MSH1 polypeptides of the present 
invention can be produced in a variety of ways, including 
production and recovery of natural polypeptides, production 
and recovery of recombinant polypeptides, and chemical 
Synthesis of the polypeptides. In one embodiment, an iso 
lated polypeptide of the present invention is produced by 
culturing a cell capable of expressing the polypeptide under 
conditions effective to produce the polypeptide, and recov 
ering the polypeptide. A preferred cell to culture is a 
recombinant cell that is capable of expressing the polypep 
tide, the recombinant cell being produced by transforming a 
host cell with one or more polynucleotides of the present 
invention. Transformation of a polynucleotide into a cell can 
be accomplished by any method by which a polynucleotide 
can be inserted into the cell. Transformation techniques 
include, but are not limited to, transfection, electroporation, 
microinjection, lipofection, adsorption, and protoplast 
fusion. A recombinant cell may remain unicellular or may 
grow into a tissue, organ or a multicellular organism. Trans 
formed polynucleotides of the present invention can remain 
extrachromosomal or can integrate into one or more Sites 
within a chromosome of the transformed (i.e., recombinant) 
cell in Such a manner that their ability to be expressed is 
retained. Suitable and preferred polynucleotides with which 
to transform a cell are as disclosed herein for Suitable and 
preferred plant MSH1 polynucleotides per se. Particularly 
preferred polynucleotides to include in recombinant cells of 
the present invention include SEQ ID NO:1, SEQ ID NO:6, 
SEQ ID. NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ ID 
NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, 
SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID 
NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID. NO:32, 
SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:37, SEQ ID 
NO:38, SEQ ID NO:41, SEQ ID NO:43, and/or SEQ ID 
NO:45. 
0078 Suitable host cells to transform include any cell 
that can be transformed with a polynucleotide of the present 
invention. Host cells can be either untransformed cells or 
cells that are already transformed with at least one poly 
nucleotide. Host cells of the present invention either can be 
endogenously (i.e., naturally) capable of producing plant 
MSH1 polypeptides of the present invention or can be 
capable of producing Such polypeptides after being trans 
formed with at least one polynucleotide of the present 
invention. Host cells of the present invention can be any cell 
capable of producing at least one polypeptide of the present 
invention, and include bacterial, fungal (including yeast and 
rice blast, Magnaporthe grisea), parasite (including nema 
todes, especially of the genera Xiphinema, Helicotylenchus, 
and Tylenchlohynchus), insect, other animal and plant cells. 
0079 Suitable host viruses to transform include any virus 
that can be transformed with a polynucleotide of the present 
invention, including, but not limited to, rice Stripe virus, and 
echinochloa hoja blanca Virus. 
0080. In a preferred embodiment, non-pathogenic sym 
biotic bacteria, which are able to live and replicate within 
plant tissues, So-called endophytes, or non-pathogenic Sym 
biotic bacteria, which are capable of colonizing the phyllo 
Sphere or the rhizosphere, So-called epiphytes, are used. 
Such bacteria include bacteria of the genera Agrobacterium, 
Alcaligenes, Azospirillum, Azotobacter, Bacillus, Clavi 
bacter, Enterobacter, Erwinia, Flavobacter, Klebsiella, 
Pseudomonas, Rhizobium, Serratia, Streptomyces and Xan 
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thomonas. Symbiotic fungi, such as Trichoderma and Glio 
cladium are also possible hosts for expression of the inven 
tive nucleotide Sequences for the same purpose. 
0081. A recombinant cell is preferably produced by trans 
forming a host cell with one or more recombinant molecules, 
each comprising one or more polynucleotides of the present 
invention operatively linked to an expression vector con 
taining one or more transcription control Sequences. The 
phrase “operatively linked” refers to insertion of a poly 
nucleotide into an expression vector in a manner Such that 
the molecule is able to be expressed in the correct reading 
frame when transformed into a host cell. AS used herein, an 
expression vector is a DNA or RNA vector that is capable of 
transforming a host cell and of effecting expression of a 
Specified polynucleotide. Preferably, the expression vector is 
also capable of replicating within the host cell. Expression 
vectors can be either prokaryotic or eukaryotic, and are 
typically viruses or plasmids. Expression vectors of the 
present invention include any vectors that function (i.e., 
direct gene expression) in recombinant cells of the present 
invention, including in bacterial, fungal, parasite, insect, 
other animal, and plant cells. Preferred expression vectors of 
the present invention can direct gene expression in bacterial, 
yeast, fungal, insect and mammalian cells and more prefer 
ably in the cell types heretofore disclosed. 
0082 Recombinant molecules of the present invention 
may also (a) contain Secretory signals (i.e., signal Segment 
nucleic acid sequences) to enable an expressed MSH1 
polypeptide of the present invention to be secreted from the 
cell that produces the polypeptide and/or (b) contain fusion 
Sequences which lead to the expression of polynucleotides 
of the present invention as fusion polypeptides. Examples of 
Suitable signal Segments and fusion Segments encoded by 
fusion Segment nucleic acids are disclosed herein. Eukary 
otic recombinant molecules may include intervening and/or 
untranslated Sequences Surrounding and/or within the 
nucleic acid Sequences of polynucleotides of the present 
invention. Suitable Signal Segments include natural Signal 
Segments or any heterologous signal Segment capable of 
directing the Secretion of a polypeptide of the present 
invention. Preferred Signal and fusion Sequences employed 
to enhance organ and organelle Specific expression include, 
but are not limited to, arcelin-5, See Goossens, A. et. al. The 
arcelin-5 Gene of Phaseolus vulgaris directs high seed 
Specific expression in transgenic Phaseolus acutifolius and 
Arabidopsis plants. Plant Physiology (1999) 120:1095 
1104, phaseolin, See Sengupta-Gopalan, C. et. al. Develop 
mentally regulated expression of the bean beta-phaseolin 
gene in tobacco seeds. PNAS (1985) 82:3320-3324, hydrox 
yproline-rich glycoprotein, Serpin, See Yan, X. et. al. Gene 
fusions of Signal Sequences with a modified beta-glucu 
ronidase gene results in retention of the beta-glucuronidase 
protein in the Secretory pathway/plasma membrane. Plant 
Physiology (1997) 115:915-924, N-acetyl glucosaminyl 
transferase 1, see Essi, D. et. al. The N-terminal 77 amino 
acids from tobacco N-acetylglucosaminyltransferase I are 
Sufficient to retain reporter protein in the Golgi apparatus of 
Nicotiana benthamiana cells. Febs Letters (1999) 453(1- 
2): 169-73, albumin, see Vandekerckhove, J. et al. Enkepha 
lins produced in transgenic plants using modified 2S. Seed 
storage proteins. BioTechnology 7:929-932 (1989) and PR1, 
see Pen, J. et al. Efficient production of active industrial 
enzymes in plants. Industrial Crops and Prod. (1993) 1:241 
250, and other Sequences as described in the Examples. 
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0.083 Polynucleotides of the present invention can be 
operatively linked to expression vectors containing regula 
tory Sequences Such as transcription control Sequences, 
translation control Sequences, origins of replication, and 
other regulatory Sequences that are compatible with the 
recombinant cell and that control the expression of poly 
nucleotides of the present invention. In particular, recombi 
nant molecules of the present invention include transcription 
control Sequences. Transcription control Sequences are 
Sequences which control the initiation, elongation, and ter 
mination of transcription. Included are those transcription 
control Sequences which are Sufficient to render promoter 
dependent gene expression controllable for cell-type spe 
cific, tissue-specific or inducible by external signals or 
agents, Such elements may be located in the 5' or 3' regions 
of the native gene. Particularly important transcription con 
trol Sequences are those which control transcription initia 
tion, Such as promoter, enhancer, operator and repressor 
Sequences. Suitable transcription control Sequences include 
any transcription control Sequence that can function in at 
least one of the recombinant cells of the present invention. 
A variety of Such transcription control Sequences are known 
to those skilled in the art. Preferred transcription control 
Sequences include those which function in bacterial, yeast, 
fungal, insect and mammalian cells, Such as, but not limited 
to, tac, lac, trp, trc, oxy-pro, Omp/lpp, rrnB, bacteriophage 
lambda () (Such as up and up and fusions that include 
Such promoters), bacteriophage T7, T7lac, bacteriophage 
T3, bacteriophage SP6, bacteriophage SPO1, metallothion 
ein, C.-mating factor, Pichia alcohol oxidase, alphavirus 
Subgenomic promoters (such as Sindbis virus Subgenomic 
promoters), antibiotic resistance gene, baculovirus, Helio 
this zea insect virus, Vaccinia virus, herpesvirus, poxvirus, 
adenovirus, cytomegalovirus (such as intermediate early 
promoters, Simian virus 40, retrovirus, actin, retroviral long 
terminal repeat, Rous Sarcoma virus, heat shock, phosphate 
and nitrate transcription control Sequences as well as other 
Sequences capable of controlling gene expression in 
prokaryotic or eukaryotic cells. 
0084 Particularly preferred transcription control 
Sequences are plant transcription control Sequences. The 
choice of transcription control Sequence will vary depending 
on the temporal and Spatial requirements for expression, and 
also depending on the target Species. Thus, expression of the 
nucleotide Sequences of this invention in any plant organ 
(leaves, roots, Seedlings, immature or mature reproductive 
Structures, etc.) or at any stage of plant development is 
preferred. Although many transcription control Sequences 
from dicotyledons have been shown to be operational in 
monocotyledons and Vice versa, ideally dicotyledonous tran 
Scription control Sequences are Selected for expression in 
dicotyledons, and monocotyledonous promoters for expres 
Sion in monocotyledons. However, there is no restriction to 
the provenance of Selected transcription control Sequences, 
it is Sufficient that they are operational in driving the 
expression of the nucleotide Sequences in the desired cell. 
0085 Preferred transcription control sequences that are 
expressed constitutively include but are not limited to pro 
moters from genes encoding actin or ubiquitin and the 
CaMV 35S and 19S promoters. The nucleotide sequences of 
this invention can also be expressed under the regulation of 
promoters that are chemically regulated. This enables the 
MSH1 polypeptide to be synthesized only when the crop 
plants are treated with the inducing chemicals. 
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0086 A preferred category of promoters is that which is 
induced by the physiological State of the plant (i.e. wound 
inducible, water-StreSS inducible, Salt-stress inducible, dis 
ease inducible, and the like). Numerous promoters have 
been described which are expressed at wound Sites and also 
at the Sites of phytopathogen infection. Ideally, Such a 
promoter should only be active locally at the sites of 
infection, and in this way the MSH1 polypeptides only 
accumulate in cells in which the accumulation is desired. 
Preferred promoters of this kind include those described by 
Stanford et al. Mol. Gen. Genet. 215: 200-208 (1989), Xu et 
al. Plant Molec. Biol. 22:573-588 (1993), Logemann et al. 
Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant 
Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec. 
Biol. 22: 129-142 (1993), and Warner et al. Plant J. 3: 
191-201 (1993). 
0087 Preferred tissue-specific expression patterns 
include but are not limited to green tissue Specific, root 
Specific, Stem specific, and flower Specific. Promoters Suit 
able for expression in green tissue include many which 
regulate genes involved in photosynthesis and many of these 
have been cloned from both monocotyledons and dicotyle 
dons. A preferred promoter is the maize PEPC promoter 
from the phosphoenol carboxylase gene (Hudspeth & Grula, 
Plant Molec. Biol. 12: 579-589 (1989)). A preferred pro 
moter for root Specific expression is that described by de 
Framond (FEBS 290: 103-106 (1991); EP 0 452 269 to 
Ciba-Geigy). A preferred Stem specific promoter is that 
described in U.S. Pat. No. 5,625,136 (to Ciba-Geigy) and 
which drives expression of the maize trpA gene. 
0088 A recombinant molecule of the present invention is 
a molecule that can include at least one of any polynucle 
otide heretofore described operatively linked to at least one 
of any transcription control Sequence capable of effectively 
regulating expression of the polynucleotide(s) in the cell to 
be transformed, examples of which are disclosed herein. 
0089. A recombinant cell of the present invention 
includes any cell transformed with at least one of any 
polynucleotide of the present invention. Suitable and pre 
ferred polynucleotides as well as Suitable and preferred 
recombinant molecules with which to transfer cells are 
disclosed herein. 
0090 Recombinant cells of the present invention can also 
be co-transformed with one or more recombinant molecules 
including plant MSH1 polynucleotides encoding one or 
more polypeptides of the present invention and one or more 
other polypeptides useful when expressed in plants. 
0091. It may be appreciated by one skilled in the art that 
use of recombinant DNA technologies can improve expres 
Sion of transformed polynucleotides by manipulating, for 
example, the number of copies of the polynucleotides within 
a host cell, the efficiency with which those polynucleotides 
are transcribed, the efficiency With which the resultant 
transcripts are translated, and the efficiency of post-transla 
tional modifications. Recombinant techniques useful for 
increasing the expression of polynucleotides of the present 
invention include, but are not limited to, operatively linking 
polynucleotides to high-copy number plasmids, integration 
of the polynucleotides into one or more host cell chromo 
Somes, addition of Vector Stability Sequences to plasmids, 
Substitutions or modifications of transcription control Sig 
nals (e.g., promoters, operators, enhancers), Substitutions or 
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modifications of translational control signals (e.g., ribosome 
binding sites, Shine-Dalgarno Sequences), modification of 
polynucleotides of the present invention to correspond to the 
codon usage of the host cell, deletion of Sequences that 
destabilize transcripts, and use of control Signals that tem 
porally Separate recombinant cell growth from recombinant 
enzyme production during fermentation. The activity of an 
expressed recombinant polypeptide of the present invention 
may be improved by fragmenting, modifying, or derivatiz 
ing polynucleotides encoding Such a polypeptide. 
0092 Recombinant cells of the present invention can be 
used to produce one or more polypeptides of the present 
invention by culturing Such cells under conditions effective 
to produce Such a polypeptide, and recovering the polypep 
tide. Effective conditions to produce a polypeptide include, 
but are not limited to, appropriate media, bioreactor, tem 
perature, pH and oxygen conditions that permit polypeptide 
production. An appropriate, or effective, medium refers to 
any medium in which a cell of the present invention, when 
cultured, is capable of producing an MSH1 polypeptide of 
the present invention. Such a medium is typically an aque 
ous medium comprising assimilable carbon, nitrogen and 
phosphate Sources, as well as appropriate Salts, minerals, 
metals and other nutrients, Such as Vitamins. The medium 
may comprise complex nutrients or may be a defined 
minimal medium. Cells of the present invention can be 
cultured in conventional fermentation bioreactors, which 
include, but are not limited to, batch, fed-batch, cell recycle, 
and continuous fermentors. Culturing can also be conducted 
in Shake flasks, test tubes, microtiter dishes, and petri plates. 
Culturing is carried out at a temperature, pH and oxygen 
content appropriate for the recombinant cell. Such culturing 
conditions are well within the expertise of one of ordinary 
skill in the art. 
0093. Depending on the vector and host system used for 
production, resultant polypeptides of the present invention 
may either remain within the recombinant cell; be Secreted 
into the fermentation medium; be Secreted into a Space 
between two cellular membranes, Such as the periplasmic 
Space in E. coli, or be retained on the outer Surface of a cell 
or viral membrane. 
0094. The phrase “recovering the polypeptide” refers 
Simply to collecting the whole fermentation medium con 
taining the polypeptide and need not imply additional Steps 
of Separation or purification. Polypeptides of the present 
invention can be purified using a variety of Standard 
polypeptide purification techniques, Such as, but not limited 
to, affinity chromatography, ion exchange chromatography, 
filtration, electrophoresis, hydrophobic interaction chroma 
tography, gel filtration chromatography, reverse phase chro 
matography, concanavalin A chromatography, chromatofo 
cusing and differential solubilization. Polypeptides of the 
present invention are preferably retrieved in “substantially 
pure” form. As used herein, “substantially pure” refers to a 
purity that allows for the effective use of the polypeptide as 
a diagnostic or test compound, and means, with increasing 
preference, at least 50%, 60%, 70%, 80%, 90%, 95%, or 
98% homogeneous. 
0.095 D. Transfected Plant Cells and Transgenic Plants 
0096] With regard to MSH1, particularly preferred 
recombinant cells are plant cells. By "plant cell' is meant 
any Self-propagating cell bounded by a Semi-permeable 
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membrane and containing a plastid. Such a cell also requires 
a cell wall if further propagation is desired. Plant cell, as 
used herein includes, without limitation, algae, cyanobacte 
ria, Seeds, Suspension cultures, embryos, meristematic 
regions, callus tissue, leaves, roots, Shoots, gametophytes, 
Sporophytes, pollen, and microSpores. 
0097. The particular arrangement of the MSH1 sequence 
in the transformation vector will be Selected according to the 
type of expression of the Sequence that is desired. In Some 
embodiments, expressing MSH1 polypeptides is desirable, 
while in others, a reduction of activity is desirable. The 
former embodiment is discussed first. 
0098. In one embodiment, at least one of the MSH1 
polypeptides or an allele thereof, of the invention is 
expressed in a higher organism, e.g., a plant. A nucleotide 
Sequence of the present invention is inserted into an expres 
Sion cassette, which is then preferably Stably integrated in 
the genome of Said plant. In another preferred embodiment, 
the nucleotide Sequence is included in a non-pathogenic 
Self-replicating virus. Plants transformed in accordance with 
the present invention may be monocots or dicots and 
include, but are not limited to, maize, wheat, barley, rye, 
millet, chickpea, lentil, flax, olive, fig almond, pistachio, 
walnut, beet, parSnip, citrus fruits, including, but not limited 
to, Orange, lemon, lime, grapefruit, tangerine, minneola, and 
tangelo, Sweet potato, bean, pea, chicory, lettuce, cabbage, 
cauliflower, broccoli, turnip, radish, Spinach, asparagus, 
Onion, garlic, pepper, celery, Squash, pumpkin, hemp, Zuc 
chini, apple, pear, quince, melon, plum, cherry, peach, 
nectarine, apricot, Strawberry, grape, raspberry, blackberry, 
pineapple, avocado, papaya, mango, banana, Soybean, 
tomato, Sorghum, Sugarcane, Sugarbeet, Sunflower, rapeseed, 
clover, tobacco, carrot, cotton, alfalfa, rice, potato, eggplant, 
cucumber, Arabidopsis, and Woody plants Such as conifer 
ous and deciduous trees. 
0099. Once a desired nucleotide sequence has been trans 
formed into a particular plant Species, it may be propagated 
in that Species or moved into other varieties of the same 
Species, particularly including commercial varieties, using 
traditional breeding techniques. 
0100. Accordingly, the present invention provides a 
method for producing a transfected plant cell or transgenic 
plant comprising the steps of a) transfecting a plant cell to 
contain a heterologous DNA segment encoding a protein and 
derived from an MSH1 polynucleotide not native to said cell 
(the polynucleotide indeed could be native but the expres 
Sion pattern could be developmentally altered, Still leading 
to the preferred effect); wherein said polynucleotide is 
operably linked to a promoter that can be used effectively for 
expression of transgenic proteins; b) optionally growing and 
maintaining Said cell under conditions whereby a transgenic 
plant is regenerated therefrom; c) optionally growing said 
transgenic plant under conditions whereby Said DNA is 
expressed, whereby the total amount of MSH1 polypeptide 
in Said plant is altered. In a preferred embodiment, the 
method further comprises the Step of obtaining and growing 
additional generations of descendants of Said transgenic 
plant which comprise Said heterologous DNA segment 
wherein Said heterologous DNA segment is expressed. AS 
used herein, "heterologous DNA, or, in Some cases, “trans 
gene' refers to foreign genes or polynucleotides, or addi 
tional, or modified versions of native or endogenous genes 
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or polynucleotides (perhaps driven by different promoters) 
in order to alter the traits of a plant in a Specific manner. 
0101 The invention also provides plant cells which com 
prise heterologous DNA encoding an MSH1 polypeptide. In 
a preferred embodiment, the transgenic plant cell is a 
propagation material of a transgenic plant. The present 
invention also provides a transfected host cell comprising a 
host cell transfected with a construct comprising a promoter, 
enhancer or intron polynucleotide from an MSH1 polynucle 
otide, and a polynucleotide encoding a reporter protein. 
0102) The present invention also provides a method of 
preparing a transgenic plant comprising: a) producing a 
transfected plant cell having a transgene encoding an MSH1 
polypeptide whereby MSH1 expression in said plant cell is 
altered; and b) growing a transgenic plant from the trans 
fected plant cell wherein the MSH1 transgene is expressed 
in the transgenic plant. The expression of the transgene 
includes an increase or decrease in MSH1 expression. In 
Some embodiments, the expression of the transgene pro 
duces an RNA that may interfere with a native MSH1 gene 
Such that the expression of the native gene is either elimi 
nated or reduced, resulting in a useful outcome. 
0103) The invention also provides a transgenic plant 
containing heterologous DNA which encodes an MSH1 
polypeptide that is expressed in plant tissue, including 
expression in a vector introduced into the plant. 
0104. The present invention also provides an isolated 
polynucleotide which includes a transcription control ele 
ment operably linked to a polynucleotide that encodes the 
MSH1 gene in plant tissue. In preferred embodiment, the 
transcription control element is the promoter native to an 
MSH1 gene. 
0105. In some embodiments, a nucleotide sequence of 
this invention is expressed in transgenic plants, thus causing 
the biosynthesis of the corresponding MSH1 polypeptide in 
the transgenic plants. In this way, transgenic plants with 
characteristics related to MSH1 expression are generated. 
For their expression in transgenic plants, the nucleotide 
Sequences of the invention may require modification and 
optimization. Although preferred gene Sequences may be 
adequately expressed in both monocotyledonous and dicoty 
ledonous plant species, Sequences can be modified to 
account for the Specific codon preferences and GC content 
preferences of monocotyledons or dicotyledons as these 
preferences have been shown to differ (Murray et al. Nucl. 
Acids Res. 17.477-498 (1989)). All changes required to be 
made within the nucleotide Sequences Such as those 
described above are made using well known techniques of 
Site directed mutagenesis, PCR, and Synthetic gene construc 
tion using the methods described in the published patent 
applications EP 0385962 (to Monsanto), EP 0359 472 (to 
Lubrizol), and WO 93/07278 (to Ciba-Geigy). 
0106 For efficient initiation of translation, sequences 
adjacent to the initiating methionine may require modifica 
tion. For example, they can be modified by the inclusion of 
Sequences known to be effective in plants. Joshi has Sug 
gested an appropriate consensus for plants (NAR 15: 6643 
6653 (1987)) and Clontech suggests a further consensus 
translation initiator (1993/1994 catalog, page 210). These 
consensuses are Suitable for use with the nucleotide 
Sequences of this invention. The Sequences are incorporated 
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into constructions comprising the nucleotide Sequences, up 
to and including the ATG (while leaving the Second amino 
acid unmodified), or alternatively up to and including the 
GTC Subsequent to the ATG (with the possibility of modi 
fying the Second amino acid of the transgene). 
0107 Expression of the nucleotide sequences in trans 
genic plants is driven by transcription control elements 
shown to be functional in plants. Transformation of plants 
with a polynucleotide under the control of these regulatory 
elements provides for controlled expression in the trans 
formed plant. Such transcription control elements have been 
described above. In addition to the selection of a Suitable 
initiator of transcription, constructions for expression of 
MSH1 polypeptide in plants require an appropriate tran 
Scription terminator to be attached downstream of the het 
erologous nucleotide Sequence. Several Such terminators are 
available and known in the art (e.g. timl from CaMV, E9 from 
rbcS). Any available terminator known to function in plants 
can be used in the context of this invention. 
0108) Numerous other sequences can be incorporated 
into expression cassettes described in this invention. These 
include Sequences which have been shown to enhance 
expression Such as intron Sequences (e.g. from Adhl and 
bronze 1) and viral leader sequences (e.g. from TMV, 
MCMV and AMV). 
0109) It may be preferable to target expression of the 
nucleotide Sequences of the present invention to different 
cellular localizations in the plant. In Some cases, localization 
in the cytosol may be desirable, whereas in other cases, 
localization in Some Subcellular organelle may be preferred. 
Subcellular localization of heterologous DNA encoded 
polypeptides is undertaken using techniques well known in 
the art. Typically, the DNA encoding the target peptide from 
a known organelle-targeted gene product is manipulated and 
fused upstream of the nucleotide Sequence. Many Such target 
Sequences are known for the chloroplast and their function 
ing in heterologous constructions has been shown. The 
expression of the nucleotide Sequences of the present inven 
tion is also targeted to the endoplasmic reticulum or to the 
vacuoles of the host cells. Techniques to achieve this are 
well-known in the art. 
0110 Vectors suitable for plant transformation are 
described elsewhere in this specification. For Agrobacte 
rium-mediated transformation, binary vectors or vectors 
carrying at least one T-DNA border Sequence are Suitable, 
whereas for direct gene transfer any vector is Suitable and 
linear DNA containing only the construction of interest may 
be preferred. In the case of direct gene transfer, transforma 
tion with a single DNA species or co-transformation can be 
used (Schocher et al. Biotechnology 4: 1093-1096 (1986)). 
For both direct gene transfer and Agrobacterium-mediated 
transfer, transformation is usually (but not necessarily) 
undertaken with a Selectable marker which may provide 
resistance to an antibiotic (kanamycin, hygromycin or meth 
otrexate) or a herbicide (basta). The choice of selectable 
marker is not, however, critical to the invention. 
0111. In another preferred embodiment, a nucleotide 
Sequence of the present invention is directly transformed 
into the plastid genome. A major advantage of plastid 
transformation is that plastids are capable of expressing 
multiple open reading frames under control of a Single 
promoter. Plastid transformation technology is extensively 
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described in U.S. Pat. Nos. 5,451,513, 5,545,817, and 5,545, 
818, in PCT application no. WO95/16783, and in McBride 
et al. (1994) Proc. Natl. Acad. Sci. USA91, 7301-7305. The 
basic technique for chloroplast transformation involves 
introducing regions of cloned plastid DNA flanking a Select 
able marker together with the gene of interest into a Suitable 
target tissue, e.g., using biolistics or protoplast transforma 
tion (e.g., calcium chloride or PEG mediated transforma 
tion). The 1 to 1.5 kb flanking regions, termed targeting 
Sequences, facilitate homologous recombination with the 
plastid genome and thus allow the replacement or modifi 
cation of Specific regions of the plastome. Initially, point 
mutations in the chloroplast 16S rRNA and rps12 genes 
conferring resistance to spectinomycin and/or Streptomycin 
are utilized as Selectable markers for transformation (Svab, 
Z., Hajdukiewicz, P, and Maliga, P. (1990) Proc. Natl. Acad. 
Sci. USA 87,8526-8530; Staub, J. M., and Maliga, P. (1992) 
Plant Cell 4, 39-45). This resulted in stable homoplasmic 
transformants at a frequency of approximately one per 100 
bombardments of target leaves. The presence of cloning 
Sites between these markers allowed creation of a plastid 
targeting vector for introduction of foreign genes (Staub, J. 
M., and Maliga, P. (1993) EMBO J. 12, 601-606). Substan 
tial increases in transformation frequency are obtained by 
replacement of the recessive rRNA or r-polypeptide antibi 
otic resistance genes with a dominant Selectable marker, the 
bacterial aadA gene encoding the Spectinomycin-detoxify 
ing enzyme aminoglycoside-3'-adenyltransferase (Svab, Z., 
and Maliga, P. (1993) Proc. Natl. Acad. Sci. USA 90, 
913–917). Previously, this marker had been used success 
fully for high-frequency transformation of the plastid 
genome of the green alga Chlamydomonas reinhardtii 
(Goldschmidt-Clermont, M. (1991) Nucl. Acids Res. 19: 
4083-4089). Other selectable markers useful for plastid 
transformation are known in the art and encompassed within 
the Scope of the invention. Typically, approximately 15-20 
cell division cycles following transformation are required to 
reach a homoplastidic State. Plastid expression, in which 
genes are inserted by homologous recombination into all of 
the Several thousand copies of the circular plastid genome 
present in each plant cell, takes advantage of the enormous 
copy number advantage over nuclear-expressed genes to 
permit expression levels that can readily exceed 10% of the 
total Soluble plant polypeptide. In a preferred embodiment, 
a nucleotide Sequence of the present invention is inserted 
into a plastid targeting vector and transformed into the 
plastid genome of a desired plant host. Plants homoplastic 
for plastid genomes containing a nucleotide Sequence of the 
present invention are obtained, and are preferentially 
capable of high expression of the nucleotide Sequence. 
0112 In Some embodiments, a reduction or Suppression 
of MSH1 polypeptide activity is desired. In some embodi 
ments, a reduction of MSH1 polypeptide activity may be 
obtained by introducing into plants an antisense construct 
based on an MSH1 cDNA or gene sequence. For antisense 
Suppression, an MSH1 cDNA or gene is arranged in reverse 
orientation relative to the promoter Sequence in the trans 
formation vector. The introduced Sequence need not be a full 
length MSH1 cDNA or gene, and need not be exactly 
homologous to the native MSH1 cDNA or gene found in the 
plant type to be transformed. Generally, however, where the 
introduced Sequence is of shorter length, a higher degree of 
homology to the native MSH1 sequence will be needed for 
effective antisense Suppression. The introduced antisense 
Oct. 21, 2004 
Sequence in the vector generally will be at least 30 nucle 
otides in length, and improved antisense Suppression will 
typically be observed as the length of the antisense Sequence 
increases. Preferably, the length of the antisense Sequence in 
the vector will be greater than 100 nucleotides. Transcription 
of an antisense construct as described results in the produc 
tion of RNA molecules that are the reverse complement of 
mRNA molecules transcribed from the endogenous MSH1 
gene in the plant cell. Although the exact mechanism by 
which antisense RNA molecules interfere with gene expres 
Sion has not been elucidated, it is believed that antisense 
RNA molecules bind to the endogenous mRNA molecules 
and thereby inhibit translation of the endogenous mRNA. 
The production and use of anti-Sense constructs are dis 
closed, for instance, in U.S. Pat. No. 5,773,692 (using 
constructs encoding anti-Sense RNA for chlorophyll a?b 
binding protein to reduce plant chlorophyll content), and 
U.S. Pat. No. 5,741,684 (regulating the fertility of pollen in 
various plants through the use of anti-Sense RNA to genes 
involved in pollen development or function). 
0113 Suppression of endogenous MSH1 gene expression 
can also be achieved using ribozymes. Ribozymes are Syn 
thetic RNA molecules that possess highly specific endori 
bonuclease activity. The production and use of ribozymes 
are disclosed in U.S. Pat. No. 4,987,071 to Cech and U.S. 
Pat. No. 5,543,508 to Haselhoff. Inclusion of ribozyme 
Sequences within antisense RNAS may be used to confer 
RNA cleaving activity on the antisense RNA, such that 
endogenous mRNA molecules that bind to the antisense 
RNA are cleaved, leading to an enhanced antisense inhibi 
tion of endogenous gene expression. 
0114 Constructs in which an MSH1 cDNA or gene (or 
variants thereof) are over-expressed may also be used to 
obtain co-Suppression of the endogenous MSH1 gene in the 
manner described in U.S. Pat. No. 5,231,021 to Jorgensen. 
Such co-Suppression (also termed Sense Suppression) does 
not require that the entire MSH1 cDNA or gene be intro 
duced into the plant cells, nor does it require that the 
introduced Sequence be exactly identical to the endogenous 
MSH1 gene. However, as with antisense Suppression, the 
Suppressive efficiency will be enhanced as (1) the introduced 
Sequence is lengthened and (2) the sequence Similarity 
between the introduced sequence and the endogenous MSH1 
gene is increased. 
0115 Constructs expressing an untranslatable form of an 
MSH1 mRNA may also be used to suppress the expression 
of endogenous MSH1 activity. Methods for producing such 
constructs are described in U.S. Pat. No. 5,583,021 to 
Dougherty et al. Such constructs may be prepared by intro 
ducing a premature stop codon into an MSH1 ORF. 
0.116) Polynucleotides of the present invention may also 
be used to Specifically Suppress gene expression by methods 
such as RNA interference (RNAi), which may also include 
coSuppression and quelling. This and other techniques of 
gene Suppression are well known in the art. A review of this 
technique is found in Science 288:1370-1372, 2000. Tradi 
tional methods of gene Suppression, employing antisense 
RNA or DNA, operate by binding to the reverse sequence of 
a gene of interest Such that binding interferes with Subse 
quent cellular processes and thereby blocks Synthesis of the 
corresponding protein. RNAi also operates on a post-tran 
Scriptional level and is sequence Specific, but Suppresses 
gene expression far more efficiently 
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0117 Studies have demonstrated that one or more ribo 
nucleases Specifically bind to and cleave double-Stranded 
RNA into short fragments. The ribonuclease(s) remains 
asSociated with these fragments, which in turn Specifically 
bind to complementary mRNA, i.e. specifically bind to the 
transcribed mRNA strand for the gene of interest. The 
mRNA for the gene is also degraded by the ribonuclease(s) 
into short fragments, thereby obviating translation and 
expression of the gene. Additionally, an RNA polymerase 
may act to facilitate the Synthesis of numerous copies of the 
Short fragments, which exponentially increases the effi 
ciency of the System. A unique feature of this gene Suppres 
Sion pathway is that Silencing is not limited to the cells 
where it is initiated. The gene-Silencing effects may be 
disseminated to other parts of an organism and even trans 
mitted through the germ line to Several generations. 
0118 Specifically, polynucleotides of the present inven 
tion are useful for generating gene constructs for Silencing 
Specific genes. Polynucleotides of the present invention may 
be used to generate genetic constructs that encode a single 
Self-complementary RNA sequence Specific for one or more 
genes of interest. Genetic constructs and/or gene-specific 
self-complementary RNA sequences may be delivered by 
any conventional method known in the art. Within genetic 
constructs, Sense and antisense Sequences flank an intron 
Sequence arranged in proper Splicing Orientation making use 
of donor and acceptor Splicing sites. Alternative methods 
may employ Spacer Sequences of various lengths rather than 
discrete intron sequences to create an operable and efficient 
construct. During post-transcriptional processing of the gene 
construct product, intron Sequences are spliced-out, allow 
ing Sense and antisense Sequences, as well as Splice junction 
sequences, to bind forming double-stranded RNA. Select 
ribonucleases bind to and cleave the double-stranded RNA, 
thereby initiating the cascade of events leading to degrada 
tion of Specific mRNA gene Sequences, and Silencing Spe 
cific genes. Alternatively, rather than using a gene construct 
to express the Self-complementary RNA sequences, the 
gene-specific double-Stranded RNA segments are delivered 
to one or more targeted areas to be internalized into the cell 
cytoplasm to exert a gene Silencing effect. 
0119 Using this cellular pathway of gene suppression, 
gene function may be Studied and high-throughput Screening 
of Sequences may be employed to discover Sequences affect 
ing gene expression. Additionally, genetically modified 
plants may be generated. 
0120 Finally, dominant negative mutant forms of the 
disclosed Sequences may be used to block endogenous 
MSH1 activity. Such mutants require the production of 
mutated forms of the MSH1 protein that interact with the 
same molecules as MSH1 but do not have MSH1 activity. 
0121 E. MSH1 Antibodies 
0122) The present invention also includes isolated anti 
bodies capable of selectively binding to an MSH1 polypep 
tide of the present invention or to a mimetope thereof. Such 
antibodies are also referred to herein as anti-MSH1 antibod 
ies. Particularly preferred antibodies of this embodiment 
include anti-A. thaliana MSH1 antibodies. 
0123 Isolated antibodies are antibodies that have been 
removed from their natural milieu. The term "isolated” does 
not refer to the State of purity of Such antibodies. AS Such, 
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isolated antibodies can include anti-Sera containing Such 
antibodies, or antibodies that have been purified to varying 
degrees. 
0.124. As used herein, the term “selectively binds to” 
refers to the ability of antibodies of the present invention to 
preferentially bind to specified polypeptides and mimetopes 
thereof of the present invention. Binding can be measured 
using a variety of methods known to those skilled in the art 
including immunoblot assays, immunoprecipitation assays, 
radioimmunoassays, enzyme immunoassays (e.g., ELISA), 
immunofluorescent antibody assays and immunoelectron 
microScopy; See, for example, Sambrook et al., ibid., and 
Harlow & Lane, 1990, ibid. 
0.125 Antibodies of the present invention can be either 
polyclonal or monoclonal antibodies. Antibodies of the 
present invention include functional equivalents Such as 
antibody fragments and genetically-engineered antibodies, 
including Single chain antibodies, that are capable of Selec 
tively binding to at least one of the epitopes of the polypep 
tide or mimetope used to obtain the antibodies. Antibodies 
of the present invention also include chimericantibodies that 
can bind to more than one epitope. Preferred antibodies are 
raised in response to polypeptides, or mimetopes thereof, 
that are encoded, at least in part, by a polynucleotide of the 
present invention. 
0.126 A preferred method to produce antibodies of the 
present invention includes (a) administering to an animal an 
effective amount of a polypeptide or mimetope thereof of the 
present invention to produce the antibodies and (b) recov 
ering the antibodies. In another method, antibodies of the 
present invention are produced recombinantly using tech 
niques as heretofore disclosed to produce MSH1 polypep 
tides of the present invention. Antibodies raised against 
defined polypeptides or mimetopes can be advantageous 
because Such antibodies are not Substantially contaminated 
with antibodies against other Substances that might other 
wise cause interference in a diagnostic assay. 
0127. Antibodies of the present invention have a variety 
of potential uses that are within the Scope of the present 
invention. For example, Such antibodies can be used (a) as 
reagents in assays to detect expression of MSH1 by plant, 
(b) as tools to Screen expression libraries and/or to recover 
desired polypeptides of the present invention from a mixture 
of polypeptides and other contaminants and/or (c) to modu 
late the function of an MSH1 polypeptide (e.g., increase or 
decrease the level or activity of an MSH1 polypeptide). 
Antibodies of the present invention can be used to target 
cytotoxic, therapeutic or imaging agents to Subjects in order 
to deliver therapeutic agents or localize imaging agents to 
RA-affected organs or tissues. Targeting can be accom 
plished by conjugating (i.e., stably joining) Such antibodies 
to the therapeutic or imaging agents using techniques known 
to those skilled in the art. 
0128 F. Methods for Effecting Mitochondrial Ectopic 
Recombination and Identification of Mutants Arising from 
Mitochondrial Ectopic Recombination 
0129. In one embodiment, the invention provides a 
method to identify a compound capable of inhibiting MSH1 
activity (e.g., effecting ectopic recombination) of a plant, 
Said method comprising contacting an isolated plant MSH1 
nucleic acid molecule with a putative inhibitory compound 
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which, in the absence of said compound, said plant MSH1 
nucleic acid molecule has the activity of Suppressing ectopic 
recombination; and determining if Said putative inhibitory 
compound inhibits Said activity. The present invention also 
comprises a method for effecting mitochondrial ectopic 
recombination comprising providing a plant, and SuppreSS 
ing expression of an MSH1-homologous gene in the plant. 
A preferred inhibitory compound is an RNA molecule 
having RNAi activity. 
0130. The invention further provides a method for iden 
tification of mutants arising from mitochondrial ectopic 
recombination comprising providing a plant, and SuppreSS 
ing expression of an MSH1-homologous gene in the plant, 
and detecting an aberrant phenotype, whereby a mutant is 
identified. A preferred aberrant phenotype includes cytoplas 
mic male Sterility. Cytoplasmic male Sterility is a plant trait 
that facilitates a cost-effective Strategy for the production of 
proprietary hybrids. Hybrid Seed is valued for producing 
higher yields and more uniform crop Stands. Hybrids are 
important in a large number of horticultural and agronomic 
crops including corn, Sorghum, rice, wheat, tomato, rape, 
Sunflower, carrot, onion, Sugar beet, to name few. Cytoplas 
mic male Sterility (CMS) mutations arise as the consequence 
of ectopic recombination events that produce novel 
expressed DNA sequences within the mitochondrial 
genome. This is well documented in the Scientific literature. 
The present invention also includes mutants identified the 
method of the invention. 
EXAMPLES 
Example 1 
Identification of the AtMSH1 Gene 
0131 A. Gene mapping, cloning, and sequence analysis. 
A map-based cloning strategy for the isolation of the CHM 
locus involved the design of PCR-based co-dominant mark 
ers, using the Cereon Arabidopsis polymorphism collection 
(Jander, et al., ibid.) to distinguish between the Col-0 and 
Landsburg erecta ecotypes used in the F mapping popula 
tions. The markers were designed in a 5-Mb region of 
Chromosome III based on information from the classical 
mapping experiments of CHM (Martinez-Zapater, et al., 
ibid.; Redei, ibid.). The primer Sequences for markers are 
available upon request. The F mapping population was 
derived from a cross between the chm1-1 mutant line and 
Landsburg erecta ecotype (pollen donor). A segregating 
Sub-population of 172 variegated plants was analyzed. 
Genomic DNA purification was conducted according to Li 
and Chory, ibid. DNA gel blot analysis was conducted using 
the protocol of Sambrook et al., ibid. High resolution 
mapping of the CHM locus on Arabidopsis Chromosome III 
delimited the gene to an 80-kb interval as shown in FIG. 1. 
0132) DNA sequencing of the candidate locus in chm1-1, 
chm1-2 and chm1-3 mutants (Kanazawa, et al... ibid.) was 
conducted in a Beckman/Coulter CEQ2000XL 8-capillary 
DNA sequencer. Two independent PCR samples for each 
mutant were sequenced. The 5' RACE analysis was done 
with the GeneRacer(R) Kit (Invitrogen, Carlsbad, Calif.). 
Mutants chm1-1 and chm1-2 were obtained from the Ara 
bidopsis Biological Resource Center, and mutant chm1-3 
was provided by a colleague. Sequence analysis of the 
interval revealed a gene candidate with Similarity in 
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sequence features to the MutS gene of E. coli (FIG.2). MutS 
is a component of the E. coli mismatch repair and DNA 
recombination apparatus (Marti, et al., ibid.). The gene, 
comprised of 22 exons, was predicted to encode a 43-amino 
acid mitochondrial targeting presequence with mitochon 
drial targeting values of 0.916 (MitoProt), 0.943 (Predator) 
and 0.856 (TargetP). RNA gel blots showed that the tran 
script derived from this gene was 3.5 kb in size and the 
encoded protein 1118 amino acids in length, predicting a 
124-kDa polypeptide. 
0133. The two sequence-indexed T-DNA insertion 
mutants were identified on the SiGnAL (Salk Institute 
Genomic Analysis Laboratory) website (Accessions 
SALKO41951 (SEQ ID NO:5) and SALKO46763 (SEQ ID 
NO:4)), and seed for the mutants obtained from the Arabi 
dopsis Biological Resource Center (ABRC). The T-DNA 
insertion positions were confirmed by DNA sequencing of 
the insertion junctions. The first insertion was located within 
the fourth exon and the second within the eighth intron. 
Analysis of the T-DNA mutants (T3 generation) revealed 
mild green-white leaf variegation, growing more intense in 
the following Selfed generation. Variegated plants having a 
green-white variegation phenotype carried a mitochondrial 
genome rearrangement Similar to that observed in the 
mutants chm1-1 and chm1-2. A population of 60 T4 plants 
segregating for one of the T-DNA (SALKO41951) mutations (16 wildtype, 31 hemizygous, 13 homozygous for the 
T-DNA) showed co-segregation of the T-DNA with the 
mitochondrial shifting phenotype. Of the 13 progeny 
homozygous for the T-DNA insertion, eight were variegated 
and the remaining five showed no obvious variegation 
phenotype. Incomplete penetrance of the variegation phe 
notype is characteristic of chm1-1 and chm1-2 mutants 
(Redei, ibid.). 
0.134 DNA gel blot hybridization analysis of mitochon 
drial genome configuration using the mitochondrial atp9 
rp116 junction Sequence associated with SubStoichometric 
shifting (Sakamoto, et al., ibid.) as probe. Total genomic 
DNA was digested with BamHI, Subjected to gel electro 
phoresis, blotted and probed. Lane Wt designates wildtype 
ecotype Columbia-0, lane C1 designates mutant chm1-1, 
and TI and T2 designate two Sister lines containing the 
T-DNA1 insertion mutation. DNA band pattern changes 
previously associated with SubStoichiometric shifting were 
noted (Martinez-Zapater, et al., ibid.). 
0.135 Cosegregation analysis of mitochondrial substo 
ichiometric shifting with the T-DNA1 insertion mutation. A 
three-primer PCR-based assay to detect substoichiometric 
shifting (Sakamoto, et al., ibid.) was used to assay wildtype 
Col-0 (Wt), mutant chm1-1 (C1) and individual plants 
Segregating for presence of the T-DNA insertion within the 
candidate CHM locus. 
0.136 All progeny homozygous for the T-DNA insertion 
mutation showed the mitochondrial shifting phenotype. 
None of the Segregants hemizygous for, or lacking, the 
T-DNA mutation showed evidence of variegation. The hem 
izygous plants showed no mitochondrial shifting. Similar 
co-segregation results were obtained for the second TDNA 
(SALKO46763) mutation as well. 
0137 To test further the possibility that the identified 
MutS-homologous Sequence was CHM, we Sequenced the 
chm1-1 and chm1-2 alleles of the gene. The chm1-1 line had 
US 2004/0210962 A1 
a single nucleotide (C-T) Substitution that gave rise to a 
premature stop codon within the fourth exon (FIG. 1E). The 
chm1-2 mutant had a single nucleotide (G-A) Substitution at 
the intron-exonjunction of Exon 2 (FIG. 1E). This substi 
tution resulted in two-nucleotide slippage of the intron Splice 
Site, producing a frameshift and premature termination of 
translation five amino acids beyond the mutation site. There 
fore, in both chm1-1 and chm1-2 mutant lines, the CHM 
candidate locus is predicted to give rise to highly truncated, 
inactive peptides. 
0138 Sequence analysis of the chm1-3 allele, derived 
from a tissue culture line by Martinez-Zapater et al. (Mar 
tinez-Zapater, et al., ibid.), revealed an amino acid Substi 
tution (Cys-Tyr) within the ATPbinding domain (FIG. 1E). 
The mutant phenotype in this case may be due to the 
Substitution of a bulkier amino acid within a Site essential for 
protein function. 
0139 B. The CHM candidate has features of a mismatch 
repair component. The MutS-homologous gene identified as 
a candidate for CHM displayed several features character 
istic of a mismatch repair component. These features 
included an ATP-binding domain (aa 761-946) comprised of 
four well conserved motifs designated M1-M4 (Obimolova, 
et al., ibid.; FIG. 2B). In addition to ATPase function, this 
domain appears to be involved in dimerization of the protein 
(Obmolova, et al.; Lamers, et al.), although this has not yet 
been demonstrated for mitochondrial MutS homologs. A 
DNA binding domain (aa 129-206) was also identified 
(FIGS. 1, 2) to contain the aromatic doublet (FY) motif that 
is characteristic of this domain in MutS and MutS-like 
proteins (FIG. 2A). This doublet was shown to be essential 
for mismatch recognition and Specific DNA binding activity 
(33, 34). We were unable to detect three other conserved 
domains characteristic of MutS. A connector domain, 
involved in inter-domain interactions, a core domain and a 
clamp domain, involved in nonspecific double-strand DNA 
binding, did not appear to be well conserved. The CHM 
candidate protein likely localizes to mitochondria. To con 
firm that the MutS-like protein localized to the mitochon 
drion, we conducted RACE-PCR and discovered a transcript 
start site at 578 residues upstream to the site predicted in the 
Munich Information Center for Protein Sequences (MIPS) 
database (Schoof, et al.) and in GenBank (Accession 
AP000382). No start site was observed by RACE analysis at 
the point predicted by the MIPS database, and three clus 
tered transcription Start Sites were detected at the upstream 
site. The confirmed start site added 102 amino acids to the 
predicted protein product and permitted the identification of 
a mitochondrial targeting presequence that was omitted from 
the previous database entries. The Sequence was annotated 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 65 
<210> SEQ ID NO 1 
&2 11s LENGTH 3673 
&212> TYPE DNA 
<213> ORGANISM: Arabidopsis thaliana 
<400 SEQUENCE: 1 
Oct. 21, 2004 
based on cDNA sequence analysis and is available as 
GenBank Accession AY191303. 
Example 2 
Plant Transformation and Biolistic Delivery 
0140. The amino acid sequence of AtMSH1 was analyzed 
with MitoProt (Claros & Vincens (1996) Eur. J. Biochem. 
241, 779-786), and the first 213 nucleotides of the gene were 




(SEQ ID NO : 48) 
MSHtranspRev 
5' GGCCATGGAAA CATCACTTGACGTCTTC3". (SEQ ID NO: 49) 
0141 PCR products were ligated to the Pgem(R-T Easy 
Vector System (Promega) and digested with NcoI to release 
the insert. Insert fragments were ligated to the pCAMBIA 
1302 vector at the NcoI site that resides at the start of gfp. 
This vector utilizes the CaMV 35S promotor. Bombardment 
experiments used 4-week-old leaves of Arabidopsis (Col-0) 
with tungsten particles and the Biolistic PDS-1000/He sys 
tem (Bio-Rad). Particles were bombarded into Arabidopsis 
leaves using 900-psi rupture discs under a vacuum of 
900-psi (1 psi-6.9 kPa). After the bombardment, Arabidop 
Sisleaves were allowed to recover for 18-22 h on Murashige 
and Skoog media plates at 22 C. in 16 h daylight. Local 
ization of GFP expression was conducted by confocal laser 
scanning microscopy with Bio-Rad 1024 MRC-ES using 
488 nm excitation and two-channel measurement of emis 
sion, 522 nm (green/GFP) and 680 nm (red/chlorophyll). 
Mitochondria were identified by their characteristic move 
ment and rapid inter-conversions from Small round to highly 
elongated, shapes. Plastids located in the cells emit red 
autofluorescence. Positive controls for mitochondrial (F1 
ATPase gamma subunit provided by Dr. D. Stern) and 
chloroplast (Rubisco Pea/SSU/TPSS, provided by Dr. L. 
Alison) targeting were included with each experiment. 
Example 3 
Identification of Homologs 
0.142 Homologs were identified by BLAST search using 
the tblastin program against the est others database. The 
MSH1 protein Sequence was used as the Query Sequence. 
The search was done using the BLOSUM62 matrix, word 
size of 3 and low complexity filter. 
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ggatto agitt tagatgaggg cqcaaaacca ttagatggtg ccagtic gaat gaagctgaca 234. O 
ggcctgtcac cittattggitt to atgitatct tctggalacc.g. citgttcacaa taccgttgac 24 OO 
atgcaatcac totttcttct aactggacct aacggtogto gtaaatc gag tittgctdaga 2460 
totaatatgcg cagotgctict acttggaatt toc ggtttaa toggttccago togaatcagot 252O 
tgtattocto actittgattc catcatgctt cacatgaaat catatgacag ccctgtagac 258O 
ggaaaaagtt cittitcCaggit agaaatgtcg gaaatacgat citattgtaag coaggctact 264 O 
to gaga agcc tagtgctitat agatgagata tocc gaggga cagagacago: aaaaggcacc 27 OO 
tgitatcgctg gtagtgtggit agaga.gtott gacacaagtg gttgtttggg tattgttatct 276 O. 
actcatctoc atggaatctt cagtttacct cittacagoga aaaa.catcac atataaag.ca 282O 
atgggagc.cg aaaatgtcga agggcaaacc aagccaactt goaaattgac agatggagtic 2880 
tgcagagaga gtc.ttgcgtt togaalacagot aagagggaag gtgttcc.cga gtcagttatc 2.940 
caaagagctgaagctottta cotcitcgg to tatgcaaaag acgcatcago togaagttgtc. 3OOO 
aaacco gacc aaatcataac titcatccaac aatgaccago agatccaaaa accagtcago 3060 
totgagagaa gtttggagaa goactitagca aaagctatog toaaaatctg toggaaaaag 312 O 
atgattgagc ctdaag caat agaatgtc.tt toaattggtg citcgtgagct tccaccitcca 318O 
totacagttg gttctt catg cqtgitatgtg atgcggagac cc.gataagag attgtacatt 324 O 
ggacagaccg atgatcttga aggacgaata cqtgcgcatc gag caaagga agg actdcaa 33OO 
gggtoaagtt ttctatacct tatggttcaa gqtaagagca togcttgtca gttagagact 3360 
citattgatta atcaactcca togaacaaggc tactcitctgg cita acctago C gatggaaag 342O 
caccgtaatt toggaacg to citcaagcttg agtacatcag acgtagt cag catcttatag 3480 
tittgaaac at tagctgtgtt totagttgat catctotato, togcaattgaa caagt cagtt 354. O 
tgctagaact agagtagatt actaagaaac catgcc.gttt ttcattttga gattittgcaa. 3600 
aacggcatcc agttcgggta agtcggatgc cqcaattacc aattittgggt cagtctgttgt 3660 
aattgtcgtt toa 3673 
<210> SEQ ID NO 2 
&2 11s LENGTH 3673 
&212> TYPE DNA 
<213> ORGANISM: Arabidopsis thaliana 
&220s FEATURE 
<221 NAME/KEY: CDS 
<222> LOCATION: (124) . . (3480) 
<400 SEQUENCE: 2 
agaggactgt gagattgttga attgcatagt cqtcgtottctgg.cgggaaa agaag.cccta 60 
gaaaaagggit gaaaggtogala aactcitactt cittcttctitc ttcttcttca gagtgtgaga 120 
gag at g cat tog att gct acc aga aac goc gito gtt to a titc cca aaa 168 
Met His Trp Ile Ala Thr Arg Asn Ala Val Val Ser Phe Pro Llys 
1 5 10 15 
tgg cqg titc titc titc cqc toc to a tat cqc act tac tot toc citc aaa 216 
Trp Arg Phe Phe Phe Arg Ser Ser Tyr Arg Thr Tyr Ser Ser Leu Lys 
20 25 30 
ccc toc toc coa att cita citt aat aga agg tac tot gag ggg at a tot 264 
Pro Ser Ser Pro Ile Leu Lleu. Asn Arg Arg Tyr Ser Glu Gly Ile Ser 
35 40 45 
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aaa coc gac caa atc ata act tca to c aac aat gac cag cag atc caa 3048 
Lys Pro Asp Glin Ile Ile Thr Ser Ser Asn. Asn Asp Glin Glin Ile Glin 
96.O 965 970 975 
aaa coa gtc agc tict gag aga agt ttg gag aag gac tta goa aaa got 3 O 96 
Lys Pro Val Ser Ser Glu Arg Ser Lieu Glu Lys Asp Lieu Ala Lys Ala 
98O 985 99 O 
atc gtc. aaa atc tdt ggg aaa aag at g att gag cott gala gca at a gaa 314 4 
Ile Val Lys Ile Cys Gly Lys Lys Met Ile Glu Pro Glu Ala Ile Glu 
995 10 OO 1 OO5 
tgt citt toa att ggit gct cqt gag citt coa cot coa tot aca gtt 31.89 
Cys Leu Ser Ile Gly Ala Arg Glu Leu Pro Pro Pro Ser Thr Val 
O 10 O15 O20 
ggit tot to a tigc gtg tat gtg atg cqg aga ccc gat aag aga ttg 3234 
Gly Ser Ser Cys Val Tyr Val Met Arg Arg Pro Asp Lys Arg Lieu 
O25 O3O O35 
tac att gga cag acc gat gat citt gala gga cqa ata cqt gcg cat 3279 
Tyr Ile Gly Glin Thr Asp Asp Leu Glu Gly Arg Ile Arg Ala His 
O40 O45 O50 
cga goa aag gaa goa citg caa gogg to a agt titt cita tac citt atg 3324 
Arg Ala Lys Glu Gly Lieu Glin Gly Ser Ser Phe Leu Tyr Lieu Met 
O55 O60 O 65 
gtt caa ggit aag agc at g got tot cag tta gag act cita ttg att 3369 
Val Glin Gly Lys Ser Met Ala Cys Glin Leu Glu Thir Lieu Lleu. Ile 
OFO O75 O8O 
aat Caa Ctc Cat gaa caa gg C tac tot Ctg gct aac Cta gcc gat 3414 
Asn Glin Lieu. His Glu Glin Gly Tyr Ser Lieu Ala Asn Lieu Ala Asp 
O85 O9 O O95 
gga aag cac cqt aat titc gga acg toc toa agc titg agt aca tota 3459 
Gly Lys His Arg Asin Phe Gly Thr Ser Ser Ser Leu Ser Thr Ser 
1 OO 105 110 
gac gta gtc agc atc tta tag tittgaaa.cat tagctgttgtt totagttgat 3510 
Asp Val Val Ser Ile Leu 
115 
catctotato, togcaattgaa caagttcagtt toctagaact agagtagatt actaagaaac 357 O 
catgcc gttt ttcattttga gattittgcaa aacgg catgc agttcgggta agtcggatgc 36.30 
cgcaattacc aattittgggt cagtctgttgt aattgtcgtt to a 3673 
<210> SEQ ID NO 3 
&2 11s LENGTH 1118 
&212> TYPE PRT 
<213> ORGANISM: Arabidopsis thaliana 
<400 SEQUENCE: 3 
Met His Trp Ile Ala Thr Arg Asn Ala Val Val Ser Phe Pro Llys Trp 
1 5 10 15 
Arg Phe Phe Phe Arg Ser Ser Tyr Arg Thr Tyr Ser Ser Leu Lys Pro 
2O 25 30 
Ser Ser Pro Ile Leu Lleu. Asn Arg Arg Tyr Ser Glu Gly Ile Ser Cys 
35 40 45 
Leu Arg Asp Gly Lys Ser Lieu Lys Arg Ile Thr Thr Ala Ser Lys Lys 
50 55 60 
Wall Lys Thir Ser Ser Asp Val Lieu. Thir Asp Lys Asp Leu Ser His Lieu 
65 70 75 8O 
Val Trp Trp Lys Glu Arg Lieu Glin Thr Cys Lys Lys Pro Ser Thr Lieu 
85 90 95 
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Glin Lieu. Ile Glu Arg Lieu Met Tyr Thr Asn Lieu Lleu Gly Lieu. Asp Pro 
100 105 110 
Ser Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Asn Lieu. Asn Trp Glu Met 
115 120 125 
Leu Glin Phe Lys Ser Arg Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val 
130 135 1 4 0 
Gly Glu Phe Tyr Glu Ala Ile Gly Ile Asp Ala Cys Ile Leu Val Glu 
145 15 O 155 160 
Tyr Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro 
1.65 170 175 
Lys Ala Gly Cys Pro Ile Met Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu 
18O 185 19 O 
Thr Arg Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Val Glin Gly Pro 
195 200 2O5 
Thr Pro Ala Arg Ser Arg Lys Gly Arg Phe Ile Ser Gly His Ala His 
210 215 220 
Pro Gly Ser Pro Tyr Val Tyr Gly Leu Val Gly Val Asp His Asp Leu 
225 230 235 240 
Asp Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Arg 
245 250 255 
Gly Tyr Cys Met Ile Ser Ile Phe Glu Thr Met Lys Ala Tyr Ser Leu 
260 265 27 O 
Asp Asp Gly Lieu. Thr Glu Glu Ala Lieu Val Thr Lys Lieu Arg Thr Arg 
275 280 285 
Arg Cys His His Leu Phe Lieu. His Ala Ser Lieu Arg His Asn Ala Ser 
29 O 295 3OO 
Gly Thr Cys Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly 
305 310 315 320 
Glu Cys Ser Ser Arg Asn. Phe Glu Trp Phe Glu Gly Asp Thr Lieu Ser 
325 330 335 
Glu Lieu Lleu Ser Arg Val Lys Asp Val Tyr Gly Lieu. Asp Asp Glu Val 
340 345 35 O 
Ser Phe Arg Asn Val Asn Val Pro Ser Lys Asn Arg Pro Arg Pro Leu 
355 360 365 
His Leu Gly Thr Ala Thr Glin Ile Gly Ala Leu Pro Thr Glu Gly Ile 
370 375 38O 
Pro Cys Lieu Lleu Lys Val Lieu Lleu Pro Ser Thr Cys Ser Gly Lieu Pro 
385 390 395 400 
Ser Leu Tyr Val Arg Asp Lieu Lleu Lieu. Asn Pro Pro Ala Tyr Asp Ile 
405 410 415 
Ala Leu Lys Ile Glin Glu Thir Cys Lys Leu Met Ser Thr Val Thr Cys 
420 425 43 O 
Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val Lys Leu 
435 4 40 4 45 
Leu Glu Glin Arg Glu Ala Asn Tyr Ile Glu Phe Cys Arg Ile Lys Asn 
450 455 460 
Val Lieu. Asp Asp Val Lieu. His Met His Arg His Ala Glu Lieu Val Glu 
465 470 475 480 
Ile Leu Lys Lieu Lleu Met Asp Pro Thir Trp Val Ala Thr Gly Lieu Lys 
485 490 495 
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Ile Asp Phe Asp Thr Phe Val Asin Glu Cys His Trp Ala Ser Asp Thr 
5 OO 505 51O. 
Ile Gly Glu Met Ile Ser Lieu. Asp Glu Asn. Glu Ser His Glin Asn. Wall 
515 52O 525 
Ser Lys Cys Asp Asn Val Pro Asn Glu Phe Phe Tyr Asp Met Glu Ser 
530 535 540 
Ser Trp Arg Gly Arg Val Lys Gly Ile His Ile Glu Glu Glu Ile Thr 
545 550 555 560 
Glin Val Glu Lys Ser Ala Glu Ala Leu Ser Lieu Ala Val Ala Glu Asp 
565 570 575 
Phe His Pro Ile Ile Ser Arg Ile Lys Ala Thr Thr Ala Ser Leu Gly 
58O 585 59 O 
Gly Pro Lys Gly Glu Ile Ala Tyr Ala Arg Glu His Glu Ser Val Trp 
595 600 605 
Phe Lys Gly Lys Arg Phe Thr Pro Ser Ile Trp Ala Gly Thr Ala Gly 
610 615 62O 
Glu Asp Glin Ile Lys Glin Leu Lys Pro Ala Lieu. Asp Ser Lys Gly Lys 
625 630 635 640 
Lys Val Gly Glu Glu Trp Phe Thr Thr Pro Llys Val Glu Ile Ala Leu 
645 650 655 
Val Arg Tyr His Glu Ala Ser Glu Asn Ala Lys Ala Arg Val Lieu Glu 
660 665 67 O 
Leu Lieu Arg Glu Lieu Ser Wall Lys Lieu Glin Thr Lys Ile Asin Val Lieu 
675 680 685 
Val Phe Ala Ser Met Leu Leu Val Ile Ser Lys Ala Leu Phe Ser His 
69 O. 695 7 OO 
Ala Cys Glu Gly Arg Arg Arg Lys Trp Val Phe Pro Thr Lieu Val Gly 
705 710 715 720 
Phe Ser Lieu. Asp Glu Gly Ala Lys Pro Leu Asp Gly Ala Ser Arg Met 
725 730 735 
Lys Leu Thr Gly Leu Ser Pro Tyr Trp Phe Asp Val Ser Ser Gly. Thr 
740 745 750 
Ala Val His Asn Thr Val Asp Met Glin Ser Leu Phe Leu Leu Thr Gly 
755 760 765 
Pro Asn Gly Gly Gly Lys Ser Ser Lieu Lieu Arg Ser Ile Cys Ala Ala 
770 775 78O 
Ala Lieu Lieu Gly Ile Ser Gly Lieu Met Val Pro Ala Glu Ser Ala Cys 
785 790 795 8OO 
Ile Pro His Phe Asp Ser Ile Met Leu. His Met Lys Ser Tyr Asp Ser 
805 810 815 
Pro Val Asp Gly Lys Ser Ser Phe Glin Val Glu Met Ser Glu Ile Arg 
820 825 83O 
Ser Ile Val Ser Glin Ala Thr Ser Arg Ser Leu Val Leu Ile Asp Glu 
835 840 845 
Ile Cys Arg Gly Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser 
85 O 855 860 
Val Val Glu Ser Leu Asp Thir Ser Gly Cys Leu Gly Ile Val Ser Thr 
865 870 875 88O 
His Leu. His Gly Ile Phe Ser Leu Pro Leu Thir Ala Lys Asn Ile Thr 
885 890 895 
Tyr Lys Ala Met Gly Ala Glu Asn Val Glu Gly Glin Thr Lys Pro Thr 
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9 OO 905 910 
Trp Llys Lieu. Thir Asp Gly Val Cys Arg Glu Ser Leu Ala Phe Glu Thr 
915 920 925 
Ala Lys Arg Glu Gly Val Pro Glu Ser Val Ile Glin Arg Ala Glu Ala 
930 935 940 
Leu Tyr Lieu Ser Val Tyr Ala Lys Asp Ala Ser Ala Glu Val Val Lys 
945 950 955 96.O 
Pro Asp Glin Ile Ile Thr Ser Ser Asn. Asn Asp Glin Glin Ile Glin Lys 
965 970 975 
Pro Wal Ser Ser Glu Arg Ser Lieu Glu Lys Asp Leu Ala Lys Ala Ile 
98O 985 99 O 
Wall Lys Ile Cys Gly Lys Lys Met Ile Glu Pro Glu Ala Ile Glu Cys 
995 10 OO 1005 
Leu Ser Ile Gly Ala Arg Glu Leu Pro Pro Pro Ser Thr Val Gly 
O 10 O15 O20 
Ser Ser Cys Val Tyr Val Met Arg Arg Pro Asp Lys Arg Lieu. Tyr 
O25 O3O O35 
Ile Gly Glin Thr Asp Asp Leu Glu Gly Arg Ile Arg Ala His Arg 
Ala Lys Glu Gly Lieu Glin Gly Ser Ser Phe Leu Tyr Lieu Met Val 
Gln Gly Lys Ser Met Ala Cys Gln Leu Glu Thr Lieu. Leu. Ile Asn 
Glin Lieu. His Glu Glin Gly Tyr Ser Lieu Ala Asn Lieu Ala Asp Gly 
Lys His Arg Asn Phe Gly. Thir Ser Ser Ser Leu Ser Thr Ser Asp 
Wal Wal Ser Ile Leu 
<210> SEQ ID NO 4 
&2 11s LENGTH 8O393 
&212> TYPE DNA 
<213> ORGANISM: Arabidopsis thaliana 
<400 SEQUENCE: 4 
aagcttgcat citctoaagaa citctgacaat cagtcaaagg gattittctot gag cottatc 60 
agcaaactitg aggtaagatc atgtttctoc aaactcaiaca citttcttcto gattittacaa 120 
titccatcata aacaaagg to ttctotgttc cittctocagg to attgttgt cagtcttatt 18O 
taatctotca aatcgaac at ttaggatatg taataa.catg attaa.gc.cat tdtcc tagac 240 
caaatacagt ttgcaa.catt gtagatgtaa gtgcttittgg ttittgcticag cqtaacgatt 3OO 
tgtc.tc.ttgc tictact agtc. aggaactago gaacticcittg gatttagaga ccc.ggcaaaa 360 
cittatcaggc titcatggatg citgttgagaa aatactcgtg cagoa aacco gtgaagaact 420 
caagttccaat gaatcc tocc aaaagtgagt accalagalacc accitcaagag tttgttgcagt 480 
ttctatotcc titattgttitt tdtcttgggit tattatctg.c aactcitttgttgtaattact 540 
ttggaaattig gaattgitatc aatactcittg cittatgtcct caagtttcct ttatatato a 600 
atatoctitaa acacattatt atcttactict cogccatata taatcagaga actaatgaaa 660 
taatctocaa ataatctoca aatacttcto cattctggitt aatggaggaa alacaccalacc 720 
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atatataact tacggagaag taatctocaa ataatctoca aatacttcto cattctggitt 78O 
aatggaggaa alacaccalacc atatataact tagtgattac ttcto cqtaa gotgacaa.ca 840 
aaactcagag gtc.tctittaa atggaagaag citaaagttgttctittgagtg ttitta actot 9 OO 
tactittagtc. aatttalagga agt caatatg gottagtaaa totaattalaga aaaccattta 96.O 
aaatctacca agtttagt cit aaaag actgt tdtctacact tagctaalacc aaaaaacaga O20 
accagaacca gcaccaaata aacctaatga aattitccatt ttaaattaaa ccacgttcag O8O 
attgttcttg tottcactitg agattcttgt gcagtggaac citctttgcct totagaaagt 14 O 
ttittcaatcg tittgcttcaa gacaggtttcaatctittctd ttacaag agt gacctc.gc.gc 200 
agtttctgat tcaaccggitt caagatc.gca ggtaaaactc tittgatgatt ttctttcact 260 
atttcaag.ca tatctotaccatataaattt totgcacatc totagaactt coctocaaga 320 
totttcaggit coctotctoc gittaataact tccitctgcat tctitc.gctg.c acttgttaga 38O 
aatcccacca acatatotag citcgaacatc tdatctitccc agttgtacat atctttittcg 4 40 
atat cq gtta ggttcttctg. tcc citggata totata actot to acaa.ccca agtgttgttt 5 OO 
agtact gtag acgaga.ccgg totctgttct tcc ttgg gala ttagcttata gttaggtgtc. 560 
gctcgttcag totttctoct tittcttcaga ggtotctdag gttggtotga titcctittgga 62O 
ggcaac attc citctottccc ctittccctcc aacttgatct tatcc.gactic tatgtcttgg 680 
gggittatcat Caactittaac Cotagttcca gCCtcatctt CitcCatgacc gtagg caatg 740 
totacgaacc gttgataaag attcttgtat ttatc gatca aac gttgaag agacittaacg. 800 
aattggctgt aatcgattct atgagacitta aagtc.tttac acaa.gcaagt gtaaact citc 860 
aatticc gacc gagittagt ct citcctcgata gccttcaata actctgtcaa cittctgtttc 920 
gcttctaaac ggtoctitcat citttctotcc acatcgtott taggitttata aactato.cgt 98O 
atac gaggta to atctittgg titcattaaga agaatagggit totcittc.cgg cittct catca 20 40 
tgatcaatct titcgattaag gttattgttct ttaagccitcc taagttctot agtgagttcg 2100 
ggatttctga gtag acgtac cqaagatcgt aaccttgtct gtacc gatga agacitgttgtc. 216 O 
ttgacaccgt togtottcat caacticatca gcgtoagicca tatcttctga atctogatag 2220 
cgtgtgagcg aaacaaacga cittagggtag agtatatata aggtotttitc gttitt.cctitt 228O 
ttttittgagg agattalacta totagatttg citgaaagtac goagattact tottttctaa 234. O 
ccaatggtaa taaatcaatt tatttaaatt agttittctitt caactgatta aaaacaatta 24 OO 
aacgcaaatt aaattittgag aatcagtatt totcittatat ataaattitat acatgaaaaa 2460 
tataaaatat ttacaacaaa aatcatcatc titatgaagag titcatgaatc. tcatcaaatc 252O 
totctgttitt citcttgcaac aaaactcacg gtgatgtc.gt citatacaaat cittgttgctt 258O 
tittatattag aatttgttag attctagtag gotggaaggg atcttgaagg atttgttgttt 264 O 
agagattitat gtcattct cattttaggagg to gagaagttcaaaag agaat calaccatcta 27 OO 
gcagotcaat toggaagtatg tdaagtgatt gatgatgaca tottttatag titttgtttct 276 O. 
attatatgaa gottgttgccc catctgaaat tittctatatt totcittagtt cittitcctctg 282O 
gcta acatac ctaagatact gtatgatatgcatccaacct caaagttata ttttgttgaa 2880 
tottalaggtg totgtcataa cct atcttaa aactgcaggc aggta aggtt acact cittca 2.940 
gtgctaga.ca caagat cittc agtccagtgg gttgtc.gc.ca aagtgcaaga tataattatt 3OOO 
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totaacaact ttgagaaaag attttgttgat gagttcgaaa acaattagtt gag cott.ccc 3060 
tittcagtagc titaagaggct gaatttittct titcgtagcta acticatgtca ttgagttcto 312 O 
tgagcaa.gcc aattgactgc atgttttgttg atccitatggc agg cacacgt to gaatact a 318O 
cgacaaagat gaaacaattg to act catat agctggaggit attgatgcat ttittaaaggt 324 O 
citctgatggit toggccactgc tigaatacccc attaaatgga agaagctaaa gttagtgttt 33OO 
taactattac tatatagtica atttagga aa gttcaatattg cittagtaaat caattaagaa 3360 
alaccatttaa aatctacaaa citcaagttcta aaagattgtt gtctacagtt agctaalacca 342O 
aaaaacagaa cca acaccala aaacaaatta accitaatgaa aattacattc taaattaaac 3480 
caggttcaga ttgttgttgt citt cacttga gattottgttg cagtggaagg to atttggat 354. O 
tatgtotagg tittgggattt gocto gagtg atctotacat gtggtgagtt totaagaaaa 3600 
tgaagttcgg gaatcgaaaa aaacgctt.ca taalacccagt aaagctacaa gagatggatg 3660 
ttacaactaa atalacacttg cacttgaaaa citaaacaaag tttittataca aagagtgc.ca 372 O 
caagtggagt ggtggtatac acagagtaaa aatgagacaa totaaacaag agaaggc.ca.g 378 O. 
toaa.gctaga C gagtggatc tdtcaaaggc citcaatgact togatalaccat atctatoctit 384 O 
acacaaatga atactg.cggg to acgaggac ggaggtoaga citgtgcggaa gatcaat acc 39 OO 
ggtgcgttta aaa.ccc.caaa toagacgctgaactacatag titc.ccaacac gatctitt cac 396 O 
Caaattctoa aagtaactat caaactcaga ggcaatcaac gitaag acacic tittcatCaag 4020 
catato aaga aacttctgca cagggitaatt agaga aggag cct gatgaaa gogacacaaa 408 O 
gtgaccagag aacttgttta coctittctta toaaagg cag citatcaa.gca atc attacca 414 O 
aacatggaga gcaaaagtga accagoatga tigtataagca gtaataggitt cittgttacca 4200 
atctoattac gggagagttcaacaaaagtt gcaccaactt gaatcaggaa cittgaacaaa 4260 
agttgcacca ttctoatatt gacittgattit aaatattaac aaaaaattat atctatgtta 4320 
ttgtag agaa gaaaaaagaa aaacgtatat aattaaagat taggaaactic aagttcctittg 4.380 
aagaaaaata agaaataaaa aaaccoaa.gc ctaaagtaaa ccttgataaa togtoatacc 4 440 
ttittctgaac gatactatto tataatacat atttaactag ataagtaatc cqcaccittgt 4500 
gcagaaaaaa aaattattaa ataaatttaa cattggatta aatatagaag titattotagt 45 60 
ggccaaaatc tataatgact ttagg gttta tatagatata totgatatoc attatatgat 462O 
caataatata ttggcaaata tagaacagaa catttatatt ttattaatat gtttagtata 4680 
taaaatgatg attcttittga tattataact tattotttat aagataaata atattgctaa 474. O 
ataatticgct taacgcatta gtaatact at ttt tatgtat ttttgtaaag gtgaaaacga 4800 
ttittatgtaa tatatgtttgtcaaaaattt gtag tattgt ggatgaatat gatattggta 4860 
ttctatttat aggaaaatat gtttittacat atgtaggaaa ttgttctttitt to cittgcaat 4920 
tgttittagaa atttgttaca agatattaat gcgggaaaaa totaaattitt totttcggaa 4.980 
tatctatagt aaaatatgat tttgttcc.ca tattittctaa tatttitactt atgitattatt 5040 
agittaatgat atacgcagtt attctaattg gcggcagatt togctatatat acttgattag 51OO 
ggg tagttitt cittttgtaga cacatcaatc totatgaaat ttacaggatgaaaaacactic 5 160 
ggcc acgaag agccaaaatt taggtttgcg ttittgctgtg tdaag agaaa atatgagtca 5220 
agtatgggitt togalaattcag taatttgaga agagttcatt gactaagtat tdacgtgagt 528 O 





























































































































































aatgacaat g g c gatatgaa 
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gcatagg cat cqagtatcct 
gcc to atcgg gtc.ttgttcc 
aaacaaaacc taaggataaa 
cittaagtaat atc.cgggaca 
agt caagata aattaa.gaga 
tttitttctaa aacaaagatt 
ataag cottt citaataatta 
tottatttitt g g tattgatt 
ttttacaatt atcaaaactg 
gtattagct g aagct cittca 
aaaaatcttic cctagtagag 
taalacactaa aagagaalacc 
ttgag cattt to aggattga 
tgaataatca aataagatac 
ttgttggtgga ggtggtttitt 
atgcatattg to agaalacat 
cagtatgcaa gqacgctata 



































Oct. 21, 2004 




























































































































































tagtgag cat gatgttcatc 
agcc.gagct g catc.gcaaag 
cgtaggctoc atcggtaaac 







aac coaaaat atgaatgacg 
tgatctatto aattgtagca 
titc.ccgtaga gagttggtog 



















tataaatcaa gtggtag togg 
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agtcgaaata gtgttatatt 
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tttittcttac tacgaccogt taaaggtaat caaaattctt gtacaatgtt citgtctttgt 218O 
ttgggtgaca tatgaaatat acgtttgaga atatttaaat acagtttgac gactaatatg 2240 
cacaaaaaga tigatgtgcaa gotiataagct actggaattg catcgtaatt coatgattot 2300 
acaggtotcg aaagtgtata caaacaagga atatatgtta taaaaattitt totttagcag 2360 
aatttgaaat aaataaaaaa tactattgaa at attagg to citaaaattta totalaccacaa 2420 
aatatggg to atactic ctitt gtttaaagtt atc gaggacg caagaatttg atttatattt 24.80 
taattittagt ttgtacgatt aatagdaaca attgttaggc taataaaacc cattaggctt 2540 
agttcaatag ttctaaacaa gtgaccagtt acatagatgt aatgacatgt catatttctt 2600 
citag tatt at ttattalacca acatc gttca agtaaaagat aatat citacg totacctaag 2660 
cgtggctagt talactaattg gaaaaaatcg citttacgtgt acataaggga atgactaagt 2720 
totgcttittg gtacgaaatg gtacacaaat gatttitt cag aatttatatt attctaagaa 2780 
caacttttgt gtactic caat titcctaatgc cqtcggcaga acaaaaacct aag caaagtt 284 O 
gtatacagta tatgcataac totcctttitt ggatcaccaa aagttgtata tataaattitc 29 OO 
taagaaatag cataaacatt agcc.gaggca totaaaatta aaattcaaga aaaaaaaaaa 2960 
aaacataaac taaaac actt ataaacacaa aaagacgata ggtoactitaa aacaaac caa 3020 
aa.catccaaa tatttatatt toaaaaccala aacco aaa.ca atacttaaac ggtaataaat 3O8O 
taccaaaaag ttgaaaatta aacg.cgagga ggagtagctg atcgagggaa aggagatcCa 314 O 
ggat.ccactc tatgagacitc atcatcatta toatggtaga tataagcaaa gocaccgtga 3200 
cgtgtcatat coatcc cittg cattt catgc tigctocq aga. tcc taag cag attgagc citt 326 O 
ttgaggatga agaagagtgttcc cattgttg gcactaacco atcctacaat cacaagtatt 3320 
tgaaccaatt gtgctcccaa cagottcc ct cotcc.gc.cca taaatagtcc atatggccitt 3380 
cc.cggggtgg cqc cataaac citcgtttaga tacttct citt togcaaacaa toctacgaat 34 40 
atcaa.ccc.cc acgc.gc.caca Coctocatgt agttgggctd cotcgagtgg atcatcatat 3500 
tgtacaagct cogcqagctt gttgcatc.cg ataaggacga cagaa.gc.cat gaag.ccgcac 356 O 
acaatcgctg. cccatggcto tacgacggag caacct gcgg titatggcc.gc. aalacc caccg 362O 
agta accogt togcaaacg to C gttacgttc cagtggcctd ataggagacg tttaccaaag 3 680 
agtgtggitta gagctgctgt gcatcctgag agtgtggtgt talacc.gctgt acggc.cgatt 3740 
cc.gcto catt goccgtagtt goalaccagaa ttatacggaa cq agitat citt agtgaaggaa 38 OO 
cc.ggggttga aaccatacca tocaalaccat aggagga agg titcctaagac tactago gag 3860 
gcagagtggc cqc.gcagagc aatagogcga ccaccitttct c galaccg acc acgac gagga 392 O 
ccttcaataa gag caccc.ca taalacctgct atgccaccala ccatctgaac aac accggag 398O 
ccagoaaagt caatggctico ggtgctaaac aaacgatcat cogctgaacg aaagggactg 4040 
gcc catcc at coggggacca aaaccagtga gagacaa.ccg ggtaaacaaa toc ggittaag 41 OO 
aaagaagagt atatoaagta agccacgaac tagt cotct citgc gatcga accacttgtg 416 O 
attccagogg cc.gc.gattgc gaacgcc.cat togtagagga agaaagagta atcagctgtg 4220 
ggagtcggaa agt citctaag agcaaagttg tdtctitccaa togaac cottc ggaggat.cct 428O 
ccaaaggcaa aggcgtaacc aaagagatag tagaagag to citc.cggctgc agcgtcaagg 434 O 
acattggtaa goatgatgtt catcgtatto ttggctotaa cagaaccago acaaag cata 4 400 
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gCgaag.ccga gctgcatggC galaga Caagg taggcagaga agaggaggta ggtgttgtct 4 460 
atgg.cgaagg citgcatcggit gaacttgttg ttaacggtgc ctaattggcc gcaaatgtag 4520 
toggcc.gc.cg cc.gtgg.cgitt ggggcCaagt agggtgg.cga gatcggcc.gc agagcatgtt 4580 
attgcticcitg acatgtttga gagagctgag agagagaaag agagatacgg agaagaaagg 4 640 
ttgtct cittg totgtc.tc.tt aaaaggaaga aggaggagtt tagggttgac tittagattcc 47 OO 
ggctag acca attaagttcg tatttalagag agtttatcaa ttatttalaga agittatgttga 476 O 
cgtaacaa.ca ttattgaatt agagatgtaa totgccaaat cittcttaata acttgcaaat 482O 
tacgatccita atcctatacg gtttittggtg attaagtgat togc catgitaa totgtgaata 488 O 
aaaaaaaggit aaattaaagg cittgtataaa aaaattacaa aaataaattt gtgaataaaa 494. O 
ttgatactag tatttaaagt aataaatcaa agaataattg toctagotca accgtatatg 5 OOO 
ttcaa.gcaaa cc gatcagaa cittactacat agatgtc gat tittagat cag cagttittatg 5060 
aaattaagttcaag attcago actictittata cqacaatctt atgataatct tdcaaaattit 5 120 
taataaagtt catalaccalaa tattaattaa gtttgctgaa gottgaalacc aaaaatgata 5 18O 
acatgggitta gcgggalacca C gttittattt gctgaaaatt gcactttaca cocittaactic 5240 
ttagatatgt coaaaattac toagatcatc aacagaag.ca ttaaaaaaaa ttatcttggit 53OO 
tttgtataat aatact acat gcatotataa agtattoaat taggaaaa.ca aaaaaatgaa 536 O 
gacacacgac atatagitttcaa.gcaa.gaga tatatacaat aattcgatcc aattgacatt 542O 
gaaacctatt alacagttcat gaataattica cqtttatacc aaaacaaaaa cattcatgtt 54.80 
taagatatat atatatatat atatatatat atattittaag atatttaatg attgaaaaaa 554. O 
gacatttatc. tcticagtttg toccaa.gc.ca taaaattca agt caagtat tacttittagg 5 6.OO 
aacatgatga totcttittga toaaaaatct attatgatgt atttgaataa atatacttaa 566 O 
aagttgttac aagtgctgat gtttcaccaa taggctttitt attgtcacta actagttcta 572O 
aaaactgaaa gotttctata tatgtatgtg totgttgttgtc. to accittaat catgttittaa 578O 
gtoaacctaa cittaatcatt atgggagaca cittgttgacitt gttatctata tatttactga 584 O 
tgagttgtaa atgagagttg acacticagaa aaatagacaa agcaaactgt tittctaaaat 59 OO 
aatgaacgtt aaattatgca catattittag tagacggtag citttctaaat cqtacaaaat 596 O 
aatgtcaaga attgacgtga catcattgat taccacatala caaatattga ttctittagta 6O20 
atacgtagta actattgatt aattgtagta catatttittt aatttagg to aactgaaaat 608 O 
tataaatgta aaattgttta citaaatacga aaa.gc.catag taagtgattt acattatatt 614 O 
ggitt tatgaa ataaaactaa agcaggcttg ttatact.gtg talactaggta agcaccacgg 62OO 
citcgacgcaa tag cacgtta gggagtctat agctogc citc tatgcatato aaaattcaca 6260 
attitttgttc gtgaaattct ttttittatcc totgatgtta gaaaccaaag goatcataag 632O 
aaaaattgcg ataatcaaga cittittgcatt aacttttgttg ccaaaaaa.ca attacgc.cala 6,380 
gagtggtaga citttgcattg citt catgatg actittaaaga accotgctgg attctaagta 6 440 
gtaccattca aatctattgt titccagotag ttctatatat tittaaagaat gagittattga 6500 
citctattagt citctaattat tatacttctt agattitttitt tttittttittg gttcaaagtt 656 O 
caac gagtag acattcacag caagattatt ttaaatgcc.g. aaagtatttic tattaatatt 662O 
cittgcaacta coactittaaa totaatccaa attattgtac agtataattgaaagtttc.gc 6680 
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atttgttgtc. tttgtttago to acatatga aagatacatt taacaagaaa aaaatgcgtg 6740 
atgcaaatac agtttgacta atatgcagaa aatatgatgt gcaaggaaaa got attggac 6800 
citgatcgcat ttaatatogt gataa.catga tactacagtt atccaaact g aatctaacga 6860 
atgaataaaa goatttgtat tdggtttagg alacatagaat gttattgaat tottcatcta 6920 
ggcaaaatta agttctataa attaatc.gcc taccaaatat g g gcc acto a tttitttgttt 698O 
aggaagttctt togcaaagatt tta aggcaac gaatggittag goaaataaag cocatttagg O4. O 
citcg accogt aaacgtttac aagtggccac ttagatttac toga catcacci ttatctaagg 71OO 
ttattatt at tdatcago cit aagtattittg gttggtaaag totaaaagga aatat coacg 716 O 
tatacctaaa cqcagotago taact agttg agaaaaaatc gttcaagtta catataagat 220 
tactittgaat aactittatct ttgagatata atttgtttag g gaattitatig cittcg attct 7280 
tgtttc galaa C gatgtacca tactatoatcatalactaggit coaga attct agacggc gcc 734 O 
cittgtaaact acaagaggaa toatcaag.ca agtaaag agg taatgctgaa tocaagacita 7400 
aattagaaag taagagattt cattagctitt aatgagttca aagggaattt caccitagtgg 460 
aagttcggatt cataactatt togttccttaa aag.cggatto atgtttaaca tatttatttg 752O 
ttaaagtaag aataattaat atggctdaaa cc.gtgttctt gtttittcttt tocgtag cac 758O 
tatgcc acta totttatt at acaaaagctt cqgaaattgg atggg acacg tittagccaaa 764 O 
to caaatgat agatatogat tccttgttac ggaaaaaaaa aaaaaaaaag atato gattc 7700 
citttgttitta gttittaattt tttttgtcgt citactitcatc act attacaa gatattaata 776 O 
tttitccitatc cqgtaaaact tactittatta acatacaaat titc.gcatttt toc gataatt 782O 
gaattic caaa cataaaataa aataaactitt ttggtoaaac acttaatgat atgagct tcc 788O 
aaaaat atta atacacattt aagatctaaa taattittgga aagaaagcta aataaatatg 794. O 
aacaaacaag ggaaattaac tagaaattitt ttttgttitta aaaaag.cgga toactggttt 8 OOO 
ttatttittat tittcttittaa aattitatgtt taattittact ttctaataat gaactagtgt 8060 
atgatgatga toc ggaagac tat coaac at gcagttaagt gttaaaaaaa attittaatta 812O 
agtttacgag aggctittaat aaaagagcta agtacatact ggalactatta aaa.gcaacca 818O 
aattgaacag aac actittct attaatctac aagaaactca ttaggataat coaagttgga 824 O 
ataatctact gtaatatott aatctoatca agaagatatt ttcactacaa tatgcaagtg 8300 
acaaaaaaaa tatttgatct attggagtga gttgttgttgt actaccattg acatalag cat 8360 
tottccacat actittcttaa attctactac atcactcittt tatgataaaa ccaaatgagc 842O 
ttcttacatc acacacaatt cataccaaaa ttatatatgt taaaaccaaa aatctoaaat 848 O 
aaatgaaacc acaaactaaa citcaaacticg accitaagttg toggtoaagt ttittctottt 854 O 
cattatcc.gg cagataagat attittaaagg toaagttaac agaagggaat gaccatgttc 8600 
tggaaatagt gct tcc ttgg ggcacaag ca gcgccaccaa alactitcott g to cittcaaaa 8660 
tdcagattcc ataaaccqtc ccaaatagog titatcttcat tcacattagc citcagg tatt 872O 
gttaccggaa ccaccgggta ataccc.gtta citatttggitt cacalaccaga agttgttgtt 878O 
gaatgtgttga totgatgagg tacatataat gcticcactitt cqccactact gctactgctg 884. O 
aaggtgttat caccattgtt gttgtcgtca totagtaacg acatgat citt titt catgtc.g 89 OO 
atttgattga attgaagcaa citgttgttct tactgcaact coatttgttct ttgctgctga 896 O 
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aattgttgcc tottcaag at toggttctitt gtcttctocq cactgttagt td gag acttic 9 O20 
gtottcttct tdaaatgggit togccaatag ttcttgattt cqttgttctgttctitccc.ggit 9 O8O 
aaactacgtg caatcgtgga ccaccitacaa atacaaatca toaga caaaa aaccittagaa 914 O 
taaggaaaaa gagatgagtt acttattagg gtaaagctac aattgtttca tattittagtt 920 O 
to gaatgtaa taaaaaaag ttaa.gagaag aaaattctat ttagcatact agaggatgtg 9260 
aataaacaat caaagcttag gttaattacc tattgc.ccca cittagcatgt aactcaagga 932O 
taatggtttc titcatgagga gtgatttgtc. citctott gag gtctggtott aggtagittaa 9380 
cccatcttaa cct gcagott titcccatttc. tcttcaacco cqc gag ccto goaacagagt 944. O 
to catcgc.cc titcaccgtga agctocacat aatcgatcaa aaggcggtot tottcagoag 95 OO 
tdcaagg.ccc titttctocaa ccttcttcta ccattcc.cca toctoctocc atcccitcccc 956 O 
acaaactcat tatttcttct tagtttittitt ttctittagtgaaagctaaat aag agaagta 962O 
gtgtcttcto cittctotaac agtc.ccacca atctotttitt gtctotctgt cittgttgaaac 968O 
ctaagttgttc citctgttttgtctttgttgtt gtgttttgtt citgtttittcc tottccccitt 974. O 
toattattta tatatacact cactctagot cottggctoc accacttittt ttgtttgttt 98OO 
gttittctata gagatataga citagtgacaa gacaatcttt ttacatttitt agagttgttgt 986 O 
accttittaga atcataaata toatctaacc actaactaaa agaaaattcc gtgcaatata 992 O 
cataccttitt tocccttaaa citacaaaaat agttctacaa gotcittaatt agcaataatt 998O 
agaatttaat gtaaacacaa aagaattacg agaacttggg togctotcgtt accocittitt c 20040 
actggtogtt ttcataagttc tittcgitatgt atcatttcct citgtccattcaactcittgat 20100 
citccaaaggc atcatcatac acaaattact aaattaccoc tottgttggit atatttctitt 20160 
tgagttittaa toatggatga aaacatgcat tigatacatta aaccaaaact tittcttctitt 20220 
totccaacta cattttgagt cottagttgc taaccaaatc tdaaagacaa aagtttacaa 20280 
gtttaattitt tittaaaaaca attctaagaa totaag citta atagt citctg. tatgg gaatt 20340 
acaagtatag aaattaataa aacco gagaa attagaaaag tita acacatt gtaaactagt 20 400 
gtoatggtag gttgaaattt tittggattaa titccaag gag acgtaacaat ggtgagttgt 20460 
ggctactitca toacaatcag tittcaaaaac citatcaatat atatoctitat agaaaaatat 20520 
tottcataac citataacaaa attittcatct tcaaatgaaa cagtgaaggg tocaatgaaa 20580 
atttitcccitt gaag cactat citgatcgtct coctataggc tataagcaaa tacttcttac 20640 
gcatatggtg gaatgaatca gaagaattitt acgagctato gatcc cacat caaaatttct 20700 
gaaaaggtot toccaaagag tat citttcct acatalaccitc gacagaccala gataa.ccgtt 20760 
cactitactac acaagttitta aactcattag titttagg gtt tttgtttitta atatgttaaa 20820 
ccaaaaaaaa gaaaaataaa ttaaatcaaa cagaaattat atttgtatat atatatatat 20880 
atatatatat atataaacga attcagocta aatcaaaaac taalacagatc caaag catala 20940 
tittatttgat titcagttaga attctattga aaagtttaag aaactaaatc aaatttaaat 21000 
gttataatta ttaagccacc caagcttcat cattctoata tacacgaaac gaggatatta 21060 
cagggctatt cattttgatc cattattitta tocaagatta aagaaataat gttaagg cat 21120 
taggtaacat g gtttaacaa ggcatcaaat coaatagaat aatccttitta atctaaattt 21180 
ttatctttitt gatagg gtta agctaaagtt atttacaact tatgttttgttgccacgitat 21240 
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atgatctaga ggtttaatgc agg gacatat attatgatta ttataattat ttaactitcct 21300 
taatgaac at tittcttagaa agcataatta aaagtaaaag aatat catgg togctggatta 21360 
ttittaaggitt atacacatta ttgaaccact aag gtttcto caagttgttcaa ggatattitat 21420 
acatg.cgatc ttacactaat citttgttgtt gtcgtataag attcgttgga titccacataa 21480 
ggagittatta caataaacta tagaaacaaa ccaaataata toaaaaagtt gatggtgttt 21540 
gtacgtdacc atgggacagg toggtottata attctdtcct cittagatatt totaatgtct 21600 
cittcto attt citttctag at attgttgatca atccaaaaaa atgaatgtct ag.cgtttcca 21660 
totttittcca tagtagaaat caaacaaaaa aatactgcaa aatactaata taacaagaaa 21720 
tatctacgtgaaagatgagt tattatatgt cattaatago gttittatgaa aatcacaaac 21780 
tatgtatt at gtc.tctggitt to atgttggg tacgitatttc agatgaacct aaaac caaaa 21840 
citatcggttg gttitttgttt citaaaataca tataacattt toagtaacat coaataaata 21900 
ggatactgaatgttaagttt acgtgtatac atattgcaac ttatttatca aaatatoaat 21960 
tggacggttgaaatttctitt tattaagttcc atgacaaaac taacgtdaac tocaaattitt 22020 
tgatgcgaca aaa.cat agta gttagtta at tag cactaca aac attagac taattittcta 22080 
galactagggit cqgatttagg gtatttcatg cca agcttga cc gatcg act gaccgatcca 22140 
cittgctag to aaaggtaata gattittctitt ttaatataga ttacctatga atgaatctitt 22200 
taaatgccaa aataaggtac atcatcaaat cataattact taaataatgc gtaaactgat 22260 
cgitatgggitt ttgaatctot caagctgtta cqgtggaact attgggg cac titc galagatt 22320 
aggacaattt citaagaagtg aaacgaaata cqttaag acc taatctotag aatatagttc 22380 
cc.gtgtc.ttt coaaag acat ttgatgccita taaaatataa atcacatgac to atcggaag 22440 
agtcgaaaaa cacaaataga act at ggtga aaattcaaat ggttcaa.cag atttittattt 22500 
totaagtatt ttaatcag at tttgttcaca aag caattct caaatttgttg tacctcaacg 22560 
gcto agagac tacagacaca aaggcgtgcc tataagacgt cagdaat atc attcactgat 22620 
tatacataaa aaataattitt taattgaatg attag acact aatcacttitt ttaattccac 2.2680 
atgattaatt atttaattga atcatctaat aaagttttgt cqttggaggit catttgaact 22740 
cc.gtgtttcg tacgggittitt catattattt citg acctittg tactgcaaag acatgtttag 22800 
cagotaag.ca totgattittg citagatatgc titttacgitta agaattattt attittattitt 22860 
aaagtatgtc titttcaggag aattattatt tttittittttgtttitttittca catcatatoc 22920 
citctdaaatt atttgtagitt tatgttgttgat ttgttittggit atatataatg tdtgaatttg 22980 
tttittittaga aacactagag actcc.gtatt gaaatgttta tittaaattat ttgatagaac 23040 
tottttittat aaacacatgt taaaaagacg gtcttgctdt atato agaaa ataaattatc 23100 
aaaact tact cotaaactat atcc.gctaga atttgttgttgt ggagaaatat cqaaaatata 23160 
aattcacatt toggataaac aaaacataaa tttittaaaat gtcataattit aaaatttagt 23 220 
ttaatgttitt tdataaaacg gtoaaattitc gttgatttgg citacttggga taaatcatta 23280 
aattitttgtt aacaagttta atttittatta aaaaataaga aagaatattg aaccaaaatc. 23.340 
gaattgatga tottttagac taatacaa.ca aactittaaac cattgaag.ca cqatago att 23 400 
titcg tatgct agatataata citagg tagta agagatgttga aagaaaaaat gattgcaaag 23460 
aacggataac tittgactaat ttcttactag atacgacaat tittatcaaat attitcgaatc. 23520 
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gtacaagtaa taaaataaac aaaaattcaa atccaac gtt totgcgtgag atgcaacttig 23580 
gcatgtactt tattgatcaa atcatcgitaa tottttgttgt aacttatata acatttitcgt 23640 
catttitttitt ttaagtttitc cccctttittg gtgactittct ttgtcgatta aaaataaagt 23700 
ttgcacgata citttggaatt agcttittaaa ttaattataa taatgttgtt cotatottaa 23760 
gttgaaagtg cagg gatgtg tacttgccaa taatcttcta galaccagagt gaatcattgt 23820 
tattotcaca gctittgatta caaacatttc ccc.ccaaaaa taaaataata caaaaac cat 23880 
atatoaattig caaatctatg g gttcatata taggittittggit aaattcttitt atctittggitt 23940 
gtgacccata toggagtatga ccttggctgt gaccittattt gtggatticta aatctaggac 24000 
ttggittatag togatagact caatatggat totaattitca taaataggat titatgcaaaa 24060 
aatgtatatg g g gaattgta ttagtaaaaa aaaaatcatt ttgcggcata tottaccalaa 24 120 
gttc gaattic cqgttattgc gttat catgc ataatagaga ttgaattat g c gacittgtcc 241.80 
attccaataa totcaaaaac aattgacaat tttittataac act actoaaa atagg cacat 24240 
ttaaacttitt attatataaa attagaaata ggcttacitta gagggattitc cataaactitt 24.300 
tdcaaaaact atttgtttct gcacacactc tdaaagaaac to atctottc ccatctaaag 24360 
atttcagact catcacagtg citcct tactic aagct attat citagaacatt tagaaagagc 24 420 
agaattcaag aaccatatat gtttcacgtt cqc.cggctitc catagdaagt gacat cataa 24480 
caagatgttt cittggcctitt caaacttcta tatttattac atcaggc.cat tctocacatc 24540 
cittittggittt tag cattatg atccaaccac accatgacga titt catgtgc aagtttcctg. 24600 
aaatcttctt ataggaagag tittttittgcc attataattic acatgtttitt cittgtaattit 24660 
tittatctotc. tcttctttitt attctaagtt toatagtgaa atattttgta atgtcttact 24.720 
tattoaatag aagtagaata atatttatto acatacaact titcctaaact tdatagaatc 24780 
citatctaggit aaacaaaatt ggtoaagaac ttaaaccatc tatttcttitt tattatgcgt 24840 
cggataagac gtttgattitt ttittgaagta tatattocto acatgtcttt ttctgaaact 24900 
tttittcgtda citgctcittct tttittatata actacaatgt gttattgttgt cqaagaataa 24960 
attcaaaaca gacaac atta tattatttct acgtttittga ttaaaacata atcacttitcc 25020 
citaaatcatc catcgaaaga atgattctica toaagaaatt acaagatggt agagittaatc 25 080 
toactittcag aatagg tatt tagtataaat coatcataga tatagataac cittatctott 25 140 
atacaataaa taactcittitt gaccaaatta attcatatgc tigcaatcttcaactcittitat 25200 
gtttaattitc gtatatacac citcaaaccita agagtatata aattggaata totagaaagga 25260 
tgcaaaatta togtatttaa ttatatatoa gaaaatatat acttattgta tactttittaa 25320 
aaagaaatcg catcacaa at tdaatcaata tttgttgttct cotaatttitt goaaagaaag 25380 
aalacca actt ttalaccaggit coc gttggitt cagtggattt gagtag tatt goctacc gag 25440 
gtttgagtaa tittaacatag tttitcc.gaac citcaggatta atttitttgag totaggaagic 25500 
citttaaaatc acttgagtta to gattaaaa aagaaagatg agittattoaia gataggatta 25560 
cgittatatat gttagataaa acataatata ttatttacaa aacaacataa acaataatgt 25 620 
tatccaaaga accaacttitt to atttaaaa attaggtaac atagtaaaat tag acattcc 25680 
atattatt at tatatagitaa aggtacagtc attagacitat tcttaggata aattitcactt 25740 
tacatcaccg goctag cqtt atgtag attt cqgtgtttct aatacatgat citgagtctitt 25800 
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ttagtccaaa goaatcgtca toataaagtt gttcggacat gaaggaacta gaaaatticta 25860 
ctaactittgg acaaaattica gttittaaata gttgataata taaccoatag titataatcag 25920 
ttaattittct attitcctggit citatgtc.gcc tagaatgata tacgaattat aaatcttatt 25.980 
tgatagaaaa gaaaatgtta taagagacaa gqcacgcaag aatgattgaa gatggtag at 26040 
aatttaggaa toc agaatac atgataaatt attaccttac ggcattc gala aaagttgttca 26100 
aattatcaat tcttattott tttitttctta taacttgttga titttgttgttgt tittagtggat 26160 
tittctaatca ttaggtaaaa agtgtggtoa tittagtttaa caaaattgta aatat cqaat 26220 
ttgatacaaa atgaaattaa toagtttalaa aataaaggitt togacaaaaaa aaaag agttt 26280 
aaaaataaat aaaaaaactt agagaatcaa aatgagagtt tta attcttg to atgttittg 26340 
ttittgatgca agaaaaagta toc gaggatg citaaatagot tagaatgtca togaatacgtg 26400 
atgaaatcat tacccaagct totaticatat gaaagtattt agggaaaatt gttcaatticag 26460 
aatttcttac aatgagtcaa tagtaggaaa gttttgtaac aattittataa aatttgg gtt 26520 
aacatttgta aggtaaaaaa aactacattg aag gaccact acatattoga citatattitta 26580 
ttttgttitta ataatcagag gtggtgttgg aaacaacgta aggttggatt aag caaatgt 26640 
gaag catcca aatcgittaat taattaatga cagcaaatca agtttggctg. ittaaacacta 26700 
aag accaatc. caccitctago tatctattitt actittgacga aacco attta tdagttgtga 26760 
aataattact citttgattac tittataaaac cittaaccitaa caagttgaaac tottttaatt 26820 
acttittgctt agctcaagttc tactggttga aagaaaagat acattgttctt ttctotatto 26880 
caagttcgag totagtgaat ggattgaaaa citctagaaga tatatgagtic atctaaaagt 26940 
taagaaagtg agagatattg agtagaagtg caaaaccitta ggitta agg to gagggtggtg 27000 
gggctattitc atcaacaatt tacgcacgaa toccaaaaca aag cittatca atttitttittg 27060 
gcatagtata totaattagt gttgttaggc aaatacttac atcattcttt taaaatatto 27 120 
tittcttctitt ttgttataaa gaaataaata actatttittt ttctitcctitt cocacaaatt 27 180 
tattittittat gaccatctoa tttittaaaga taacttgata gattaggaac toacatttaa 27240 
actagtttca aaatctgtaa aag atctato tttactattt atattacaaa ggctitatggt 27.300 
aattitccaca citttataaat g g g attttgt gcaaaagaaa cccttcttag togcctattt 27360 
ttgcaactitt accotctato tcc.gaaaaat gcataataac totatgaagit taaaaataat 27420 
aaacaatata ttggctattg tdaagtttitt aaaatttaat aagtaatata toaaatcgag 27480 
actcitc.gaga cigaggagttcaactcittitat aatticcittitt taaaccottt agaatatoat 27540 
atatttctitc tag agtgtta citttctttct acaaaattat tatctaatct titactctgta 27600 
atattacatt togaaaagttg cacattcatg tatgcatcat titcctaattt tagaaaagat 27660 
atatttccta gttaatgata tacggatcaa tttitccaaac aattatttgt gatatottaa 27720 
agaaactitta atttcagttg to catgaaac atgtggtaat atagaga.gca titcc taggta 27780 
acaacatcaa cittgtaatat atatattoct gaacaatgtt acaag catct aatgagctitc 27840 
atagttcatc gtgcatgcgt tdttgtagag gaatattaac agttggaact gtattgc.cat 27900 
caaactgttg toc gag.cggc ataacatcat citcctacacc atttgctgct tittccagota 27960 
attgagctitt aatago agca gtagc cattc gttgcagttt cagaatticcg atgcgttittg 28020 
aaacaacgta aacaac agca aag acaaaga gagaaaatcc aactato agg attatcc tot 28080 
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tgatagtgcc acagaaaa.ca agagittagtt agtattatta ttcaccitata gaatggtttg 281 40 
gtaaaacaga gtctattotc titttcaaata cct gtcaatt acatcttgac gotgcattgt 28200 
tgaaagtaga ttacgggtoc togacaa.cag agatctatoga cctttgtatt cactcitcggc 28260 
ttttittaagt acticcagtag attcatctac aaatgttaac atgtataata ataataatat 28320 
gtoagttitta totcittaatc tatttitcact aagg acttaa ttatctggca tattatgaat 28380 
gacataccala aagccacgag agtgtttgta citt.cgttcaa cct cotgitaa cccaagttcaa 28440 
gagagtattt togatcacaca ttgtttataa attaagaagc cqaatatgca aacaagtgta 28500 
aatgcacaat catttcataa citagttttitt totgacctga accatcagot gcc.gtgaacg 28560 
cctgag actt toagittatgc tittcagdatc ggatgtcacg ccago atttg citctataaac 28 620 
aaccacaaat gttagattca citggaaacta acactgaact cittitttittag td catgatgc 28680 
atttaccalat aaacaaaag.c ataatacaac ttaaacatgt coaa.gaggag toccaattga 28740 
attgctggat tttgtaggat aaatatagoa gagtttccala gatgtacata citgtcgttta 28800 
cgtotgagaa citgtag acto tdttccacca cc gaggagaa got citcticta caatcattga 28.860 
aag cactcitt tacacaaaaa tttcaaaagg agctggctgg taaaaac agt ggcagagaga 28920 
gagaatgctt aag coatgag actttacctd ttcttgagct gctttccitca tottatcctt 28.980 
agcttgcaaa ttagcactitc. tcaagtttac cct caaacto accacaaaca cagtgacaaa 29040 
actcat atta gtttcaccca tittatcttitc cct gaactca tactcitcact citcttgttgt 29 100 
accagaattic taagtaactg agatcaaact caatttcaag gaaatactitt aaaac acto a 29160 
tatatoattg aaaaggatat ataac attcc totcgttctt acaaactact acaacgatga 29220 
citcaagtacc cittatgccaa aaggittaaac goacactato acatcatttgtccitagagat 29280 
tgaattactic aactg.cctaa agacaaccitt aattgtacaa atgcaaggitt catatattot 29340 
acttgttgaaa tottgtag at to cacaagca gacagtaaac caaattitcca agtacct gtg 29 400 
atattgattc titccacgttt Caaggagtga citgagtggat tda acct gat catcaga agg 29 460 
aagctgaggit gcgagcagat coaaattgaa ttgaagg gala ttgagaagag agagaccatc. 29520 
citgagccaat cogttgagcc totgtaacga aaacttctot totccitccat citcccctcct 29580 
tgatttaccg tactgttgaa to gagataat atgtccaatc gtcttctogt acgcttctitc. 29640 
ccattctdtc titcgtottct coacttcaac aacaaccitca tocatgtcgt aactgcaaat 297.00 
ttcatalaatt ataaaactgc agagtttagt aatcaaaaga gatataalaca agctacggaa 29760 
totcccaatig caatctgcta atagotctdt aaacatccaa cacgtataac catctaatgg 29820 
tittctgitatgaattat gatc gaatcactac aggaacggta totagaag act c gattgattit 29880 
gatgggatat aagggtoaca aacttacatt gttgatcga aagagatgaa gag.cggaga a 29940 
aatgagaatgaaattgcgaa act agggitat aaggttgaag aagatctggg aaccagagag 30 000 
tgttggagat caatattgat citgtagaaga caccitcaaat tittgatttct ggggaagaag 30 060 
agaaataact aaaaacgacg tagttittaga taalaccatgt citattotaaa ccc.ggittatc. 30120 
ttgcaattgc tatcattgtc. tdgtocaatg tocggittitat cagittattta gttatatggt 30 180 
catattotta ttggittaaaa tittctago at tacttattga tigaataaaga agtttactgc 30240 
tgagttttgttcaaagtaca C gttaatcgg atttatgaaa cigacaattac acagacitgac 30 300 
ccaaaattgg taattgcggc atccg actta ccc.gaactg.c atgcc.gttitt gcaaaatcto 30360 
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aaaatgaaaa acgg catggit ttcttagtaa totactctag ttctago: aaa citgacittgtt 30420 
caattgcaca tagagatgat caactacaaa cacagotaat gtttcaaact ataagatgct 30 480 
gacitacgt.ct gatgtactica agcttgagga cqttcc.gaaa ttacggtgct titc catcggc 30540 
taggittagcc agagagtagc cittgttcatg gagttgatta atcaatagag totctaact g 306.00 
acaag.ccatg citcttacctt gaaccataag gtatagaaaa cittgaccctt gcagtcctitc. 30660 
citttgctoga tigcgcacgta titcgtccttcaag atcatcg gtctgcagtt togtaacaga 30720 
aatcctcaga atcaataact titcgttittct gtctattota agagaagttt tataatatta 30780 
atatggtaag tatgtacctg. tccaatgtac aatctottat cqggtotccg catcacatac 30840 
acgcatgaag aaccaactgt agatggaggt ggaagct cac gag caccaat tdaaaga cat 30900 
totattgctt caggctcaat catctttittc ccacagattt tdacgatago ttittgctaag 30960 
toctitctoca aacttctotc agagctgact g gtttittgga totgctgg to attgttggat 31020 
gaagttatga tittggtoggg tittgacaact tcagotgatg cqtcttittgc ataga.ccgag 31080 
aggtaaagag cittcagotct ttggataact gacitcgg gaa cacct tccct cittagctgtt 311 40 
tdaaacgcaa gactictotct gcag actoca totgttcaatt tocaagttgg cittggitttgc 3.1200 
cctitcgacat tittcggctcc cattgctitta tatgttgatgt tttitc.gctgt aag aggtaaa 31260 
citgaagatto catggagatg agtagataca atacccaaac aaccacttgt gttcaag act c 31320 
totaccacac taccagcqat acaggtgcct tittgctgtct citgtc.ccitcg gcatatotca 31380 
totataag.ca citaggottct c galagtagcc tdgcttacaa tagat.cgitat titc.cgacatt 31440 
totacctgat ggcacagaac cagttgagag gat atcaaac attacaatta aagaaaaaaa 31500 
aacagtttgg toga attctag atttgtatgc titatatatat acctggaaag aacttitttcc 31560 
gtotacaggg citgtcatatg atttcatgtg aag catgatg gaatcaaagt gaggaataca 31 620 
agctgattica gctggalacca tta aaccq ga aattic caagt agagcagot g c gcatattga 31 680 
totgagcaaa citcgatttac caccaccgtt agg to cagtt agaagaalaca gtgattgcat 31740 
gtoaacggta ttgttgaacag cq gttccaga agata catca aaccaataag gtgacaggcc 31800 
tgtcag ctitc attcgactgg caccatctaa taggittittgcg ccctatatta aaatatato a 31860 
aaataggtgc atgagatata taagaataag acagoccago atgttttgttg atttcttaga 3 1920 
aattgcacgc atctgtctac aaactcaacg actag caag.c acagttacct catctaaact 3 1980 
gaatcc gaca agc gttggaa aaacco actt togccittcto cottcactgt agttgtgcac 32040 
agtacttaga ttaaaactac agaaatttct taatgagaat tdattaa.gcg caaacttacc 32100 
aag catggga aaataatgct tittgaaatga ccagaag cat agatgcaaag acaagaacat 32160 
ttattitttgt ttgcaattta acggataact cqc.gcaacag titccaac acc cgagcttittg 32220 
cattctoact agcttcatgg tatctgcaac aaaag cataa catgatatat caatacatac 32280 
ccagtatt at tdaataaatt tottttggat ggttcaataa aac gaggaaa caacctgact 32340 
aaag caattt coacctittgg g g togtaaac cattcttcto caacctttitt toctittcgag 32400 
totaaggcag gtttcagotg ttittatttgg tottc.ccctg cagtaccago coagatagat 32460 
gg.cgitaaacc gtttcc cctt gaaccaaaca gacticatgct citcttgcata td.cgattitcg 32520 
ccttitcgggc caccaagtga agcagtggtg gccittaattic ttgatataat agggtgaaaa 32580 
toctoagcta cotacacatg gatgttittga citcttacaaa tacgacaaga toaccagdac 32640 









































































































































































aac cotaaaa gqaataaact 
tat cqtaagc aggagggttc 
ggaagaagta gaggaga aaa. 
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ata actttac tacaa.gcaaa 
cittaagaaga tigtggct citc 
cgaattagtc. tattittatca 
atgtgagtaa gottgaaatt 
gaatact atc tdatc galaga 
aag catcitat to caatagoc 
gta acagtct tcatalagata 
agtaacaaag atcacaaaac 




catttgataa cca agctaaa 
totaatagtic to agaag aga 
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gaaac atcta gaattacata 
cacaaagtgt titcaccalatg 
gtacaaatca caaat atcca 
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agaacgctaa totaaag agt 
citggaaatgg aacgc.ctg.cg 
ttgatgagga cqccaag agt 
agtttgatgg gaga.ccgaaa 
tggttcc togt ggaagatgtg 
catata acct c gatgacittg 
cago acticgg gtatggatcc 
cctittaatat gtattatcag 
tgg gtttgat cacagatgaa 
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citagagt citc agagtgg gat 
ttcatgtcag atttctittgg 
tgcc.galacca totcg to gag 







































Oct. 21, 2004 
US 2004/0210962 A1 Oct. 21, 2004 
44 
-continued 
gaag accagt toggatatgc gatgtttcto actittgctta cagtacttgttccactcaga 395.40 
tgtgtc.tttg accatgagat ggtaaatgaa cacago acgc titttgaccala ttctgaaag c 39600 
togactitatg gottggctitt caacagaagg gttccaaaca acatcaagaa toacaactct 39660 
tgaag.cgc.ca acaagacitga tacccitcaga acatgcttitt gttgatgcca gtagaactitt 39720 
agatccactg. tctggitttgttgaagttgtc gatcatatgc tigcctgtctd tttgttcaac 39780 
tttaccatgc atcaag agaa tttgttcc cc titcagtc.cag tdacattctg caatgagctg. 39840 
citccatgatc agcttcagag tdtcaatata ttggctatac accaacactt totctittcac 39900 
ggttccactg atgcggatga agtcgataag gaactttgtt ttcacaccitt cotcg tattt 39960 
aagttctaagc citcttgagag titcctaatgttgctgg.ccca ataaccaagt cittccttctt 40020 
ggtoggattg cago.acaaat acagagatgg gtgtactgaa acagotgaaa gottgtgctic 40080 
aaattcaaat gtgttittgag aagtgtcaat totgtcaaga attittcttct gttgaaaagg 40140 
cgggttcaac acgaca acac agt citcttag acctggaagg citttcttgaa goatggttcc 40200 
ttcatggaca to cacaaaat gag caatcat agccittaaga tocacaattic tatttitcctc 40260 
attcaccott cogtgttcto cittcttggct acacttgcta agttcatgta toctogaaga 40320 
aatcgitatct ttatcagotg gtc.ttgc.cag goatalagacg ttagaaagtt cottgaaatt 40380 
attctggaac agtgtc.cctg aaagaaagat acgcttittct gttctgacitt cagtaag cac 40 440 
tttcCaaatg agaCtactict g gtttctogg g g togtggccc togtoaagga Ccago aacco 40500 
cggcaattct accaacatcc toctaaacac ttgcattcct tcagtgttct tatttgcc.gc. 40560 
gagcttctica tacagagggit agctaatticc aagaatgctt ttctgct tcc accacgaaac 40620 
tagcttaacc atacggatgg aattatgatg cctattitccc totaaacgtg agacagottc. 40680 
agcatcctca taccctgata actgcag act attcatgtta taaaatggaa tatttacgitt 40740 
ccatttcc to actitcgtc.tt cocaagtacg cattagagtt gcaggagcta toaccatagg 40 800 
atggctattt goaaac cqtt ttaagtatga citgaagaaaa acgacggtoa aacgtgtc.tt 40860 
accagttcca gccittatgcg aaataatgca tocgc.cactt cocittaacco citacgctgtt 40920 
caacto atta attitttgttg toccagotaa attctitccaa ataaattcaa accottcttg 40980 
ttggtotggg tacaaagtat citttgatgcc agg gacgitat togc.ca.gacag titccittctat 41040 
attatccaaa goggcgacaa aactgctggg atctgaag.ca toaaacticaa goctottagg 41100 
taaagg gtca coctittctat cactacattt cittattgtca tta acactag gacgatactt 41160 
gtoctocaca atgcaggaaa atgaacatgt taagaactca gataagaaaa toaacaaata 41.220 
gtacaactica atctaggatt to a gag.cgct ataaaaatgt taccatggct ggtgagatgt 41280 
citttgatcto gacago caca tacgcacagt ggacgcattt caaac cqatt to atcatcca 41340 
ggacaaagtc gtgtgtc.cct ttgctacata gcatatotcc attctaatac atcagaga.gc. 41400 
aagtaattta atttcatggit gaatcaatga tacaaaaaaa aaaggtggag atacgaacca 41460 
aaaag.cacgc aacaagattg to agg catag cct gggcaat atagaagaat tagtagt citt 41520 
actittatcag g g g tagatga gtgcattcct tccaatgtta gag caac gtt catat ctitcc 41580 
cacaa.gctgt citaattctitt citcctcittct gttittctoga taag cacagg citcctc.gcag 41640 
ccaaatctoa agtttaaagg aggtgaatct tctgtc.gagt agtttattgt citcttctoca 41700 
tdacagagitt tttc.gccaccataaaaactc. tcaccattca agtggttctt citcccitcacc 41760 
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citatggaaac toctocqttc ccttggitttc ccatgttcat ttaccttcto acttgagctc. 41820 
toccitaacta caggatctitc. tctagaatca accitctgcta ttttgtc.cca ggagaaaata 41880 
tottccittga aaacgtctitt gctcitccaac atagatttag citagdaggitt aattacatcg 41940 
aagttatgct tccitacgaaa agtccitcgac ttctitatgat ggtatactitt titcacttggg 42000 
ttctttitc.gc atgtag catc gitotctggta ccaccctcitt catccitcaga acaaacgaaa 42060 
toactatoag agotcitctac atcagaagaa totgaactitt cocccacgta atcagatgag 42120 
tdagaatcat tag catctitc atccatatoa citctdaccag aatctotato titc.gc.cacta 42180 
actitccitcto ttgaatcagt coctaattcc totaaagggit ctitccitcatc atcagaacta 42240 
gaacttagaci ttacaaccitc atcag acaca taagttcttct cotcacccct caaattagda 42300 
to atccagaa gaatatocaca aacct cagaa ccago attga catcc togac atgctgattic 42360 
totc.ccg.cga tagttccaag gaaaacaa.ca to atcatcat catcc.ggaga taaagggttc. 42420 
totttaccac toactittagc atcatcctca toaaaatcac aaaccotagg agaaatcacc 42480 
gaag cagaac caacattgtc atcatcctct acatgatcat tctdtctotg aacagttcca 42540 
acgaaaacaa catcatcatc atcatctata gggittaaaat tagaagctitt citcttcacat 42600 
cccaaattac gatcatcago atcaaaatca caaaccotat caccaaaatc aaacgattitc. 42660 
gattgtaaat tcc.cagaagt agaaccaaca ttctdatcat citc.gcttacc titcaggatat 42720 
toagttctaa caaatacaac atcgtcgtca to atcct tcc toc gocgtcg tittcttctitc. 42780 
citcggagaag gtgaacaagc atcacgcatg tta actotcc tottctoagt cotcgaattt 42840 
acacaaccoa gag actgatc ttcttcttct coagaaatcc cctittgattt attgagaatc. 42900 
gagttcaagt aagatticagt cotcgaacga gttcttctag caacacaact agt catato c 42960 
atggctgaag agagaaatcg aaaaccotag aatagtggat ttgacgaaga aggaagaaag 43020 
citcatgtcct citctoctotg ttgttctotgc aaattitttitt ttttittgcct ttgg.cggitaa 43 080 
cgattoaact ttctogaaac attcaataaa aaaggitttitt ttttgtttgt ttctittatta 43140 
gggtaaattg taatatttga aaagatgagg ggctaagtga aaattaatag ataagtttgc 43200 
ttcatttcta ttggtgggaa ttgattgaca tagagtttcaaagttaaag gtggatgtta 43260 
citggttctgt cagtagatag agg tatttaa taggggtoaa aat attagt g gaaaaatgaa. 43320 
aagcttittag tatttcaaat atattittaca aattggittac taattitttitt tattgtaatg 43380 
gtgctggtaa ggacaaaaat totattattt gcttaggatt citctoctitta tattittgatg 43440 
tgagtatgtg actaatattt citgcaaacga tittagtgttg ggittattaga gaaagatato 43500 
ttctggagaa cqaaaatctg gaggtgagat cattgctgat ttgaattgta aattitttitat 435.60 
gaaaattittg togtaatcaa atctaatggc gaaaattcat agacagagtic acticacagag 43620 
atatgcaatt tatacaactt ttacgattat atattittittg cggitttaatc tatcaaaaca 43680 
tgtattataa cittaaataga agattatt at tatttgtttgtttcaaaaat aaaaagagitt 43740 
tgcggaataa ttagtagaac atgttagagt taatataaat atgatagaga atgagttaaa 43800 
tagaatgtta actittgacac ttctaaattt ataattacag taataaatta tacataccag 43.860 
aggctatata taaaaatact aaaaaaataa attatatoac tittaatactt atttaaaatg 43920 
tgtaacaatc taaaaaaatg gtotggtagt atattacgaa ttaaattitta ttagttatat 43980 
aaaaaaaaat atgatgaaga ggctdaattic citcaaag caa tittatgtgag agttcaatta 44040 
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ttattagatt totaaaatta tatttittgag attggattitc taaagttcta tttittgagtt 44 100 
tgaactitt.ca acgagittata aaattggaaa tacaaaatct tatggaatcg aattatctaa. 44 160 
cc.gg gtttag gttccaccga totagacitaat cqgatcagot caagttctaa aatatgtaaa. 44220 
agctic gtaac gagaactittcaaatttgggg caaaaaaa.ca toga actttct aaatgtcatt 4428O 
taaatctoaa agtttggttt gactittataa taaaatggitt aagttttgtt gaccgagtca 44340 
ttittagg cat gtcgittaaat titttgttaat taaaagatga cc.gagittaac ttittcataat 44400 
gtttgg gttt agaacgatac Cittatatgta tittagaaaga tacct cataa gotttctgat 44 460 
accotacgitt gtgatggittt ttctotttaa tdacatcata tatgtatata agatttattt 44520 
attitcc caaa cigaaaaatta actctgtcgt citttittatta acggaaattt atcgatatgc 44580 
citataatgat tcaatcaacg aaatttacta ttittattata aagttcaaacc aaaatttaag 44640 
attittattaa cattttgaaa attcatgttt titatgtc.cca aatttgaaag tittgcaaaaa. 44700 
aattittgaca tttittccc.ga totaaattta ccatttaaac aataaaaagt aaaaggtoaa. 44760 
aatgtaac at tittagaaa.ca caaaggacaa aatgataaat atcatgccala C go gttgatc. 44.820 
ggtttittagc ticttittctitc cqattitcgtt ttittctttct tcatctotaa gattaag cac 44880 
accttgg cat coatttitcgt ttgaatctoa acgttttittg cittgattitta gcttctgaga 44940 
gagtccagat coaaggaatt gaggaagaa taatgtcggc aaggcatcgg caatcgtc.gt 45 000 
atc.gagatcg gagtgacgaa ttcttcaaaa ttgtggagac totaaggaga to gattgctc. 45060 
cggcto cqgc ggc gaataat gtgcc.gtatg gtaataatcg gaacgatggit gc gagaagag 45120 
aggatctitat caacaaatcc gagttcaa.ca agaga.gctitc. tcatattggt ttagctatta 45 180 
atcaaacg to goagaagcta togaa.gcttg cqaaacgtaa gttgttt tag tdtttagctic 45240 
atttgatttg gtgagatctt gtgaatctgg attagttaac citgtaatggc tittagct tag 45.300 
gaattagaat ggtgcttaga to gagaac cq atttatttag togtotgaat ttctoaagtg 45360 
cittatcttag tactc.gagaa totgtaattg gtatggaaga tigctd tattt totgcataat 45 420 
tgttaactitt gtcgttitttgttgcaaatca gttgcaaaga gga catcagt gtttgatgat 45.480 
cc tacticagg agatacaaga gctgacggta gtcatcaagc aagagatcto tcc totaaat 45540 
totgctctgg to gacct tca attgttcc.gc agttctgaga atgatgaagg gaataactct 45 600 
agagacaggg acaaaagtac toacticagoa actgttgttg acgatctaaa gitatcgtttg 45 660 
atggatacta ccaaag agitt taaggatgtt cittaccatga galacc gaggt tttittctittg 45720 
titcc.gtcg at ttctttitcga taaagcttga gitatgcagtc gtgactgagc tatgatttac 45780 
ttgtctggtg ttgcagaata toga aggtoca togaaagtaga aggcaactct tct cittcaaa. 45840 
tgcttcaaaa gaatcaacaa acco attcgt togc.cagogt cotttggct g c taaggctgc 45900 
tgctagtgaa totgttccitc titccatgggc aaatgggtot tottcatctt catctoagitt 45960 
agtc.ccatgg taaagtacta tta accgaat aaccacagtt gcaaatacag catacttctt 46020 
gaaatctggc taagaatttg gtctaatggg agtccagaaa gttgtcatgg gtttacitaga 46080 
atgttittctg taccatgtca gtcgttgctg atttalagatc togcttgtca agaactcaag 46140 
acgttt cata atctotgctt ttacaggaag ccgggagagg gagaatcttic accattgttg 4620 0 
cagoagag to aacaacaa.ca gcaa.cago aa cagcaacaaa togtoccatt gcaag acaca 46260 
tatatgcagg gtc gag caga agctotacac accgttgaat caacaatcca toagctaagc 46.320 




























































































































































to caatgatt catagaacat 
aggat.cgatc aaaac atgga 
gcc aggtatic toaac agitat 
citcattgcat ttctdatgat 
gattittaaag agtttcaa.ca 
tgtaaag act talagagaaaa 
taatgtcact titcatgtaaa 
ttctotttitc attaccactg 
titt attatgt aaagacaaaa 
taagttaatc aatctacgac 
caa.cacalata atcaccalatt 
tagct cittca aattcaggac 
titcgtctaag citc.gctggitt 
agcttatagt agg cactaca 
aatgacagag acattcttga 
tacticag citt catgtttittg 
acagaatgaa citaaatcatt 
gtoaagacitg citctaac acc 
cgg tacticag titatcatcac 
aaggaaaaac togtaattta 
gttggttitta cccittgg cac 
aaaaggtgcc cctttittcaa 
caaacattgt gtccaaattit 
cagdalactaa cagtagt citt 
ttgg tatttic aatataaaag 
tgcatatoat acctgaagcc 
ccittaacaga cittacttaca 
ggg acto agt titcaggatca 
gatcc ttgga act gtattac 
aaaagcticct atatttgaaa 
cctacagg to agctgacaaa 
aatgttgtc.cc aag acco aca 
tacctaggta agc acct gca 
acago: aaatt gttatgcaaa 
citt.cgcc agg gctatoagct 
catttitctgg cattgc gagg 
aagaaatgca tataaatgc 
46.380 
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cctctgttat cactcgg tag 
tgc catc.cat taaagagata 
acticagotgt aaatacctaa 
aacatacatt ttgaagg gta 
aag acactda aggtgacitac 
ggagtaaatc. tctagaatcc 
agaaataaag aatagaccac 










agg ccc.gaga tigtgctitcct 
catcaa.gcaa gottttgtac 
aacttgg gtt gtgaaaaag.c 
gagctittagg to gatcaaga 












gc gaacgtac attgctogctg 
tgctogt gta agtaatgaag 
attgttgttcg aactccattt 
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tittccataag aaccaaacta catttcagtc gttgttgttt cittgtttccg tittaaattitt 55500 
aatctaattt attgttittat gtacgtgcct tattittattg ttcaaatcct citc.gcaatgt 55560 
acgtatagitt totggtgtac got atcgtgt acgtatatta gttittggtgc cittcaacatc 55 620 
aaaaactgtt agatttatac titatgttgttg tacgcaattt cocaatgtac gataaacgaa 55680 
gtttaatata citatatagtg tacgtacacg aagacatcta gtaatacitta aagtggtaat 55740 
to attcaaaa goc agaaa.ca taaaaaagga caggcagttt atataaaggg aaatt cataa 55800 
gataagataa ataaactgga acg attcaaa aaa.cataatt ttittaaacga agcatacaca 55860 
tgtgttgcaa aatatgtgtg catcc.gtoat accaaaagac to gagagtag agcc.gagtag 55920 
agtag cittag accittagcag ctittgcttct agtagaatat agccatctoc citgg.cgtacc 55.980 
agtagaaaaa acaaac cotg cago catgat ggaacgtgca ttacccitacg caacticggcg 560-40 
ggtggacaaa cctocaagac cittitcc.ca.gc gg.cgagcatt titcagtgtga agctggctda 5 6100 
tgtgatacat caccatctot gcaa.ccg.cgt ggc.ca.gcttcaagggtgggt gtcatttcc c 56160 
agaacttittc gctgataggg aggaaatcca agtgattacc ggtacacgta aggaacaaac 5 6220 
cggttgcgaa goaa.gcaaag g gatcagata aag.cgacggit totcatgact gaaaggccct 56280 
gagctact.gt cacgaagttg citc.gcttggc galacaccittcaaggtaalacc gcc.gg gatgg 56340 
atccacgttc tacaag cacc togaagtatg gcc agaaggg agaccc.cggit toggagtaacg 56 400 
acggccacgt catgaattica to gattgcaa gggtgttgat gtcagaactg. tag actaagt 56.460 
to cittagcgt citctatogga gtctggctga C ggggaggta gttgacaagt atgct tatgg 56.520 
ggitttggcaa ttggattcct aggtacaact c ggttggagg ggittagcgga gg taggaaag 56580 
gcattgttitt toaaacgagg aggtotagac ggatttgttgt attcaactaa gtgttgtttgt 56640 
catgagttitt aaagaggaga ataac catca atgtaagtgg gtgggtgacg toggatgtata 56700 
tittagtgcat catattagta acttittaatt taaacaaatt cotgttgtacc totcataatc. 56760 
gc gcc.gtgta C gtctacaaa atact catta cqttctotga cagaaggttg agttgacgtc. 56820 
tgtttgtatg gcatataagt ggaacaatat ggctt catgt atagtgctat attagggg to 56.880 
aacgcattta citaacaatct tittcaaataa acattaactt acttattitta totgccaaat 56940 
caattgagta cattgctcgg talaccgtgta C gttctaatag agatattaat gagagtgttga 57 000 
tggaggtoac ttctagagtg tatttgacag cqagtaatta atttggagcg aaatcttcta 57060 
tatatgggitt atacgacg to aaacaaattt cottttgttct tcatttacaa atatogtogc 57 120 
toactatata atctittatag ttggaattaa actatgccac gtgtacatta toatatatog 57 180 
tgtacgtaga tattittatta ttittattatt ttaatgatgt citcat attag agtactittga 57240 
gctagtatgt ttcaatcaat tacaaagtgg taatttaatt aaaaacaaac titccattact 57300 
gataatcaac gtaaaaagct cacatattgttgcatggaaa acttataaat atgacaggat 57360 
cgtggc gaat gtgagctcta caggatctgg citaatcc gtt tag cacacaa ccagatgtaa 57 420 
cattggttgc aaagattatt galaga.gtotc gatctaatgt alacacacctic cqc.gcattca 57480 
ggagtgctta cqtcaacaca titc.cgggaac gaaaaactgt tag.cgitatgt gtattittaaa 575 40 
gtattaccat atttctittat atcttittagc accitcctcac aaatgtcacg td.cgtccitcc 576.00 
gatticcaaag cataatggitt gottc.cgaag agc.cgaaggit agacaccacc catgtgagca 57660 
ttaccago ac atatgtaaag aattgcgcat gcaagggttg cagoggc gtt cottgggg.cg 57.720 
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attcgctota agtgtaggat agctocctgg atgtcag act catgtgtaac gagacgcagt 57780 
ccitt catggit aaatagocgt ggggittacca gcttgtaagc accgttgaaa gaaggat.cta 57 840 
tagc gatctt cqgagttgat gtcatttgga togtggcctg. cc.gc.gtagaa gtcatcggga 57900 
togtogcaca toctaaaat gtttgcattt ttgagga cat coggacggta gacaatgtct 57960 
cittccacgag gaccggattt talacataggit cog aggtacc accalacattt gttcagccatt 58 020 
ttcttggcta tottc.gcaag caaatcgtca ggaatatttg g gtttgtcat atttaggagt 58080 
aaggtgtttc gagaaaatga aatttgaaca cittaaataag catcattgaa gatatggttg 58140 
ggtaagttat g gttgtattt attgcaaagg tattaagtga titatgtgitat tcatattgtc. 58.200 
aaatcaaagt aatagtatto catatataat ttgttatcgt tdttatgagc aacctcttitt 58260 
taataacago ttaaaactag acgtgitacgt tttactgacg gtcttagtgt acgtocacat 58320 
ttacatttct acatttactic aacaaacagt gtacgttgta gtgitatgttt tagtgaacgt 58380 
ccacatttac atttctacat ttgcc caaca aacagtgitac gttgtag tdt acgtttaagt 58440 
gtacgtocac atttacattt citacatttgc ccaacaaaca gtgitacgttg tagtgitacgt 58500 
tittagtgtac gitccatattt acatttctac atttacticaa cag acagtgt acgctgtagt 585.60 
gtactattag tdtacgtoca ttcataaata toaccattta toagacaaac caaag acctc. 58620 
atatgtttgc atgtgttatt ttittagtgta cqttagagtt gatatotcat gctagtgaac 58680 
gtocatatot agttitt.ccga gacaaagaaa aaaccitctaa gtattatttg gtagatgcac 58740 
gtgtacggag ttgttggacgc titagattitta atatocaaat ttacatttac tdcagtgtct 58800 
aaatat cata totgaatttg goggaaaaat attcaacttg agaalacatala cacaccittgc 58.860 
aaatttctta agcaataata taatttcaac ataaacataa acaatatagt agaaggctta 58920 
toataatttg aaa.cataa.ca tag.cggataa cataaacaaa catataaagt agaatggaat 589 80 
aactatagoa tittgactaac acgc.ctggca cac gaccaga ggtaa.ca.gcg gttgcaaacg 590 40 
ttittggaaag citcctgatac catgitaacaa tataaggcgc aag gagg cat actaatticca 591.00 
tggctogtag gataagagaa cqtaggacca tatgtattgc tigtatggagg gtcaaacttic 591.60 
tittattitcCt c gatgaactc atc accoa aa acticgagtgg caa.ccgagtc. caatggataa 59220 
tggttgcggg talaga.gctd tagaaacaag cc.gcc catat aatcataccc agcacatatg 59280 
aatacaatgg cqcatgcaag tdttgcattt gctcgtact g gag catgacg citgitalaga.gc. 59340 
citgatggcto cattgatgtt togttcatgc gttagaacac gaatacctitc gitaatacacg 59400 
gcc.gtgggat tattagctgc aaaac accitt aagaaaaatg titc gatgtcg goctt catca 5946.0 
gc ggat.ccgg agggattgttg gocccitccag cittggaagttc atcgggc gag to acaca agg 59520 
tgagaatatt goatctttg agg acatc.cg gacggtagac aatgtcticitt coacgagtgc 59580 
cggctogtac caatggacca aggtoggacc agcattgg to agc.caggttc ttagctatot 59 640 
toga gagtaa atcgtoggga agagtcgggit talaccatgtt togaaatgaga tag to agagg 5.9700 
togtoagtaa tittcttcact ttaataacca citactgttgaa tittggttgg g g caattacgg 59760 
ttgaaatgaa tdtcatactt gtgttggtaa gogttggctg. tcaaatcaat ttatcacttig 59820 
agittatgtta taaagttaat atgcagtgta cq agacatat agatatgtac gitacacattt 59880 
acattatgta attataagtgaac gatgttgt acgacaatat gatagaggac aataa attaa 59940 
cittctgacaa totccaaatt aaatgtagitt gcaatcatat atataagttca ggitttgttca 60000 






























































































































































gggttittgag Caacgg tagg 










agagtgttgaa toc totaaaa 












gatcactgt g g g tottctat 
citgcc.gc.ctic aacct gtaga 
aatatatatg tacacagaac 
agctgtgtct coatcagaag 
cgatgcact g g catctottg 
cgtacacata toggaaaaaga 
toggc.ccct g tatgggtacc 
tgaaacatag gottaccatag 
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aaga cagtcc cagacattga acctaagcag acagt cittac caacaacaat attitccticta 62340 
toctgaaaca tagtttaact aacttcttaa gogaatatgt acgtacacca tittaaacaga 62400 
ttgtta agag tattagtaga cqacatacca gatgggattg totggat.cca gcataaggaa 62460 
citattaaaaa tocagtgtct aatatotcitt cittcagoggc agaagaattic aatccatcat 62520 
ttgcagtaaa atcactittca ttattagogc catcctgitat cqaaccagac agtacagtta 62580 
tacatatgga ttataaaata tittagcaatg tacgtacatg acttacatgttcatcaatga 62640 
atccittgcat atctitccitta ttggaatcag gttccitcaat agtgttcaaca gcaaaagaaa 62700 
catttittctt cqgctttgaa ggttittctitc titcc.gcagtg gtatgtactic caggg acatc. 62760 
caaatctitcc totttggaat tacagocaac agaaagtgca ggagtgtc.ca catcatgaga 62820 
aacacgagtc. aaccttgaag actittctogt tocagtgctt cottttgtag acatccttct 62880 
cgatggctitc titcgcagtaa ccggtgccitt atccatagaa ataggtggitt cocgc gaatc. 62940 
atgg galaggt atggtttgtt citggccttitt gcc ttittgga totaaggg cag cacgitatctg. 63000 
gtoacggaca aagttctittca tatcttcatg cattggatac atttggtott coagctoctit 63060 
caaag accitc citcatttcaa caataaacct citcagg caca ggctcitccaa aacaatcctc. 63120 
agcagtctdt totttatcac agtccatttc agatttctgt tttitt cataa caggttctitt 63180 
agggctcqgg ccc.ggtgcat titcgtttcct cittaa.catct acaatagacc agttgctgct 63240 
attaattggit tittcttctag gtgcaatacc aaaaaaattt gtaaaaaaaa catttatact 63300 
tatacttaca totctottct agttgttggtg gg.cgcg actg. citttggtact citagcatago 63.360 
citccaaccoa titcatcctcc toccactggit gcc catctat caacagtgcc tdaatgtaat 63420 
caa.cccttgg atcatcaact tcatcatc.cc atgaaagaga tiggaggacaa acattatcac 63480 
citggitttcac aatatagttg accitcaacct acacaaataa gitatgttaac catagataat 63540 
gtacatttac ttattatgta cqtacataca caatttaaca cacct catca gcagoctoac 63600 
actccaaaat gcgagatgtc. c.ggattgcto goaga gaggc aagacgatgg atagaccitct 63660 
cago: aaatgt cotgttaggit acatcatcag gtoctagott agcaattgat gggattgttt 63720 
cgaaagctaa aagctggaga gctaatggga aaccato gag to catalagac cottacaagta 63 780 
taccccittat tagtttctga gcatcgtaag gagtttggaa atttgctato citccccaaag 63840 
tacgggtaaa gqacacccitt coccatgggt atttgcagaa aaacticcagg ttcttagtag 63900 
totcgacagt citt.cgaagta ggcctgttgg ggittact.gtg gg.ccgctacc acaccgtcaa 63960 
ccaaaataat aagagatagt gccagttgct tccaccocto catgcttitcc toctoctgca 64020 
gccagotcac caaatcagoa attgttggaa cc.gtgtc.ccc aaaccitctoa toaaacagag 64 080 
tottccaaac actictoacac toaggitttca cactgataac atcatcaacg totttcttct 64140 
tgggatactt cocacattcc agcccagtta agatactaaa ttctottaat citaaatctga 64200 
ttggatgacc gcc gaataca atccacatct cattcaccitt citttgtcact aactgacggc 64260 
atattagtico aaggacaagc titagcattga aagatgc citt gtttittgggt attittaaaaa 64320 
gttitcc caaa taggagaatcg agaagaaact gcatctotgg tittcc cctitt agtacttittg 64380 
citatgtgaga aatgtactico ggtttagagt acgc.gttcat citt.cgtotcg galagg gtacc 64 440 
ggtotagagc aaagagtc.tt gotggtaact cittcaactgt aagat cittca gttcggagcaa 64500 
cacttggact acctgcaatt aaaagttcata tactgttgag caaacagaag tagtgtacgt 645 60 
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acacagacat tittctagatt ataactcaaa atcatattitt togcggaaac agagattitcc 64620 
aattctactt citcaatttitt catcctaaag atatgctaaa titcc.gacaaa ttctaac act 64680 
ttaatcaaac aagctttaca attctgatac accoaaagac aacaaacggit aaattagaga 64740 
ttctaaccoa gttcctcc.gt tacctttgtc gcagag.cgitt ttctocq cq g g gaaactcitt 64800 
aatacacgct tctoctitccc togg accatgc tigctitccitcg g g actitcgtc gittaactitta 6.4860 
titcc cago.ca tagctaaaga tigctatttcg ccggaggttcaaattitcgcc ggaaaaaa.ca 64920 
gtaactittct cittggctt.cg ccgggaaaaa cagta actitt citcttggttt cqc.cgggaaa 64.980 
aacagtaact ttctottggc titcgc.cggga aaaac agitaa citttctott g g ctitcgc.cgg 65040 
gaaaaa.cagt aagttt cact tcatcggatg toggagttca gtggcacaat tdaactaccc 65100 
aacaatticga agittatgtcg aattittgaag caatggatac togaattitcgt titc.gctttct 65160 
gattctdtct caatctotcc gttattotct tttitcgttitt citcggitttct tcgtttcagt 65220 
tttitttittitt tttgttcttitt toaaaactga accgcatcaa citaaaccgaa accaactgct 65280 
gtagggitttg gtttacgc.cg tdaacttaac cqatacgaac toctocacgg tittggtttgt 65.340 
gccatt atta agttitt.ccca aggtaatttg gtc.cgaaatt gaatgaaaag acaaaacgtg 65 400 
aaaaccagtt citcactittga caaacggtga gag caaatct tttittcgtoc actitttgtga 65460 
aaatttctitt ttgtttaatt gatgattgaa aagaaaacgg cacaaaccaa accitcaatct 65520 
ttgtttitttc citcaatgttga gitatt attat tag catcaca tottctatog aaagatacca 65580 
aagaatgaaa aaaaatatat atacaaaatc atataagtgt atcatatata gatcgtagitt 65 640 
caatagagitt aaaacatttc citcaaatctt tacagittaaa aagaagaatt caaaaaaaaa 65700 
aaaacatgta atttcttgca totttaacca taaccittgac cqggtotttit aatattgcc.g. 65760 
gtogccttitc cct gtgtggit citg accgtca gtgctic gacc aggacgggta caaatcatat 65 820 
toactaattg g gttactata taaatcttga gtctdaagttc ccacttitcct aaacttgttc. 65880 
atgccttcat tigtottggct cq agtcataa totgttgctitc citccagatga gccatacaca 65940 
ttgctgttgtc. cc.ggtgttgat tccttggittt agatctgatg gtgatatgtt toctitctago 66000 
acacgtgcaa cct gctcgtt atttittacac caatcactca titcgattagc attagtaaca 66060 
ttittaaaatg act act attt agcaaattga aaaaaggtgt agctaagaaa acatgtttgt 66120 
cc cattgcta gggctgatca aataagcaaa atataaggct agg catacat accaaac caa 66180 
citgagatcga acacgg tatt aaccqaalacc aattcggagc ggcaaccalaa acg acco aaa 66240 
tataaatcaa totttgtaag titatattgtt cog aagccaa aaactaaact gaactgacaa 66300 
atgaaaatat cittggttcta ggtttctaac tocc gtataca gtttgaaaac cqgaaag.cgit 66360 
aaatgc ctitt agagaaaaga aaagaatgat taatttacct gatccatgcg aggtotacgt 66 420 
ggagctgtgg accgaacaca agctg.cggca caa.gcaacca toc gagc.cat citcttctittg 66480 
tdatactcat tattoagttt tittatcaacc acaacctcaa agtttccitaa titcagatact 66540 
tggittaa.gca aaggtogtgc citgttccaaa ttattoacac ataggitttitt cittcattcaa 66600 
aaatcacatc gtaaac atta totgaaggitt agattatttg catgtaatta tattacttac 66660 
ccaatcaa.cc aagctgttat citgcatggac attgtttaca totaatagggc gacgtc.cagt 66720 
tattagcticc agaagtacaa cqccaaatga gaaaacgtoa gacttitt.ccg tdagtttitcc 66780 
gcttgaag.ca tatto.cggag coaaatacct aaaatccaaa agttt cataa tatgtaaaga 66840 
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ttcacataaa cittittaacaa aactgcataa atgtagatat ttggtagctt caagattatc 66900 
tttacccaaa agttcc catc acacgtgtag atacatgagt atttgttatca gaag caatct 66960 
tggcaag acc aaaatcagca accitaagaaa tagaaga gag acacatgata caaagatact 67020 
tdatgacaat atcgtaccaa ataacaaata aaaggaagaa taaatcatac ctittgcttca 67080 
aatttgaaat citatcaatat gtttgacgcc ttgatatoac ggtgaataat tittaggattg 67140 
cctgcatata tataaatgcc tag.cgagtaa acaaacatga cctag ctata tatttattta 67200 
ttittgagaaa caaatatgga attataccat gacctatatt tattacacat gatcttatag 67260 
acttacaatt ttcatgaaga taagacaatc ctittgg caga accaacagda atcttcaatc. 67320 
ttgaactoca titccatcgta gg.ccgtocct titcctgtcac aaatticgatt cocaagaatt 67380 
tactaattga aaacattgaa ggatgcaaga aacaataaga gagtttattt tittatttittt 67440 
citaaccatgg aggtgaaact c gaga.gtgtt gttgg galaca aactoataga caa.gcaatct 675 00 
ttgagcatcg gcgatgcaat aaccqacaag agcaa.ccaaa totcitat gat gtact.cggct 67560 
aatgatcc.ca accitctgctt gaaactcitct ttctoctitga gaactcc citt citttcaattg 67620 
tittcacagda acttctittcc cattacgitaa catacctittgaacacgitatc cqaaaccgcc 67680 
ttgtc.ctaac aaattggcct cagagaatcc attggtggct citagatagot cotcgtaatt 6.7740 
gaaagtgcct toatatatgc ctaagccitaa tocaa.gc.cct ggtgatggtg gaggaagaac 67800 
tgattgatcc gagtagtttg agtcgtag to tcc.gctgctg. CCqctgctoa togaaatgcgg 67860 
tggacgtggt ggtgcagagg agg gagacitt cqgtggtggc actgacatca ccacgtgat c 67920 
tgatcgtogt gatgcattitt gttgttgctg accaccgtaa gogactic cat citgagaaacg 67.980 
catgaacata atatotataa aaacggtotc. tctatggatc catatacaag tittaaaaatg 68040 
tagaaaaaac atgtaataga attatcataa aatgcatatt catgattaat titccccaaat 68100 
atatgaaaat gacgtatatg taaaagaaaa totagataat citagttagca caactatatt 68160 
acgttctaaa to attatato tagcc gagta gaagggaaaa tatagttcaa gaaaatgtag 68220 
ataagttcata cittcaagatt caatttattt taaatctttgttttacctat g g gag caggg 68280 
ggtgcttcat tigtotctitcg togtttctitc ttacaaagga aaaatatoaa agccaatgcc 68340 
acaagaagica caaatcctcc toctatgg.cg atccc.gacca tagctcc citt tdata attct 68400 
ttggaagatt gtgcc.ggtgg agaagagcct ggagtggtag atggagtact aggagatcto 684 60 
cc.gc.ca.gagg gacitc.gctgg aggtggaggg citcag actoc citaccc.gagg aggaggagtg 68520 
ggtgttgagg gaggtogcgg agatcttggC ggagttgaag gagtggcggg agaggg.cggit 68580 
ggaggagaag aaggcCtcaa gigagaagiac ggtggagggg aaggcgt.cala gggaggtgaa 68640 
ggaatgcttg gagatggagg C ggaggtaa gaggtggtgg gaga.cggagg Cagaggagat 68.700 
ggtgtcaaag gaggtogalagg agtgatggca ggtggaggag aaggagt cala gggaggtgaa 68760 
ggagttgttgg gaga aggcgt Caagg gaggt galaggagttg togggagatgg aggcagagga 68820 
gaaggggtca agg gaggtgg gggaga aggc gtagagggag gtataggagg alacggtggta 68880 
ggtggaggtg gaggaggaag gg.cgggtgga agg gCagtag gcqgaggtgg agggggalagg 68940 
gCgggaggaa gqqcagtagg toggaggtega ggagtaacgg gCagaggct g aggcggagga 69000 
ggaattggga gaggctgtgg aggaggtogac ggagtaCCaC cqggagg.cgg CGCC gatgac 69060 
atat cittc.cc gctagtaaaa aaaaataagc gacgggataa agaagaaaaa agaatgttaa 69 120 
US 2004/0210962 A1 Oct. 21, 2004 
57 
-continued 
aag.cgg galaa agaggtotga totcitcttgc caccgag act agacittgagt tittgattact 69180 
tdaatcttitt taaaaaacct ttggtacacc gatatagagg agaatatacg taatcttatt 69240 
tttgtatgag titatatagitt totgttctitc ttgcatcaaa agc gaaagaa agaaatgaga 69300 
gcacttacta cattgacatt totcc gatgt ttattattaa citatctaaca toaagttaca 69360 
ccaaaataat coattcaaac togaaacgtac ggacaataaa taagtattitt gttaatcata 69420 
ttcaatcaag gttcttaata acagotttaa caaaaaaaaa alaggttcgta ataac aggcc 694.80 
aattatatoa atatggttct titcagatato cagataatgt ttittgctcitt cagataatat 69540 
atgtttatgt aaataattat tattgitatca g g g toaatgt cqtatcattc tatatatott 69600 
gtttaaaa.ca toccacaaga C gottaatct aagtagaaat aaaaacagaa gttcaacg act 696.60 
gattgcaatg atactttgtc. aagtttggitt taggtoaaata ttttgtttitt gtoaaattga 69.720 
tittaataaaa ataccagtga tatatggtoc gaacaaccaa ttttacttaa tattggtaat 69780 
agtattattt ttattitttgt taacttagga aatcttaggit cqaaactctg actatgtaat 69840 
aatatatagg gottataaaa catcggacaa acaac galacg ttcaaacgaa gaacttaata 69900 
cacgacgtca ttcaagaatg gatcaagctt ttgttgattt toaagttgttgt atgtttacaa 69960 
galaggtoaaa ataatttggit agtggacatt gacaag cat gccaaaatgg ccaaaacaaa 70020 
gtocactato aattgttctac aacactataa cctttittcat tatgtatttgtctttittctt 70 080 
ggaatgttitt attcaacaac aacaaaatta togtaagaaa taaaaaattt gacagtgtga 70140 
tataaagaaa cittata acat attactittca atcctatgtt taaaaaaaaa acactaaaaa 70200 
tgaaaatcat tigtgctaaga atataataac acattcacat tacacaaaca tatatgaaaa 70260 
attctaatag accoactitcg ttatattagt aatacgatat tatagacaag aagaaactcg 70320 
atcaaacgac goaaagctct tatataagcc ttaaaactca aggaggc gcc to atgacgcc 70380 
aag cagotcc aaatgtgatg to atctgtgg aaaatgc.ccg atc.gc.gtcct c gatgat citc. 70440 
cactgtcg at titccccittaa tottctoctd catgaagitat gcgacggaga cagg cactac 70500 
gacgtogttt cotggttgta to acatggca agg cactgac acttgtc.cca aaatctotct 70560 
citcgtogcta coaaacacta tottagotaa ggcaagagct gtctogggct tcatcttctt 70620 
aagggactitc. tcgaac ctitt go accgagag agagt citcto gag to gacca C gaatgagga 70680 
gaaatcaa.cc gcc caagctt cqtagttgga gccaatgctd gtaatgatcg tdtcaatgtc. 70740 
ttittgactica aaccotccitt totaatccitc actgtttata tacctatttg catttcaatc. 70800 
tagtaacgtt actaatttga toatctaaat atcattttct citttgcgcaa aaaaaaaaaa 70860 
toattittctt ttatattata agtacgttgc attgatatat atagtcaaac attatcaatt 70920 
gttgcattaa attatgg.ccg actittctdac citataactat aataaatato taaagtaatc. 70980 
agtcaaagta toatactitca aac agittaac toccattcga taatttctat atataggaga 71040 
atatag tatgttagtggtoc acgtgatata taaagatggg ttaagttitta gtactitctaa 71100 
citttaaaaat gacaataaat atattgattc atcatatgat aataaaatca taacacattt 71160 
tittctaattt to gatgitatc tatatgaaat gaatgtctta ttgacatatt gatagdatat 71220 
gtag catgtt tacatatatt Catctacgta tatatgcgta gacto cagag aagtaagaga 71280 
agatgtgatc atatgtcata to catccaac aagctagaag citgat catgt coacatgttc. 71340 
aacacttggc aacagttaca cittcattaca tatagatato aaccacataa aaact attaa 71400 
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aggaccagac cocaaaagtt ttgttttgtc. cataccttgt cattttctitc titccaaattt 73740 
g gaccaatta ttattttaca ttaaactcag aaaag gtttg aaattittcct ttatcttcac 73800 
agittaatgat ttagagtaaa tatgtaaag.c attcgaatat aattactgtt titcacaaaaa 73860 
gaagaagaat aatattittag gtgttgttitt to catgitatg gatacaaaag citagccticta 73920 
tgcctaattg tdttagtata gagtgatcga tactatagaa gotgtactitt tttcc.gtag a 73980 
taactaaaga C gaggggcaa agc gattoto cacaagaaga gtaattic cat catatgtata 74040 
gcataactitt tittgacttitt to acctaaag aaaaaaag.ca tacttatttg actaaataaa 74100 
titcggttctg. tataaaggct gaaatactgg agaaaaagct tagttttgtc. gtgtagtgat 74160 
caatgtatat tdacaaaaga gaagagacitg gaaaaaagttc tacgaccaac tttitcct tcc 74220 
citttggccitt aactitcactc acacatcatt ttittaatatt accoaaattt gtocatttitc. 7428O 
aaac cattaa gacgcgatat tdtgcattitt gagattgtta gcttgtagag aattaaactt 74340 
cgaaaatcct agttacaatt ttatttcata caaggtotca cag atccaca ccataccgtt 74400 
accttgttga tatacaagtt gaagttgtcc ttagatatta to agcttgtt toacaaatca 74 460 
taaggtotaa aaaaagattg cqatatgagt ttgttacaat cattagaata aaagaaaaag 74520 
agagtaaaag aaaataagat aataaatgag gaaaatgaga gttggagagt ggagagacita 74580 
gagaatacaa attgccttitt gcctittaaaa gocggttcct actictotttc. tcc.gaaataa 74640 
atgtcgittag cattattatc gatcgitatct atctatacac acatgcgitac caccacgtgt 74700 
tttgttgctat aatcatccita taattctitat taccaatcto tag atttgtt gttacttgtt 74760 
ttataaactc titttgtttitt cqgattoatt togg cacaacc tatccaaaaa aaag.gtttaa 74.820 
atgagtatgt tittaaaaaga aactaatgtt attgccaatc tdagtactcc galagagatca 74880 
agctaaaatt gtaaggacca aataacaaac aatctittgca aacctttitta gctcaaaagg 74940 
aaactactac taaacacatt ataag attga acatggtgac ataaatacaa actactaatt 75000 
acaactagda gtttaaatat gattogtata toattgatac taacaagatt agaaaaaaaa 75060 
aacactatat ataatgattg attaacaagt ttcttgtato ttagaaaaaa gaggaaaaaa 75.120 
catattgatt gtttittagtt ttatacaact ttgtacacat aattaacct g caaag agagt 75180 
attitcgacta togaaaggaat atgtaaatca toaaaggaaa citatttatga aagatacaat 75.240 
aatataaacg tdagttgttc. tcaaaaggca ttagcctcitc attitcccatc gitatttaaat 75.300 
gggagtattg caaggaaaac atatatgttg gtgtaaatga citttcttggit tatgcagaag 75.360 
aatgaaatta aacttic galaa atcto cagaci ttacgggitta gottaagtgt gatggcaaat 75 420 
ccag coaagt cqttgttgaaa totcc ctgaa catttitataa aacaaaataa citgtttattt 75480 
ttcacatato ttgaagctta gtttgaaatt tittgcatggit attittggittt actatocaac 75540 
aataaaacgg gtttaatacg tataatttgg tdaaactaac tatttitttcc titacatgg to 75600 
cactictoaac tattittaaag agatgaaaag titatcatcat tigattacgaa aatgatatot 75660 
aacttctott atacgc.ccca catccacaca aatgccittaa tdaaaaggitt atc.gc.gtttg 75720 
cgattagaac aaaccaaaac gttaccttca atcataattit gcg atcttgt tittggittagc 75780 
taatagagitt atagatcaac tacgtcctag tocaaaatct gtggittataa citgtagttta 75840 
taatagitaaa aataaaagct tacagtaacc citcttittcat cattgtaaga titcataacaa 75900 
tgctcittaat atgaatatac aaattitcatt ttcaagagat atcgtaaag.c gaaaacatat 75960 




































































































































































acttaattca to cattgata 
taccttgct g g c gitatcttg 
ttctggcaac gito acttaga 
cagatalacta acaatcaaaa 
atattactgttcaatcacct 
aaatagottt to attcctaa 
tottacatca tatatalactit 
agg tatgccg aattgcttga 
tgtgtttaac gtacatgtc.g 
gag acagtat aaagt cagot 
toccatcago gtoaaagtgg 
taaaaccalaa Caggaaataa 
aaaaacaagt to acaagctic 
acagggaaat aaccittaagt 
cca acttittg aggggtogtg 
aac attatag toatago atc 
tag caaagtt attcagttgt 
titactitt cat toccitadata 






atcacaaggt gag to agaga 
ggttggtaga cittggaccat 
agctaatgta taagcaagat 
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aggaaatacc agctactgtt cogitttctat citttitccaaa aaaacttgaa cigagacaata 78300 
aacaaagaac acagga catc ttattgatat cacat cacta agacitactitt goc agaagag 78360 
tatgtag cat tcg tatttac acagoagagc acatcccata ttattaactt aaatttgaga 78420 
agaaacttica gttcaaaaag aaa.catcaag agctgttgtaa aaagaaattic attggaagat 78.480 
atatgtacct togcaactaga aac agcgatg atgttcgaaa ttcttgataa tocaaaggga 78540 
agctg.ccctg caaaaatggg cittggctggit tatgctgaca ttgtcacatt taccttctitc. 78600 
acco atggaa gogctgcaac tacct cattt gcc ttgttct caaactacaa aagagtcgta 78660 
atccatccat caaagataca citaaaagaac to attcattg cittatataac caatgatata 78720 
gctocaaaat cotcctaatg g gatgaagtt citatcagtag taatatgata aaagaatagt 78780 
gaatggtaat gtcatttacc atgtc.tttga citgga catgc gggtgttgtc. agctocaaac 78840 
ggaacgaaac ctacaacaag agaccaaaca tottt cagoa gccttgaaca aacaatctaa 78 900 
aacagaacaa attggtgaag gataaagtat tattattacc to accoaaag cittcattaat 78960 
ccccaaatct titcacaaaac cacaagaaac aatatatgtc. ccaaaatcag gatcaataat 79020 
citgagacaga gccttcaaca catctttittctgatgtttga gcaac actot caccaac act 79080 
actactagot gtttitccaaa atgcataagt taaaaaatat cagaacttgc titagt citcct 79140 
togcgtataa cqttaacaat ttittcaggcg gag acaaagg aacaaactitt ata accittga 79200 
gctgaag Cag Ctttagctac agagagattctgagagacco gtttgaggat tcttgtcCtg 79260 
gagattgaga taatggaagc titgagaatgg agaaacttgt gagaaagaag caatcttgtt 79320 
gtggaattgc titcttctttg g g totgaatc. tcgaaagaag gatgcc.gcaa cqactgtgga 79380 
tgaagaag.cg gcattgctac aagagagaga C galagagagt ggcaaaaaaa act agcgg to 794-40 
tgttgataatt tdatc.gctca actictittaaa agataaaact ttittcaaagc tittittattat 79500 
ttittattatt attattocaat atatoataaa tttittacatt totaatcaga tattattgtt 79560 
tttitttactg atgtgttgtca aattacatct aagataaatc aaaattaagt titttactgat 79620 
gtatgttgaa ttctacaaaa gtttcttttgtta acacaaa atgttaaatg tittcgaaatt 79680 
aagataaatc aaaattaagt aaattaaaac ttaaaaagac aggaaag cag atttgattga 79740 
agtaaattica gatgattaaa atgttagatt tag agaaatt ttcaaaaaaa tag actaata 79800 
gtag atctag caattaatca agattgttat tigcaccgttc taaaactaca aatcttaatc. 79860 
tatagittaat cqactcitcgt tataattgac taactatgcc taacaatatt g gttttgttgt 79.920 
citccatctaa aattacitaga attaagcaag cattagaatt cagtttgata agtttaccta 79.980 
agcatctaaa ccgggttggc agt catctag titattaaggc tictoctaa.ca ataattic cag 80040 
taataaacgc atctoggatt ttacatatta acttataatc aaattittagt togttactict 80 100 
agaactagot ttaagaataa toaaaggaga agaactctag ggataaatac talacagatta 80 160 
tdgatttacg atttcatcta aatttctaat gataaactitt aaaccoaaga aggagattac 80 220 
totag acataa ttaaagaaac ataaaacatg tittgaataag attacataaa gaaatcaaaa 80280 
gtagaatgga gtttaaaaaa tatcttittct citataggitat aag gttittga aatttctgaa 80340 
gtagtatcca caaaccitcaa agaatttgga gag caaaaaa toaaataaag citt 80393 
<210 SEQ ID NO 5 
&2 11s LENGTH 368 
&212> TYPE DNA 
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<213> ORGANISM: Arabidopsis thaliana 
<400 SEQUENCE: 5 
tggg acaccg tttacacacg aac gtttact citaatagagc atgtatgtat gattgtctaa 60 
titccagtgta totggtocatc. cittgttactg. c.gcatagoca acctagogga accocggatt 120 
ttgaac cogt catcttatca agacitgattctg.cgc.cg acc tittgcgactic cacggag cac 18O 
aattictatog togctattgca atatatgcct gcatacacgt citgcatatgc tiggtotcatc 240 
gc gttittgga ggtottct catcagatacct atccagaggc tiggctg.ccca attatggtac 3OO 
acaatcctitt ttgaattitca agctgcagcc cqggcc.gtog accacgc.gtg cccittagttg 360 
agtcgitat 368 
<210> SEQ ID NO 6 
&2 11s LENGTH TO3 
&212> TYPE DNA 
<213> ORGANISM: Hordeum vulgare 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (2) ... (2) 
<223> OTHER INFORMATION: n is a c, g, or t 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (7) . . (7) 
<223> OTHER INFORMATION: n is a c, g, or t 
<400> SEQUENCE: 6 
gnacggnaaa gtoctittgac togtttgatg gttct cotat tacgaactt titatgcaagg 60 
taagggagat atatggcc to gacgagaaaa citagtttccg caacgtoact atcto gttgg 120 
aagg gaggcc toaacctitta tat cittggaa citgctactca aattggagtg atatoaactg 18O 
aggggatc.cc cagtttacca aaaatgctac toccitccaaa ttgttgcc.ggg citt.ccgtcaa 240 
tgtatattag agatcttctt cittaatccitc catcttittga tigttgccitct gcaattcaag 3OO 
aggcttgcag gottatgtgc agcataactt gttcaattcc agaatttacct gcataccat 360 
cago gaagct totgaaacta cittgagtoga aagaggittaa totacatc gala ttttgtagaa 420 
taaaaaatgt cottgacgag attatgttga t gaatggaat cactgagctt to agctato c 480 
agaacaaatt gctic galacct gctitcggtgg titactggctt gaaagttgat gctgatatac 540 
taattaaaga atgtag attt attitcgaaac gtataggtga agtgatatot ttagotggcg 600 
aaagtgacca ggcaat atct tcatcggaat atattoccaa goagttcttic aatgatatgg 660 
agtcatcttg gaagggg.ccg tdtgaaaagg gtc catgctd aag 703 
<210 SEQ ID NO 7 
<211& LENGTH: 232 
&212> TYPE PRT 
<213> ORGANISM: Hordeum vulgare 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (2) ... (2) 
<223> OTHER INFORMATION: Xaa can be any naturally occurring amino acid 
<400 SEQUENCE: 7 
Thr Xaa Lys Ser Phe Asp Trp Phe Asp Gly Ser Pro Ile Asp Glu Lieu 
1 5 10 15 
Lieu. Cys Llys Val Arg Glu Ile Tyr Gly Lieu. Asp Glu Lys Thr Ser Phe 
2O 25 30 
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Arg Asn Val Thir Ile Ser Leu Glu Gly Arg Pro Glin Pro Leu Tyr Lieu 
35 40 45 
Gly Thr Ala Thr Glin Ile Gly Val Ile Ser Thr Glu Gly Ile Pro Ser 
50 55 60 
Leu Pro Llys Met Leu Lleu Pro Pro Asn. Cys Ala Gly Lieu Pro Ser Met 
65 70 75 8O 
Tyr Ile Arg Asp Leu Lleu Lleu. Asn Pro Pro Ser Phe Asp Wall Ala Ser 
85 90 95 
Ala Ile Glin Glu Ala Cys Arg Lieu Met Cys Ser Ile Thr Cys Ser Ile 
100 105 110 
Pro Glu Phe Thr Cys Ile Pro Ser Ala Lys Lieu Val Lys Lieu Lieu Glu 
115 120 125 
Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn Val Lieu 
130 135 1 4 0 
Asp Glu Ile Met Leu Met Asn Gly Ile Thr Glu Lieu Ser Ala Ile Glin 
145 15 O 155 160 
Asn Lys Lieu Lieu Glu Pro Ala Ser Val Val Thr Gly Lieu Lys Val Asp 
1.65 170 175 
Ala Asp Ile Lieu. Ile Lys Glu Cys Arg Phe Ile Ser Lys Arg Ile Gly 
18O 185 19 O 
Glu Val Ile Ser Leu Ala Gly Glu Ser Asp Glin Ala Ile Ser Ser Ser 
195 200 2O5 
Glu Tyr Ile Pro Lys Glu Phe Phe Asin Asp Met Glu Ser Ser Trp Lys 
210 215 220 
Gly Pro Cys Glu Lys Gly Pro Cys 
225 230 
<210 SEQ ID NO 8 
&2 11s LENGTH 540 
&212> TYPE DNA 
<213> ORGANISM: Hordeum vulgare 
<400 SEQUENCE: 8 
citagtgtaaa togcggcttg gttgataggc ctdatggtot goggaaatggg ttggalacctic 60 
caac aggttc ttittgg acto citgcgaaagg atgtc.gagag cattgttact gcgatatgcg 120 
aaga caagct gttggacctg tacaacaaga gaagcatcto a gag cagatt gaggtggtot 18O 
gtgtaactgt aggtgctagg gagcaa.ccgc caccittcaac cqttggcagg to cagcatct 240 
atat cattat cagacgtgac aacaagctict atgttggaca gacggatgat citcgtgg gcc. 3OO 
gtottggtgc ticatagatcc aag galaggta tocaagatgc cacaatatta tacatcgtgg 360 
titcc togcaa gag.cgttgcg togccaactgg agacitcttct cataaatcag citaccct cqa 420 
aaggttittaa got caccaac aaggcagatg gcaag catcg gaactittggt atgtctgtaa 480 
ccitctggaga agc catggcc gcgcactgaa citgcc cc act galacatccag ttitta actog 540 
<210 SEQ ID NO 9 
&2 11s LENGTH 168 
&212> TYPE PRT 
<213> ORGANISM: Hordeum vulgare 
<400 SEQUENCE: 9 
Ser Val Asn Gly Gly Lieu Val Asp Arg Pro Asp Gly Lieu Gly Asn Gly 
1 5 10 15 
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Leu Glu Pro Pro Thr Gly Ser Phe Gly Lieu Lieu Arg Lys Asp Val Glu 
2O 25 30 
Ser Ile Val Thr Ala Ile Cys Glu Asp Llys Lieu Lleu. Asp Leu Tyr Asn 
35 40 45 
Lys Arg Ser Ile Ser Glu Glin Ile Glu Val Val Cys Val Thr Val Gly 
50 55 60 
Ala Arg Glu Gln Pro Pro Pro Ser Thr Val Gly Arg Ser Ser Ile Tyr 
65 70 75 8O 
Ile Ile Ile Arg Arg Asp Asn Lys Lieu. Tyr Val Gly Glin Thr Asp Asp 
85 90 95 
Leu Val Gly Arg Lieu Gly Ala His Arg Ser Lys Glu Gly Met Glin Asp 
100 105 110 
Ala Thr Ile Leu Tyr Ile Val Val Pro Gly Lys Ser Val Ala Cys Glin 
115 120 125 
Leu Glu Thir Lieu Lleu. Ile Asin Glin Leu Pro Ser Lys Gly Phe Lys Lieu 
130 135 1 4 0 
Thr Asn Lys Ala Asp Gly Lys His Arg Asn. Phe Gly Met Ser Val Thr 
145 15 O 155 160 
Ser Gly Glu Ala Met Ala Ala His 
1.65 
<210> SEQ ID NO 10 
&2 11s LENGTH 540 
&212> TYPE DNA 
<213> ORGANISM: Hordeum vulgare 
<400 SEQUENCE: 10 
citagtgtaaa togcggcttg gttgataggc ctdatggtot goggaaatggg ttggalacctic 60 
caac aggttc ttittgg acto citgcgaaagg atgtc.gagag cattgttact gcgatatgcg 120 
aaga caagct gttggacctg tacaacaaga gaagcatcto a gag cagatt gaggtggtot 18O 
gtgtaactgt aggtgctagg gagcaa.ccgc caccittcaac cqttggcagg to cagcatct 240 
atat cattat cagacgtgac aacaagctict atgttggaca gacggatgat citcgtgg gcc. 3OO 
gtottggtgc ticatagatcc aag galaggta tocaagatgc cacaatatta tacatcgtgg 360 
titcc togcaa gag.cgttgcg togccaactgg agacitcttct cataaatcag citaccct cqa 420 
aaggttittaa got caccaac aaggcagatg gcaag catcg gaactittggt atgtctgtaa 480 
ccitctggaga agc catggcc gcgcactgaa citgcc cc act galacatccag ttitta actog 540 
<210> SEQ ID NO 11 
<211& LENGTH 4 44 
&212> TYPE DNA 
<213> ORGANISM: Zea mays 
<400 SEQUENCE: 11 
taattact to cittagacaag ggaaatatta taacticc cct ggc.cccitact atgcaca agg 60 
citagcaccac tat cagttca acaaaactag g gogg catgg totcagttag citc.ccgc.ctic 120 
citattgaata tocaatagoa aaaag accitt cagctgacta gttcc.gtcga gtagcaactg 18O 
ccitc.gc.ca.ga gattc.gagat ataccgaagt toc totgctt cocgtctgcc ttgttgatga 240 
gcttgaagcc cctoga aggg agctggttta tagaagggit titccagotgg caggcaacgc 3OO 
tott gccagg gaccalagacg tataataccg tag.cgtoccg catgcct tcc titc gatctgt 360 
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ggg.cgttcaa go.gc.cccaga agatcgtocg totgtccaac atagagcct g ttgtc.gcttic 420 
tgataatcac gtagatgcta gatc 444 
<210> SEQ ID NO 12 
&2 11s LENGTH 94. 
&212> TYPE PRT 
<213> ORGANISM: Zea mays 
<400 SEQUENCE: 12 
Ser Ser Ile Tyr Val Ile Ile Arg Ser Asp Asn Arg Lieu. Tyr Val Gly 
1 5 10 15 
Glin Thr Asp Asp Leu Lieu Gly Arg Lieu. Asn Ala His Arg Ser Lys Glu 
2O 25 30 
Gly Met Arg Asp Ala Thr Val Leu Tyr Val Leu Val Pro Gly Lys Ser 
35 40 45 
Val Ala Cys Glin Leu Glu Thir Lieu Lieu. Ile Asn Gln Leu Pro Ser Arg 
50 55 60 
Gly Phe Lys Lieu. Ile Asn Lys Ala Asp Gly Lys His Arg Asn. Phe Gly 
65 70 75 8O 
Ile Ser Arg Ile Ser Gly Glu Ala Val Ala Thr Arg Arg Asn 
85 90 
<210> SEQ ID NO 13 
&2 11s LENGTH 338 
&212> TYPE DNA 
<213> ORGANISM: Medicago truncatula 
<400 SEQUENCE: 13 
caatggtaat aattctaatg g g acacatca titc.cgaaaag tttittatcaa caatttcto a 60 
ggagggaatc. tctittagcta atcca attga agttt cacat aag gaggttg agagtgctat 120 
cact gtaatc toccaagatt ttatagogga actg.cga-agg aaaaagatca catcatalact 18O 
tatcaagata aagtgtttct taattggcac tagggaatgg ccaccitc.cga tigacitatatg 240 
citcttcaagt gtctacgtga tigctoragacc agatcagaaa citctacgtag gagagacgga 3OO 
taatcto gag gatcgagttc gtgcacatcg atcgaaag 338 
<210> SEQ ID NO 14 
&2 11s LENGTH 679 
&212> TYPE DNA 
<213> ORGANISM: Allium cepa 
<400 SEQUENCE: 14 
ggaatctt.ca toggaaaggcc gtgttgaagag gatacatgct gaggatgtgt ttgctgaagt 60 
tgacaaagct gcticagtc.tt totct attac agittatggaa gacitttgttc caatcgtttc 120 
tagagtaaaa goggittatgt cittct cittgg aggtocaaag ggtgaagitat gttatgctag 18O 
agaacatgaa gotgtttggit toaaagga aa gogttittato coatctgttt go.gctaatac 240 
acctggggaa gag cagat.ca agaaacttaa acctgccttg gattoaaaag gaagaaaagt 3OO 
cggagaggaa toggttcacaa C gatcaat at tdagaatgca ttalactaggt atcatgaatc 360 
tacggaaaag goaagaatta aagttittgga cittattalaga gaactittctg gagaaatgca 420 
ggctaaaatt aacatccttg tottctottc catgctgctt gtcatatota aatctottitt 480 
tggc catgtt agtgaaggta ggaga agagg atgggtgttt cott gacctgc acaattic coa 540 
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aatcataagg ataatagttt goacactggit aatgaaacac ttgagctaag agatttatca 600 
ccitt tatggit ttgatgctgt gcaaggaagit gcaatggaaa atactgtcag aatgcattct 660 
atgtttctitt tactgg gcc 6.79 
<210 SEQ ID NO 15 
&2 11s LENGTH 179 
&212> TYPE PRT 
<213> ORGANISM: Allium cepa 
<400 SEQUENCE: 15 
Glu Ser Ser Trp Lys Gly Arg Val Lys Arg Ile His Ala Glu Asp Wal 
1 5 10 15 
Phe Ala Glu Val Asp Lys Ala Ala Glin Ser Leu Ser Ile Thr Val Met 
2O 25 30 
Glu Asp Phe Val Pro Ile Val Ser Arg Val Lys Ala Val Met Ser Ser 
35 40 45 
Leu Gly Gly Pro Lys Gly Glu Val Cys Tyr Ala Arg Glu His Glu Ala 
50 55 60 
Val Trp Phe Lys Gly Lys Arg Phe Met Pro Ser Val Trp Ala Asn Thr 
65 70 75 8O 
Pro Gly Glu Glu Glin Ile Lys Lys Lieu Lys Pro Ala Lieu. Asp Ser Lys 
85 90 95 
Gly Arg Lys Val Gly Glu Glu Trp Phe Thr Thr Ile Asn. Ile Glu Asn 
100 105 110 
Ala Lieu. Thir Arg Tyr His Glu Ser Thr Glu Lys Ala Arg Ile Llys Val 
115 120 125 
Leu Asp Lieu Lieu Arg Glu Lieu Ser Gly Glu Met Glin Ala Lys Ile Asn 
130 135 1 4 0 
Ile Leu Val Phe Ser Ser Met Leu Leu Val Ile Ser Lys Ser Leu Phe 
145 15 O 155 160 
Gly His Val Ser Glu Gly Arg Arg Arg Gly Trp Val Phe Pro Asp Lieu 
1.65 170 175 
His Asn. Ser 
<210> SEQ ID NO 16 
&2 11s LENGTH 662 
&212> TYPE DNA 
<213> ORGANISM: Citrus sinensis 
<400 SEQUENCE: 16 
attggtttga tigcago agaa gocagtgctg tacataatac agttgatatg cagtcattat 60 
ttct cotgac togtocaaat gggggtggta aatctagttt acttagatca atttgttgctg 120 
cittcgttact togg catatgt ggtottatgg toccc.gcaga gtcagoctoa attcc titact 18O 
ttgatgctat catgcttcac atgaaatcct atgatagocc tigctgacggg aaaagct cat 240 
ttcagg tatt citggttccitt gtact gaggit totaagtttg citcatgc.cat gatagat.cga 3OO 
gottagcc at gatcttgttga gg catggtag tagta actogg togcaggtgag aaatgttgag 360 
tact acaatt tacacattgc actitcaccitc. tcatctoaaa totggtggala aag.cgtaatg 420 
tattaattitt citgtggatat tatatgtctg cattctotta atttcagtat ttgctgcaaa 480 
aggittatcto cattaagttg cacatgttgc ticagtacctt aagtttittac tittgaacaag 540 
caatttitttg tatgttggaa ttatctitcga taggagtggit atcaagtaat atgcaaataa 600 
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titcc gttitta atggttcagg tagaaatgtc. agaaatacgg toaattgtca citgcaac cac 660 
tt 662 
<210 SEQ ID NO 17 
&2 11s LENGTH 81 
&212> TYPE PRT 
<213> ORGANISM: Citrus sinensis 
<400 SEQUENCE: 17 
Trp Phe Asp Ala Ala Glu Gly Ser Ala Val His Asn Thr Val Asp Met 
1 5 10 15 
Glin Ser Lieu Phe Leu Lieu. Thr Gly Pro Asn Gly Gly Gly Lys Ser Ser 
2O 25 30 
Leu Lieu Arg Ser Ile Cys Ala Ala Ser Lieu Lieu Gly Ile Cys Gly Lieu 
35 40 45 
Met Val Pro Ala Glu Ser Ala Ser Ile Pro Tyr Phe Asp Ala Ile Met 
50 55 60 
Lieu. His Met Lys Ser Tyr Asp Ser Pro Ala Asp Gly Lys Ser Ser Phe 
65 70 75 8O 
Glin 
<210> SEQ ID NO 18 
&2 11s LENGTH 600 
&212> TYPE DNA 
<213> ORGANISM: Solanum tuberosum 
<400 SEQUENCE: 18 
gcacacagac actgttgtatt gtgcactgat atcgagcaat gtattgg gtt acggcaaaaa 60 
acgtc.gc.cgt titcagttccc cgttgg.cgitt cactgtc.cct tittccitcc.gt coaccacttic 120 
gcc.ggc gttt cittctott to tct coacata citctgtgcc.g. agagcagata cqttgcttga 18O 
aggagcggaa gttttittgcc acaacggcaa aaaaaaacto aaacaac caa aaagttgttcc 240 
agaggaaaaa gacitatgtta at attatgtg gtggaaagag agaatggaat tottgagaaa 3OO 
gcc titcttct gttctactgg citaagaggct tacatattgt aacttgctgg gtgtggatcc 360 
gagtttgaga aatggaagttc ttaaagaggg aac acttaac toggagatgt togctgttcaa 420 
gtoaaaattt cotcgtgaag titttgttctg. tagagtaggit gatttittatg aag caattgg 480 
attc gatgct totattottg toggaatatgc tiggitttaaat coatttggtg goctocqctic 540 
agatagtata ccaaaagctg. gttgtc.cagt tdtgaatcta agacagacgt toggatgatct 600 
<210 SEQ ID NO 19 
&2 11s LENGTH 187 
&212> TYPE PRT 
<213> ORGANISM: Solanum tuberosum 
<400 SEQUENCE: 19 
Met Tyr Trp Val Thr Ala Lys Asn Val Ala Val Ser Val Pro Arg Trp 
1 5 10 15 
Arg Ser Lieu Ser Leu Phe Leu Arg Pro Pro Leu Arg Arg Arg Phe Phe 
2O 25 30 
Ser Phe Ser Pro His Thr Lieu. Cys Arg Glu Glin Ile Arg Cys Lieu Lys 
35 40 45 
Glu Arg Llys Phe Phe Ala Thir Thr Ala Lys Lys Lys Lieu Lys Glin Pro 
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50 55 60 
Lys Ser Val Pro Glu Glu Lys Asp Tyr Val Asn. Ile Met Trp Trp Lys 
65 70 75 8O 
Glu Arg Met Glu Phe Leu Arg Llys Pro Ser Ser Val Lieu Lieu Ala Lys 
85 90 95 
Arg Lieu. Thir Tyr Cys Asn Lieu Lieu Gly Val Asp Pro Ser Lieu Arg Asn 
100 105 110 
Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn. Ser Glu Met Lieu Lleu Phe Lys 
115 120 125 
Ser Lys Phe Pro Arg Glu Val Leu Phe Cys Arg Val Gly Asp Phe Tyr 
130 135 1 4 0 
Glu Ala Ile Gly Phe Asp Ala Cys Ile Leu Val Glu Tyr Ala Gly Lieu 
145 15 O 155 160 
Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro Lys Ala Gly Cys 
1.65 170 175 
Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp Asp 
18O 185 
<210> SEQ ID NO 20 
&2 11s LENGTH 3396 
&212> TYPE DNA 
<213> ORGANISM: Oryza sativa 
<400> SEQUENCE: 20 
atggcc attc agcggctgct c gc gagctcg citcgtggcc.g. ccacgcc.gc g g togctt.ccc 60 
gtogcc.gc.cg actic gtttct coggcgcc.gc caccgcc citc gctgctoccc gct coccgc.g 120 
citgctattta acaggagg to citggtotaaa cca aggaaag totcacgaag catttcc att 18O 
gtgtc.tagga agatgaacaa acaaggagat citctgtaatg aaggcatcct gcc acatatt 240 
citgtggtgga aagagaaaat ggagaggtgc aggaaac cat catcaatgca attgacticag 3OO 
agacittgttgt attcaaat at tittaggattg gatccaactt taagaaatgg aagcttgaag 360 
gatggaagcc tdaacacgga aatgttgcaa ttcaaatcga agtttcc to g togaagttcta 420 
citttgcagag togg gagattt citacgaggct gttgg gtttg atgcatgitat cottgtggag 480 
catgcaggct taaatccttt toggaggcttg cqttctgata gtattocaaa agctggatgt 540 
ccagtcatga atttgcggca gacattggat gatttgacitc gatgtggitta citctgtgtgc 600 
atagttgaag aaattcaagg cccaa.cccaa gotcgtgcta ggaaaggc.cg atttatttct 660 
ggcc atgcac atcctggtag to cittatgta tittggtottg citgaagtaga ccatgatgtt 720 
gagttc.cctg atccaatgcc totagttggg atttcac gat citgcaaaagg citattgcctg 78O 
atttctgtgc tagaga caat gaaaa.cat at tdagctdagg agggcttaac agaggaagca 840 
gttgttacta agctitc.gcat atgcc.gittat catcatctat accittcatag titctittgagg 9 OO 
aacaattctt Cagg cacatc acgctgggga gaatttggcg aaggtgggct attgttgggga 96.O 
gagtgcagtg gaaaatcttt to agtggttt gatggtaatc. citattgaaga actgttatoc 1020 
aaggta aggg aaatatatgg gcttgaagag aag actottt toc gtaatgt cagtgtc.tca 1080 
ttggaaggga ggc citcaa.cc cittgttatctt galacagota citcaaattgg ggtgatacca 1140 
actgagggaa tacccagttt gctaaaaatt gttct cocto caaactittgg togcc titcca 1200 
toattgtata ttagagatct tcttcttaac cctocatctt ttgatgttgc atcatcagtt 1260 
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<213> ORGANISM: Oryza sativa 
&220s FEATURE 
<221 NAME/KEY: CDS 
<222> LOCATION: (1) . . (3396) 
<400 SEQUENCE: 21 
atg goc att cag cqg citg citc gog agc tog citc gtg gcc goc acg cc.g 48 
Met Ala Ile Glin Arg Lieu Lleu Ala Ser Ser Lieu Val Ala Ala Thr Pro 
1 5 10 15 
cgg togg citt coc gtc gcc gcc gac to g titt citc cqg cqc cqc cac cqc 96 
Arg Trp Lieu Pro Wall Ala Ala Asp Ser Phe Leu Arg Arg Arg His Arg 
2O 25 30 
cct cqc toc toc cog citc ccc gog citg cita titt aac agg agg to c togg 144 
Pro Arg Cys Ser Pro Leu Pro Ala Lieu Lleu Phe Asn Arg Arg Ser Trp 
35 40 45 
tot aaa cca agg aaa gtc. tca cqa agc att toc att gtg tot agg aag 192 
Ser Lys Pro Arg Lys Val Ser Arg Ser Ile Ser Ile Val Ser Arg Lys 
50 55 60 
atgaac aaa caa goa gat citc tot aat gala ggc atg citg cca cat att 240 
Met Asn Lys Glin Gly Asp Lieu. Cys Asn. Glu Gly Met Leu Pro His Ile 
65 70 75 8O 
citg togg tog aaa gag aaa atg gag agg togc agg aaa cca to a toa atg 288 
Leu Trp Trp Lys Glu Lys Met Glu Arg Cys Arg Lys Pro Ser Ser Met 
85 90 95 
caa ttg act cag aga citt gtg tat to a aat att tta gga ttg gat coa 336 
Gln Leu Thr Glin Arg Leu Val Tyr Ser Asn. Ile Leu Gly Leu Asp Pro 
100 105 110 
act tta aga aat gga agc titg aag gat gga agc citg aac acg gala atg 384 
Thr Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Ser Lieu. Asn Thr Glu Met 
115 120 125 
ttg caa ttcaaa tog aag titt colt c.gt gala gtt cita citt toc aga gtg 432 
Leu Glin Phe Lys Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val 
130 135 1 4 0 
gga gat titc tac gag got gtt ggg titt gat gca tot atc citt gtg gag 480 
Gly Asp Phe Tyr Glu Ala Val Gly Phe Asp Ala Cys Ile Leu Val Glu 
145 15 O 155 160 
cat go a ggc tita aat cott titt gga ggc titg cqt tot gat agt att coa 528 
His Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro 
1.65 170 175 
aaa got gga tot coa gtc atgaat ttg cqg cag aca ttg gat gat ttg 576 
Lys Ala Gly Cys Pro Wal Met Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu 
18O 185 19 O 
act cqa tot ggit tac tot gtg toc at a gtt gala gaa att caa goc coa 624 
Thr Arg Cys Gly Tyr Ser Val Cys Ile Val Glu Glu Ile Glin Gly Pro 
195 200 2O5 
acc caa got cqt gct agg aaa ggc cqa titt att tot goc cat gca cat 672 
Thr Glin Ala Arg Ala Arg Lys Gly Arg Phe Ile Ser Gly His Ala His 
210 215 220 
cct ggt agt cot tat gta titt ggit citt got gala gta gac cat gat gtt 720 
Pro Gly Ser Pro Tyr Val Phe Gly Leu Ala Glu Val Asp His Asp Val 
225 230 235 240 
gag titc cct gat coa atg cct gta gtt ggg att to a cqa tot gca aaa 768 
Glu Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys 
245 250 255 
ggc tat tdc citg att tot gtg cita gag aca atg aaa aca tat to a got 816 
Gly Tyr Cys Leu Ile Ser Val Leu Glu Thr Met Lys Thr Tyr Ser Ala 
260 265 27 O 
gag gag ggc tita aca gag gaa goa gtt gtt act aag citt cqc at a to c 864 
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Glu Glu Gly Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg Ile Cys 
275 280 285 
cgt tat cat cat cita tac citt cat agt tot ttg agg aac aat tot to a 912 
Arg Tyr His His Leu Tyr Lieu. His Ser Ser Lieu Arg Asn. Asn. Ser Ser 
29 O 295 3OO 
ggC aca. tca cqc togg gga gala titt ggc gala ggt ggg Cta ttg togg gga 96.O 
Gly. Thir Ser Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly 
305 310 315 320 
gag toc agt gga aaa tot titt gag togg titt gat ggit aat cot att gala OO 8 
Glu Cys Ser Gly Lys Ser Phe Glu Trp Phe Asp Gly Asn Pro Ile Glu 
325 330 335 
gaa citg tta toc aag gta agg gala at a tat ggg citt gaa gag aag act O56 
Glu Lieu Lieu. Cys Lys Val Arg Glu Ile Tyr Gly Lieu Glu Glu Lys Thr 
340 345 35 O 
gtt titc cqt aat gtc. agt gito tca ttg gala ggg agg cct caa coc ttg 104 
Val Phe Arg Asn Val Ser Val Ser Leu Glu Gly Arg Pro Gln Pro Leu 
355 360 365 
tat citt gga aca gct act caa att ggg gtgata cca act gag gga ata 152 
Tyr Leu Gly Thr Ala Thr Glin Ile Gly Val Ile Pro Thr Glu Gly Ile 
370 375 38O 
ccc agit ttg cta aaa att gtt citc cct coa aac titt ggt g g c citt coa 200 
Pro Ser Leu Leu Lys Ile Val Leu Pro Pro Asn Phe Gly Gly Leu Pro 
385 390 395 400 
toa ttg tat att aga gat citt citt citt aac cot coa tot titt gat gtt 248 
Ser Leu Tyr Ile Arg Asp Leu Leu Leu Asn Pro Pro Ser Phe Asp Val 
405 410 415 
gca to a to a gtt caa gag got toc agg citt at g g gt agc ata act togc 296 
Ala Ser Ser Val Glin Glu Ala Cys Arg Leu Met Gly Ser Ile Thr Cys 
420 425 43 O 
tog att cott gala titt aca toc at a cog goa goa aag citt gtg aaa tta 344 
Ser Ile Pro Glu Phe Thr Cys Ile Pro Ala Ala Lys Lieu Val Lys Lieu 
435 4 40 4 45 
citc gag toa aaa gag gtt aat cac atc gala ttt tot aga ata aag aat 392 
Leu Glu Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn 
450 455 460 
gto: ct c gat gag gtg ttg titc at g g gt agc aat gct gag citt tot got 4 40 
Val Lieu. Asp Glu Val Lieu Phe Met Gly Ser Asn Ala Glu Lieu Ser Ala 
465 470 475 480 
atc. citg aat aaa ttg citt gat cot gcc goc ata gtt act ggg ttcaaa 488 
Ile Lieu. Asn Lys Lieu Lleu. Asp Pro Ala Ala Ile Val Thr Gly Phe Lys 
485 490 495 
gtt gala gC c gat ata cita gtgaat gala tot agc titt att to a caa cqt 536 
Val Glu Ala Asp Ile Lieu Val Asn. Glu Cys Ser Phe Ile Ser Glin Arg 
5 OO 505 51O. 
ata got gala gta atc. tct tta ggt ggit gala agt gac cag goa ata act 584 
Ile Ala Glu Val Ile Ser Lieu Gly Gly Glu Ser Asp Glin Ala Ile Thr 
515 52O 525 
toa tot gala tat att cog aaa gag titc titc aat ggt atg gag to a tot 632 
Ser Ser Glu Tyr Ile Pro Lys Glu Phe Phe Asn Gly Met Glu Ser Ser 
530 535 540 
tgg aag gga cqt gta aaa agg gtg cat gct gaa gag gag titc. tca aat 680 
Trp Lys Gly Arg Val Lys Arg Val His Ala Glu Glu Glu Phe Ser Asn 
545 550 555 560 
gtt gat at a got gct gag goa citg to a aca gog gtc att gala gat titt 728 
Val Asp Ile Ala Ala Glu Ala Leu Ser Thr Ala Val Ile Glu Asp Phe 
565 570 575 
citg cca att att toa aga gta aaa tot gtg atg toc toa aat gga agt 776 
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Leu Pro Ile Ile Ser Arg Val Lys Ser Val Met Ser Ser Asn Gly Ser 
58O 585 59 O 
tog aag gga gala atc agt tat goa aaa gag cat gaa tot gtt togg titt 1824 
Ser Lys Gly Glu Ile Ser Tyr Ala Lys Glu His Glu Ser Val Trp Phe 
595 600 605 
aaa ggg agg cqa titc aca cca aat gtg togg gcc aac act cot ggit gala 1872 
Lys Gly Arg Arg Phe Thr Pro Asn Val Trp Ala Asn Thr Pro Gly Glu 
610 615 62O 
cita cag ata aag caa ttg aag cott gca att gac toa aaa ggit aga aag 1920 
Leu Glin Ile Lys Glin Leu Lys Pro Ala Ile Asp Ser Lys Gly Arg Lys 
625 630 635 640 
gto gga gaa gala togg titc acc act atc aaa gtt gag aat got tta acc 1968 
Val Gly Glu Glu Trp Phe Thir Thr Ile Llys Val Glu Asn Ala Leu Thr 
645 650 655 
agg tac cat gala gct tot gat aat gca aaa cqt aaa gtt citt gag ttg 2016 
Arg Tyr His Glu Ala Cys Asp Asn Ala Lys Arg Lys Wall Leu Glu Lieu 
660 665 67 O 
ttg aga gga citt toa agt gala ttg cag gac aag attaat gtc. citt gtc 2O64 
Leu Arg Gly Lieu Ser Ser Glu Lieu Glin Asp Lys Ile Asn. Wall Leu Val 
675 680 685 
titt toc to a acg atg citc atc ata aca aaa goa citt titt ggit cat gtt 2112 
Phe Cys Ser Thr Met Leu Ile Ile Thr Lys Ala Leu Phe Gly His Val 
69 O. 695 7 OO 
agt gala gga cqa aga agg ggit togg gtg citt cott act ata tot coc ttg 216 O 
Ser Glu Gly Arg Arg Arg Gly Trp Val Leu Pro Thr Ile Ser Pro Leu 
705 710 715 720 
tgt aag gat aat gtt aca gag gala atc. tca agt gaa atg gala ttg to a 2208 
Cys Lys Asp Asin Val Thr Glu Glu Ile Ser Ser Glu Met Glu Lieu Ser 
725 730 735 
gga act titt cot tac togg citt gat act aac caa gogg aat goa at a citg 2256 
Gly Thr Phe Pro Tyr Trp Leu Asp Thr Asn Gln Gly Asn Ala Ile Leu 
740 745 750 
aat gat gtc cat atg cac tot ttg titt att citt act ggit coa aac ggit 23O4. 
Asn Asp Val His Met His Ser Leu Phe Ile Leu Thr Gly Pro Asn Gly 
755 760 765 
ggit ggit aaa toc agt atg citg aga to a gtc. tot gct gct gca tta citt 2352 
Gly Gly Lys Ser Ser Met Leu Arg Ser Val Cys Ala Ala Ala Lieu Lieu 
770 775 78O 
gga at a tot ggc citg atg gtg cca gct gct tca gct gtc atc cca cat 24 OO 
Gly Ile Cys Gly Leu Met Val Pro Ala Ala Ser Ala Val Ile Pro His 
785 790 795 8OO 
titc gat toc atc atg citg cat at g aaa goa tat gat agc cca gct gat 2448 
Phe Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp 
805 810 815 
ggit aaa agt to g titt cag att gala at g to a gag ata cqa tot tta gtc 2496 
Gly Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ser Leu Val 
820 825 83O 
tgc cqa gct aca gct agg agt citt gtt cita att gat gaa at a tot agg 2544 
Cys Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Asp Glu Ile Cys Arg 
835 840 845 
ggc aca gala aca gca aaa gqa aca tot at a got got agc atc att gala 2592 
Gly Thr Glu Thr Ala Lys Gly Thr Cys Ile Ala Gly Ser Ile Ile Glu 
85 O 855 860 
aga citc gat aat gtt goc toc at a ggc atc ata tota act cat ttg cat 264 O 
Arg Lieu. Asp Asn Val Gly Cys Ile Gly Ile Ile Ser Thr His Lieu. His 
865 870 875 88O 
ggc att titt gac citt coa citg to a citc. cac aat act gat ttcaaa got 2688 
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Gly Ile Phe Asp Leu Pro Leu Ser Lieu. His Asn. Thr Asp Phe Lys Ala 
885 890 895 
atg gga acc gala atc atc gat agg toc att cag cca aca tog aaa tta 2736 
Met Gly Thr Glu Ile Ile Asp Arg Cys Ile Gln Pro Thr Trp Llys Leu 
9 OO 905 910 
atg gat ggc atc tdt aga gag agt citt got titt caa aca goc agg aaa 2784 
Met Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Lys 
915 920 925 
gala ggt at g cct gac ttgata att aga aga got gag gaa cita tat ttg 2832 
Glu Gly Met Pro Asp Lieu. Ile Ile Arg Arg Ala Glu Glu Lieu. Tyr Lieu 
930 935 940 
gct at g agc aca aac agc aag cat aca to a to a gct gtc. cac cat gala 2880 
Ala Met Ser Thr Asn Ser Lys His Thr Ser Ser Ala Val His His Glu 
945 950 955 96.O 
ata toc at a goc aac tot act gta aat agc titg gtt gag aag cott aat 292.8 
Ile Ser Ile Ala Asn Ser Thr Val Asn Ser Leu Val Glu Lys Pro Asn 
965 970 975 
tac citg aga aat gga cita gag citt caa tot ggit toc titc gga tta cita 2976 
Tyr Lieu Arg Asn Gly Lieu Glu Lieu Glin Ser Gly Ser Phe Gly Lieu Lieu 
98O 985 99 O 
aga aaa gaa att gag agt gtt gtt acc aca at a toc aag aag aaa citg 3024 
Arg Lys Glu Ile Glu Ser Val Val Thir Thr Ile Cys Lys Lys Lys Lieu 
995 10 OO 1005 
ttg gat citc tac aac aaa agg agc atc. tca gaa citg att gag gtg 3 O 69 
Leu Asp Leu Tyr Asn Lys Arg Ser Ile Ser Glu Lieu. Ile Glu Val 
O 10 O15 O20 
gto tdt gtt gct gtg ggit gct agg gag caa ccc cca cott toa act 3114 
Val Cys Val Ala Val Gly Ala Arg Glu Gln Pro Pro Pro Ser Thr 
O25 O3O O35 
gtt ggc agg toc agc att tat gta att atc aga C gt gac agc aag 31.59 
Val Gly Arg Ser Ser Ile Tyr Val Ile Ile Arg Arg Asp Ser Lys 
O40 O45 O5 O 
citc tat att goa cag acg gat gat citt gtg g g t c ga citt agit gct 3204 
Leu Tyr Ile Gly Glin Thr Asp Asp Leu Val Gly Arg Lieu Ser Ala 
O55 O60 O65 
cac aga. tcg aag gala ggt at g cag gait gcc acg ata tta tat att 3249 
His Arg Ser Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile 
OFO O75 O8O 
ttg gta cott gogg aag agc att goa toc caa citg gaa act citt citc 3294. 
Leu Val Pro Gly Lys Ser Ile Ala Cys Glin Lieu Glu Thir Lieu Lieu 
O85 O9 O O95 
ata aat cag cita cct ttg aaa ggt ttcaag citc atc aac aag goa 3339 
Ile Asin Glin Leu Pro Leu Lys Gly Phe Lys Lieu. Ile Asn Lys Ala 
1 OO 105 110 
gat ggc aag cat cqa aat titc ggt at a tot citt gto coa gga gag 3384 
Asp Gly Lys His Arg Asn. Phe Gly Ile Ser Lieu Val Pro Gly Glu 
115 120 125 
gca att gcc gca 3396 
Ala Ile Ala Ala 
130 
<210> SEQ ID NO 22 
<211& LENGTH: 1132 
&212> TYPE PRT 
<213> ORGANISM: Oryza sativa 
<400 SEQUENCE: 22 
Met Ala Ile Glin Arg Lieu Lleu Ala Ser Ser Lieu Val Ala Ala Thr Pro 
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1 5 10 15 
Arg Trp Lieu Pro Wall Ala Ala Asp Ser Phe Leu Arg Arg Arg His Arg 
2O 25 30 
Pro Arg Cys Ser Pro Leu Pro Ala Lieu Lleu Phe Asn Arg Arg Ser Trp 
35 40 45 
Ser Lys Pro Arg Lys Val Ser Arg Ser Ile Ser Ile Val Ser Arg Lys 
50 55 60 
Met Asn Lys Glin Gly Asp Lieu. Cys Asn. Glu Gly Met Leu Pro His Ile 
65 70 75 8O 
Leu Trp Trp Lys Glu Lys Met Glu Arg Cys Arg Lys Pro Ser Ser Met 
85 90 95 
Glin Lieu. Thr Glin Arg Lieu Val Tyr Ser Asn. Ile Leu Gly Lieu. Asp Pro 
100 105 110 
Thr Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Ser Lieu. Asn Thr Glu Met 
115 120 125 
Leu Glin Phe Lys Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val 
130 135 1 4 0 
Gly Asp Phe Tyr Glu Ala Val Gly Phe Asp Ala Cys Ile Leu Val Glu 
145 15 O 155 160 
His Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro 
1.65 170 175 
Lys Ala Gly Cys Pro Val Met Asn Leu Arg Gln Thr Lieu. Asp Asp Leu 
18O 185 19 O 
Thr Arg Cys Gly Tyr Ser Val Cys Ile Val Glu Glu Ile Glin Gly Pro 
195 200 2O5 
Thr Glin Ala Arg Ala Arg Lys Gly Arg Phe Ile Ser Gly His Ala His 
210 215 220 
Pro Gly Ser Pro Tyr Val Phe Gly Leu Ala Glu Val Asp His Asp Val 
225 230 235 240 
Glu Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys 
245 250 255 
Gly Tyr Cys Leu Ile Ser Val Leu Glu Thr Met Lys Thr Tyr Ser Ala 
260 265 27 O 
Glu Glu Gly Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg Ile Cys 
275 280 285 
Arg Tyr His His Leu Tyr Lieu. His Ser Ser Lieu Arg Asn. Asn. Ser Ser 
29 O 295 3OO 
Gly. Thir Ser Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly 
305 310 315 320 
Glu Cys Ser Gly Lys Ser Phe Glu Trp Phe Asp Gly Asn Pro Ile Glu 
325 330 335 
Glu Lieu Lieu. Cys Lys Val Arg Glu Ile Tyr Gly Lieu Glu Glu Lys Thr 
340 345 35 O 
Val Phe Arg Asn Val Ser Val Ser Leu Glu Gly Arg Pro Gln Pro Leu 
355 360 365 
Tyr Leu Gly Thr Ala Thr Glin Ile Gly Val Ile Pro Thr Glu Gly Ile 
370 375 38O 
Pro Ser Leu Leu Lys Ile Val Leu Pro Pro Asn Phe Gly Gly Leu Pro 
385 390 395 400 
Ser Leu Tyr Ile Arg Asp Lieu Lleu Lieu. Asn Pro Pro Ser Phe Asp Wall 
405 410 415 
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Ala Ser Ser Val Glin Glu Ala Cys Arg Leu Met Gly Ser Ile Thr Cys 
420 425 43 O 
Ser Ile Pro Glu Phe Thr Cys Ile Pro Ala Ala Lys Lieu Val Lys Lieu 
435 4 40 4 45 
Leu Glu Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn 
450 455 460 
Val Lieu. Asp Glu Val Lieu Phe Met Gly Ser Asn Ala Glu Lieu Ser Ala 
465 470 475 480 
Ile Lieu. Asn Lys Lieu Lleu. Asp Pro Ala Ala Ile Val Thr Gly Phe Lys 
485 490 495 
Val Glu Ala Asp Ile Lieu Val Asn. Glu Cys Ser Phe Ile Ser Glin Arg 
5 OO 505 51O. 
Ile Ala Val Ile Ser Leu Gly Gly Glu Ser Asp Glin Ala Ile Thr 
52O 525 
Ser Ser Glu Tyr Ile Pro Lys Glu Phe Phe Asn Gly Met Glu Ser Ser 
530 535 540 
Trp Lys Gly Arg Val Lys Arg Val His Ala Glu Glu Glu Phe Ser Asn 
545 550 555 560 
Val Asp Ile Ala Ala Glu Ala Leu Ser Thr Ala Val Ile Glu Asp Phe 
565 570 575 
Leu Pro Ile Ile Ser Arg Val Lys Ser Val Met Ser Ser Asn Gly Ser 
58O 585 59 O 
Ser Lys Gly Glu Ile Ser Tyr Ala Lys Glu His Glu Ser Val Trp Phe 
595 600 605 
Lys Gly Arg Arg Phe Thr Pro Asn Val Trp Ala Asn Thr Pro Gly Glu 
610 615 62O 
Leu Glin Ile Lys Glin Leu Lys Pro Ala Ile Asp Ser Lys Gly Arg Lys 
625 630 635 640 
Val Gly Glu Glu Trp Phe Thir Thr Ile Llys Val Glu Asn Ala Leu Thr 
645 650 655 
Arg Tyr His Glu Ala Cys Asp Asn Ala Lys Arg Lys Wall Leu Glu Lieu 
660 665 67 O 
Leu Arg Gly Lieu Ser Ser Glu Lieu Glin Asp Lys Ile Asn. Wall Leu Val 
675 680 685 
Phe Cys Ser Thr Met Leu Ile Ile Thr Lys Ala Leu Phe Gly His Val 
69 O. 695 7 OO 
Ser Glu Gly Arg Arg Arg Gly Trp Val Leu Pro Thr Ile Ser Pro Leu 
705 710 715 720 
Cys Lys Asp Asin Val Thr Glu Glu Ile Ser Ser Glu Met Glu Lieu Ser 
725 730 735 
Gly Thr Phe Pro Tyr Trp Leu Asp Thr Asn Gln Gly Asn Ala Ile Leu 
740 745 750 
Asn Asp Val His Met His Ser Leu Phe Ile Leu Thr Gly Pro Asn Gly 
755 760 765 
Gly Gly Lys Ser Ser Met Leu Arg Ser Val Cys Ala Ala Ala Lieu Lieu 
770 775 78O 
Gly Ile Cys Gly Leu Met Val Pro Ala Ala Ser Ala Val Ile Pro His 
785 790 795 8OO 
Phe Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp 
805 810 815 
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Gly Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ser Leu Val 
820 825 83O 
Cys Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Asp Glu Ile Cys Arg 
835 840 845 
Gly Thr Glu Thr Ala Lys Gly Thr Cys Ile Ala Gly Ser Ile Ile Glu 
85 O 855 860 
Arg Lieu. Asp Asn Val Gly Cys Ile Gly Ile Ile Ser Thr His Lieu. His 
865 870 875 88O 
Gly Ile Phe Asp Leu Pro Leu Ser Lieu. His Asn. Thr Asp Phe Lys Ala 
885 890 895 
Met Gly Thr Glu Ile Ile Asp Arg Cys Ile Gln Pro Thr Trp Llys Leu 
9 OO 905 910 
Met Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Lys 
915 920 925 
Glu Gly Met Pro Asp Lieu. Ile Ile Arg Arg Ala Glu Glu Lieu. Tyr Lieu 
930 935 940 
Ala Met Ser Thr Asn Ser Lys His Thr Ser Ser Ala Val His His Glu 
945 950 955 96.O 
Ile Ser Ile Ala Asn Ser Thr Val Asn Ser Leu Val Glu Lys Pro Asn 
965 970 975 
Tyr Lieu Arg Asn Gly Lieu Glu Lieu Glin Ser Gly Ser Phe Gly Lieu Lieu 
98O 985 99 O 
Arg Lys Glu Ile Glu Ser Val Val Thir Thr Ile Cys Lys Lys Lys Lieu 
995 10 OO 1005 
Leu Asp Leu Tyr Asn Lys Arg Ser Ile Ser Glu Lieu. Ile Glu Val 
O 10 O15 O20 
Val Cys Val Ala Val Gly Ala Arg Glu Gln Pro Pro Pro Ser Thr 
Val Gly Arg Ser Ser Ile Tyr Val Ile Ile Arg Arg Asp Ser Lys 
Leu Tyr Ile Gly Glin Thr Asp Asp Leu Val Gly Arg Lieu Ser Ala 
His Arg Ser Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile 
Leu Val Pro Gly Lys Ser Ile Ala Cys Glin Lieu Glu Thir Lieu Lieu 
Ile Asin Glin Leu Pro Leu Lys Gly Phe Lys Lieu. Ile Asn Lys Ala 
Asp Gly Lys His Arg Asn. Phe Gly Ile Ser Lieu Val Pro Gly Glu 
115 120 125 
Ala Ile Ala Ala 
<210> SEQ ID NO 23 
&2 11s LENGTH 433 
&212> TYPE DNA 
<213> ORGANISM: Sorghum bicolor 
<400 SEQUENCE: 23 
aaggaaggca togcaggatgc tacgatatta tacatcttgg titcctggcaa gag.cgttgcc 60 
tgc.ca.gctgg aaaccottct cataaatcag citt cottcga ggggcttcaa got catcaac 120 
aagg cagacg gaaag catag gaactitcggt atatoto gaa totctggaga ggcaatcgc.c 18O 
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acco agctaa actaatcago taaagatcta atttagttag tottgacgct agtgagt citc 240 
attittgcatc citt catctot tittgcttittg gctactcaat aggaggcagg alacta actoga 3OO 
caccatatgc cqc cocaatt ttgtgagatgaattatcagt ggtgctaccc ttgttgcatag 360 
taggggccita ggggg.cgatc titcc cittgtc. taagcatgta gtacggtgca aatgattagc 420 
aatgcaatga cac 433 
<210> SEQ ID NO 24 
&2 11s LENGTH 64 
&212> TYPE PRT 
<213> ORGANISM: Sorghum bicolor 
<400 SEQUENCE: 24 
Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile Lieu Val Pro Gly 
1 5 10 15 
Lys Ser Val Ala Cys Glin Leu Glu Thir Lieu Lieu. Ile Asn Glin Leu Pro 
2O 25 30 
Ser Arg Gly Phe Lys Lieu. Ile Asn Lys Ala Asp Gly Lys His Arg Asn 
35 40 45 
Phe Gly Ile Ser Arg Ile Ser Gly Glu Ala Ile Ala Thr Glin Lieu. Asn 
50 55 60 
<210> SEQ ID NO 25 
&2 11s LENGTH 667 
&212> TYPE DNA 
<213> ORGANISM: Sorghum bicolor 
<400 SEQUENCE: 25 
tggtaaatct actatottgc gatcagtctg tdcagottcg citgcttggaa tatgtggcct 60 
gatggtacct tcaactitcag citgtaatc.cc gcattttgat to cattatgc tigcatatgaa 120 
agccitacgat agcc.ca.gc.cg atgggaaaag titcatttcag attgaaatgt c ggagatacg 18O 
tgctittagtc agcc.gagcta citgctaggag tottgtc.ctg attggtgaaa tatgtagggg 240 
cacagaaact gcaaaaggaa cct gtattgc tiggtag catc atcgaaaggc tiggataatgt 3OO 
tggctgccta ggcatcatat caacticacct gcatgggatt tittgacttgc citctotcact 360 
cago actact gatttcaaag citatgggaac talagtogto gacgggtgca ttcatccaac 420 
atggaaactg atggatggca totgtagaga aagccittgct tittcaaacag coaggaggga 480 
agg catgcct gagttcataa totagaagggc tigaggagcta tatttgacta toagtacaaa 540 
taacaa.gcag accgcatcaa togg to cacaa tagcct cqt aatgacago C ccagtgtaaa 600 
tggcttggitt gagaa.gc.ctd aatat citgaa atacaggcta gaaattctgc citggtacctt 660 
tgagcc.g 667 
<210> SEQ ID NO 26 
<211& LENGTH 222 
&212> TYPE PRT 
<213> ORGANISM: Sorghum bicolor 
<400 SEQUENCE: 26 
Gly Lys Ser Thr Met Leu Arg Ser Val Cys Ala Ala Ser Lieu Lieu Gly 
1 5 10 15 
Ile Cys Gly Leu Met Val Pro Ser Thr Ser Ala Val Ile Pro His Phe 
2O 25 30 
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Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp Gly 
35 40 45 
Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ala Leu Val Ser 
50 55 60 
Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Gly Glu Ile Cys Arg Gly 
65 70 75 8O 
Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser Ile Ile Glu Arg 
85 90 95 
Leu Asp Asn Val Gly Cys Lieu Gly Ile Ile Ser Thr His Lieu. His Gly 
100 105 110 
Ile Phe Asp Leu Pro Leu Ser Leu Ser Thr Thr Asp Phe Lys Ala Met 
115 120 125 
Gly Thr Glu Val Val Asp Gly Cys Ile His Pro Thr Trp Llys Leu Met 
130 135 1 4 0 
Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Arg Glu 
145 15 O 155 160 
Gly Met Pro Glu Phe Ile Ile Arg Arg Ala Glu Glu Leu Tyr Leu Thr 
1.65 170 175 
Met Ser Thr Asn Asn Lys Gln Thr Ala Ser Met Val His Asn Glu Pro 
18O 185 19 O 
Arg Asn Asp Ser Pro Ser Val Asn Gly Lieu Val Glu Lys Pro Glu Tyr 
195 200 2O5 
Leu Lys Tyr Arg Leu Glu Ile Leu Pro Gly Thr Phe Glu Pro 
210 215 220 
<210 SEQ ID NO 27 
&2 11s LENGTH 351 
&212> TYPE DNA 
<213> ORGANISM: Glycine max 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (89).. (91) 
<223> OTHER INFORMATION: n is a c, g, or t 
<400 SEQUENCE: 27 
ggaaatattt tottacaatc ttgttacago aag galacaca aaaatttaat agtgttgatct 60 
ttgacatgtc titccatataa agtcagtcnn inctitttgcac caagttaggc ccaaatttitt 120 
toatcaaaga aatagaaaag aatgagaaag tacaaac cac aagaatticcg cct caaggat 18O 
gtatgcaaaa ataagtaatg atattggcaa gtacgaagct tcgtaacaac togcttcttct 240 
gtoaa.gcaat cittcagaaga atatgtc.ttc atggtotcta gtaccatatt aatgcaataa 3OO 
cc cctogcag aatgagatat toc tactaca ggcattggitt citgccitcgtg c 351 
<210> SEQ ID NO 28 
&2 11s LENGTH 4O6 
&212> TYPE DNA 
<213> ORGANISM: Glycine max 
<400 SEQUENCE: 28 
ggaatticggc acgaggctga gct caatgaa atattgaaac atttaatcga gcc cacatgg 60 
gtggcaactg g gttagaaat tdactittgaa accittggttg caggatgtga gatc.gcatct 120 
agtaagattg gtgaaatagt atctotggat gatgagaatg atcagaaaat caactic gttc 18O 
tottttatto citcacgaatt ttittgaggat atggagticta aatggaaagg to gaataaaa 240 
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gctggtagcc citygagagga acaaattaaa cagcttaggc atgctittaga ttctaaaggt 1920 
agaaaggtag g g gaggaatg gtttaccaca ccalaaggtog aggctgcatt aacaaggtac 1980 
catgaa.gcaa atgcca aggc aaaagaaaga gttittggaaa ttitta agggg acticgctgct 20 40 
gagttgcaat acagtataaa cattcttgtc titttctitcca tattgcttgt tattgccaaa 2100 
gctittatttg citcatgcaag tdaagggaga agaaggagat gggtotttcc cacgcttgta 216 O 
gaatcc catg g gtttgagga tigtgaagttca ttggacaaaa cccatgggat galagataagt 2220 
ggitttattgc catattggitt coacatagoa galaggtottg togcgtaatga tigttgatatg 228O 
caatcatt at ttctgttgac agg accgaat ggtggtogga aatcaagttt tottagg to a 234. O 
atttgtgctg. citgcactact toggatatgt ggact catgg titcctgcaga atcagcc cta 24 OO 
attccittatt ttgacticcat cacgcttcat atgaagttcat atgatagtcc agctgataaa 2460 
aagagttcct titcaggttga aatgtcagaa citt.cgatcca to attgg.cgg aacaaccaac 252O 
aggagccttg tacttgttga tigaaatatgc cqaggaacag aaactgcaaa agg gacittgc 258O 
attgctggta gcatcattga aaccottgat ggaattgggt gtctgggitat totaticcact 264 O 
cacttgcatg gaatatttac tittgc.cccita aacaaaaaaa acactgtgca caaag caatg 27 OO 
ggcacaa.cat coattgatgg acaaataatg cctacatgga agttgacaga tiggagtttgt 276 O. 
aaagaaagtc. ttgcttittga aacggctaag agggaaggaa titcct gag ca tattgttaga 282O 
agagctgaat atctittatca gttggtttat gctaaggaaa togctttittgc agaaaattitc 2880 
ccaaatgaag aaaagttt to tacct gcatc aatgttaata atttgaatgg alacacatctt 2.940 
cattcaaaaa gottccitatc aggagctaat caaatggaag titttacgcga ggaagttgag 3OOO 
agagctgtca citgtgatttg ccaggatcat ataaagg acc taaaatgcaa aaagattgca 3060 
ttggagctta citgagataaa atgtc.tcata attggtacaa gogagctacc accitc catcg 312 O 
gttgtaggitt cittcaag.cgt citatgtgatg titcagaccag ataagaaact citatgtagga 318O 
gag act gatg atcto gaggg acgggtocga agacatc gat taaaggaagg aatgcatgat 324 O 
gcatcattcc tittattittct totcc.caggit aaaagcttgg catgccaatt tdaatctotg 33OO 
citcatcaa.cc aactittctgg toaaggottc caactgagca atatagotga tiggtaaacat 3360 
aggaattittg gcactitccaa cct gtataca taa 3393 
<210 SEQ ID NO 30 
&2 11s LENGTH 3393 
&212> TYPE DNA 
<213> ORGANISM: Glycine max 
&220s FEATURE 
<221 NAME/KEY: CDS 
<222> LOCATION: (1) . . (3393) 
<400 SEQUENCE: 30 
atg tac agg gta gcc aca aga aac gtc goc gtt titc titc cct cqt togc 48 
Met Tyr Arg Val Ala Thr Arg Asn Val Ala Val Phe Phe Pro Arg Cys 
1 5 10 15 
tgttcc citc gog cac tac act cot tot cta titt coc att titc act tca 96 
Cys Ser Leu Ala His Tyr Thr Pro Ser Leu Phe Pro Ile Phe Thr Ser 
2O 25 30 
titc gct coc to t c gt titc citt aga ata aat gga tigt gta aag aat gtg 144 
Phe Ala Pro Ser Arg Phe Leu Arg Ile Asin Gly Cys Wall Lys Asn. Wal 
35 40 45 
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tog agt tat acg gat aag aag gtt to a agg ggg agt agt agg gcc acc 192 
Ser Ser Tyr Thr Asp Lys Lys Val Ser Arg Gly Ser Ser Arg Ala Thr 
50 55 60 
aag aag coc aaa ata cca aat aac gtt tta gat gat aaa gac citt cot 240 
Lys Llys Pro Lys Ile Pro Asn. Asn Val Lieu. Asp Asp Lys Asp Leu Pro 
65 70 75 8O 
cac at a citg tog tog aag gag agg ttg caa atg togc aga aag titt to a 288 
His Ile Leu Trp Trp Lys Glu Arg Lieu Gln Met Cys Arg Llys Phe Ser 
85 90 95 
act gtc. cag tta att gaa aga citt gala ttt tot aat ttg citt ggc citg 336 
Thr Val Glin Lieu. Ile Glu Arg Lieu Glu Phe Ser Asn Lieu Lieu Gly Lieu 
100 105 110 
aat to c aac titg aaa aat gga agt citg aag gaa goa aca citc aac togg 384 
Asn Ser Asn Lieu Lys Asn Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn Trp 
115 120 125 
gala atg ttg caa titc aag toa aaa titt coa cqt caa gta ttg citt togc 432 
Glu Met Leu Glin Phe Lys Ser Lys Phe Pro Arg Glin Val Lieu Lieu. Cys 
130 135 1 4 0 
aga gtt ggg gala titc tat gaa got togg gga ata gat gct tot att citt 480 
Arg Val Gly Glu Phe Tyr Glu Ala Trp Gly Ile Asp Ala Cys Ile Leu 
145 15 O 155 160 
gtt gala tat gt g g gt tta aat coc att ggt ggit citg cqa to a gat agt 528 
Val Glu Tyr Val Gly Lieu. Asn. Pro Ile Gly Gly Lieu Arg Ser Asp Ser 
1.65 170 175 
atc coa aga gct agt tdt CCt gtc gtgaat Ctt Cagg cag act tta gat 576 
Ile Pro Arg Ala Ser Cys Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp 
18O 185 19 O 
gat citg aca aca aat ggit tat to a gtg togc att gtg gag gag got cag 624 
Asp Leu Thir Thr Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Ala Glin 
195 200 2O5 
ggc cca agt caa got cqa toc agg aaa cqt cqc titt ata tot ggg cat 672 
Gly Pro Ser Glin Ala Arg Ser Arg Lys Arg Arg Phe Ile Ser Gly. His 
210 215 220 
gct cat cott gga aat coc tat gta tat gga citt gct aca gtt gat cat 720 
Ala His Pro Gly Asn Pro Tyr Val Tyr Gly Leu Ala Thr Val Asp His 
225 230 235 240 
gat citt aac titt coa gaa cca at g cct gta gta gga ata tot cat tot 768 
Asp Leu Asin Phe Pro Glu Pro Met Pro Val Val Gly Ile Ser His Ser 
245 250 255 
gc g agg ggit tat tdc attaat at g gta cita gag acc atg aag aca tat 816 
Ala Arg Gly Tyr Cys Ile Asn Met Val Leu Glu Thr Met Lys Thr Tyr 
260 265 27 O 
tot tot gala gat togc titg aca gaa gaa goa gtt gtt acg aag citt cqt 864 
Ser Ser Glu Asp Cys Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg 
275 280 285 
act tcc caa tat cat tac tta ttt ttg cat aca toc titg agg cqg aat 912 
Thr Cys Glin Tyr His Tyr Leu Phe Leu. His Thr Ser Leu Arg Arg Asn 
29 O 295 3OO 
tot togt gga acc toc aac togg gga gaa titt ggit gag gga ggg cita tta 96.O 
Ser Cys Gly. Thir Cys Asn Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lieu 
305 310 315 320 
tgg gga gaa tot agt tot aga cat titt gait togg titt gat ggc aac cot 1008 
Trp Gly Glu Cys Ser Ser Arg His Phe Asp Trp Phe Asp Gly Asn Pro 
325 330 335 
gto tcc gat citt ttg gcc aag gta aag gaa citt tat agt att gat gat 1056 
Val Ser Asp Leu Lleu Ala Lys Wall Lys Glu Lieu. Tyr Ser Ile Asp Asp 
340 345 35 O 
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gag gtt acc titt cqg aac aca act gtg tot to a gga cat agg gct cqa 104 
Glu Val Thr Phe Arg Asn. Thir Thr Val Ser Ser Gly His Arg Ala Arg 
355 360 365 
cca tta act citt goa aca tot act caa att ggit gcc att coa aca gaa 152 
Pro Leu Thir Leu Gly Thr Ser Thr Glin Ile Gly Ala Ile Pro Thr Glu 
370 375 38O 
gga at a cott tot ttg titg aag gtt tta citt coa toa aat toc aat gga 200 
Gly Ile Pro Ser Lieu Lleu Lys Val Lieu Lleu Pro Ser Asn. Cys Asn Gly 
385 390 395 400 
tta coa gta ttg tac ata agg gaa citt citt ttgaat cot cot to a tat 248 
Leu Pro Wall Leu Tyr Ile Arg Glu Lieu Lleu Lieu. Asn Pro Pro Ser Tyr 
405 410 415 
gag att goa toc aaa att caa goa aca toc aaa citt atg agc agt gta 296 
Glu Ile Ala Ser Lys Ile Glin Ala Thr Cys Lys Lieu Met Ser Ser Val 
420 425 43 O 
acg tdt to a att coa gaa titt aca tot gtt tog to a gca aag citt gta 344 
Thr Cys Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val 
435 4 40 4 45 
aag cita citt gala togg agg gag gttcaat cat atg gaa ttt tot aga ata 392 
Lys Lieu Lieu Glu Trp Arg Glu Val Asn His Met Glu Phe Cys Arg Ile 
450 455 460 
aag aat gta citg gat gaa att ttg cag atg tat agt acc tot gag citc 4 40 
Lys Asn. Wall Leu Asp Glu Ile Leu Gln Met Tyr Ser Thr Ser Glu Lieu 
465 470 475 480 
aat gaa at a ttg aaa Cat tta atc gag coc aca togg gtg gCa act ggg 488 
Asn Glu Ile Leu Lys His Leu Ile Glu Pro Thir Trp Val Ala Thr Gly 
485 490 495 
tta gaa att gac titt gala acc ttg gtt go a gga tigt gag atc gca tot 536 
Leu Glu Ile Asp Phe Glu Thir Lieu Val Ala Gly Cys Glu Ile Ala Ser 
5 OO 505 51O. 
agt aag att ggit gaa ata gta tot citg gat gat gag aat gat cag aaa 584 
Ser Lys Ile Gly Glu Ile Val Ser Lieu. Asp Asp Glu Asn Asp Glin Lys 
515 52O 525 
atc aac tog titc. tct titt att cot cac gaa ttt titt gag gat atg gag 632 
Ile Asin Ser Phe Ser Phe Ile Pro His Glu Phe Phe Glu Asp Met Glu 
530 535 540 
tot aaa tog aaa got cqa ata aaa aga atc. cac ata gat gat gta titc 680 
Ser Lys Trp Lys Gly Arg Ile Lys Arg Ile His Ile Asp Asp Val Phe 
545 550 555 560 
act gca gtg gala aaa goa gct gag goc tta cat ata gca gtc act gala 728 
Thr Ala Val Glu Lys Ala Ala Glu Ala Lieu. His Ile Ala Val Thr Glu 
565 570 575 
gat titt gtt cot gtt gtt tot aga ata aag got att gta goc cot citc 776 
Asp Phe Val Pro Val Val Ser Arg Ile Lys Ala Ile Val Ala Pro Leu 
58O 585 59 O 
gga ggit cott aag gga gaa ata tot tat got cqg gag caa gaa go a gtt 824 
Gly Gly Pro Lys Gly Glu Ile Ser Tyr Ala Arg Glu Glin Glu Ala Wal 
595 600 605 
tgg ttcaaa ggc aaa cqc titt aca cog aat ttg togg gct ggit agc cct 872 
Trp Phe Lys Gly Lys Arg Phe Thr Pro Asn Leu Trp Ala Gly Ser Pro 
610 615 62O 
gga gag gaa caa att aaa cag citt agg cat gct tta gat tot aaa ggit 920 
Gly Glu Glu Glin Ile Lys Glin Leu Arg His Ala Lieu. Asp Ser Lys Gly 
625 630 635 640 
aga aag gta ggg gag gala tag titt acc aca Cca aag gtC gag gCt gCa 968 
Arg Llys Val Gly Glu Glu Trp Phe Thr Thr Pro Lys Val Glu Ala Ala 
645 650 655 
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gtt aat aat ttgaat 
Lieu. Asn 
975 
gga gct aat caa atg 
Gly Ala Asn Glin Met 
att togc cag 




























cca aat gala gala aag titt tot acc toc atc aat 
Pro Asn. Glu Glu Lys Phe Ser Thr Cys Ile Asn. Wall Asn. Asn 
965 970 
gga aca cat citt cat toa aaa agg titc cta tota 
Gly Thr His Lieu. His Ser Lys Arg Phe Leu Ser 
98O 985 99 O 
gala gtt tta cqc gag gaa gtt gag aga gct gtc act gtg 
Glu Val Leu Arg Glu Glu Val Glu Arg Ala Val Thr Val 
995 10 OO 1005 
gat cat ata aag gac cita aaa toc aaa aag att gca ttg 
Asp His Ile Lys Asp Leu Lys Cys Lys Lys Ile Ala Lieu 
O 10 O15 O20 
act gag ata aaa tot citc ata att ggit aca agg gag cita 
Thr Glu Ile Lys Cys Lieu. Ile Ile Gly Thr Arg Glu Lieu 
O25 O3O O35 
cca to g gtt gta ggit tot to a agc gtc. tat gtg atg titc 
Pro Ser Val Val Gly Ser Ser Ser Val Tyr Val Met Phe 
O40 O45 O5 O 
gat aag aaa citc tat gta gga gag act gat gat citc gag 
Asp Llys Lys Lieu. Tyr Val Gly Glu Thir Asp Asp Leu Glu 
O55 O60 O65 
gto cqa aga cat cqa tta aag gala gga atg cat gat gca 
Val Arg Arg His Arg Lieu Lys Glu Gly Met His Asp Ala 
OFO O75 O8O 
Ctt tat titt Ctt gtc. cca ggit aaa agc titg gca togc caa 
Leu Tyr Phe Leu Val Pro Gly Lys Ser Lieu Ala Cys Glin 
O85 O9 O O95 
tot citg citc atc aac caa citt tot ggit caa ggc titc caa 
Ser Lieu Lieu. Ile Asn Gln Leu Ser Gly Glin Gly Phe Glin 
1 OO 105 110 
aat at a gct gat ggit aaa cat agg aat titt goc act tcc 
Asn. Ile Ala Asp Gly Lys His Arg Asn. Phe Gly Thr Ser 
115 120 125 
tat aca tala 
Tyr Thr 
130 
<210> SEQ ID NO 31 
&2 11s LENGTH 1130 
&212> TYPE PRT 
<213> ORGANISM: Glycine max 
<400 SEQUENCE: 31 
Met Tyr Arg Val Ala Thr Arg Asn Val Ala Val Phe Phe Pro 
1 5 10 
Cys Ser Leu Ala His Tyr Thr Pro Ser Leu Phe Pro Ile Phe 
2O 25 30 
Phe Ala Pro Ser Arg Phe Leu Arg Ile Asin Gly Cys Wall Lys 
35 40 45 
Ser Ser Tyr Thr Asp Lys Lys Val Ser Arg Gly Ser Ser Arg 
50 55 60 
Lys Llys Pro Lys Ile Pro Asn. Asn Val Lieu. Asp Asp Lys Asp 
65 70 75 
His Ile Leu Trp Trp Lys Glu Arg Lieu Gln Met Cys Arg Lys 
85 90 
Thr Val Glin Lieu. Ile Glu Arg Lieu Glu Phe Ser Asn Lieu Lieu 
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Asn Ser Asn Lieu Lys Asn Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn Trp 
115 120 125 
Glu Met Leu Glin Phe Lys Ser Lys Phe Pro Arg Glin Val Lieu Lieu. Cys 
130 135 1 4 0 
Arg Val Gly Glu Phe Tyr Glu Ala Trp Gly Ile Asp Ala Cys Ile Leu 
145 15 O 155 160 
Val Glu Tyr Val Gly Lieu. Asn. Pro Ile Gly Gly Lieu Arg Ser Asp Ser 
1.65 170 175 
Ile Pro Arg Ala Ser Cys Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp 
18O 185 19 O 
Asp Leu Thir Thr Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Ala Glin 
195 200 2O5 
Gly Pro Ser Glin Ala Arg Ser Arg Lys Arg Arg Phe Ile Ser Gly. His 
210 215 220 
Ala His Pro Gly Asn Pro Tyr Val Tyr Gly Leu Ala Thr Val Asp His 
225 230 235 240 
Asp Leu Asin Phe Pro Glu Pro Met Pro Val Val Gly Ile Ser His Ser 
245 250 255 
Ala Arg Gly Tyr Cys Ile Asn Met Val Leu Glu Thr Met Lys Thr Tyr 
260 265 27 O 
Ser Ser Glu Asp Cys Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg 
275 280 285 
Thr Cys Glin Tyr His Tyr Leu Phe Leu. His Thr Ser Leu Arg Arg Asn 
29 O 295 3OO 
Ser Cys Gly. Thir Cys Asn Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lieu 
305 310 315 320 
Trp Gly Glu Cys Ser Ser Arg His Phe Asp Trp Phe Asp Gly Asn Pro 
325 330 335 
Val Ser Asp Leu Lleu Ala Lys Wall Lys Glu Lieu. Tyr Ser Ile Asp Asp 
340 345 35 O 
Glu Val Thr Phe Arg Asn. Thir Thr Val Ser Ser Gly His Arg Ala Arg 
355 360 365 
Pro Leu Thir Leu Gly Thr Ser Thr Glin Ile Gly Ala Ile Pro Thr Glu 
370 375 38O 
Gly Ile Pro Ser Lieu Lleu Lys Val Lieu Lleu Pro Ser Asn. Cys Asn Gly 
385 390 395 400 
Leu Pro Wall Leu Tyr Ile Arg Glu Lieu Lleu Lieu. Asn Pro Pro Ser Tyr 
405 410 415 
Glu Ile Ala Ser Lys Ile Glin Ala Thr Cys Lys Lieu Met Ser Ser Val 
420 425 43 O 
Thr Cys Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val 
435 4 40 4 45 
Lys Lieu Lieu Glu Trp Arg Glu Val Asn His Met Glu Phe Cys Arg Ile 
450 455 460 
Lys Asn. Wall Leu Asp Glu Ile Leu Gln Met Tyr Ser Thr Ser Glu Lieu 
465 470 475 480 
Asn Glu Ile Leu Lys His Leu Ile Glu Pro Thir Trp Val Ala Thr Gly 
485 490 495 
Leu Glu Ile Asp Phe Glu Thir Lieu Val Ala Gly Cys Glu Ile Ala Ser 
5 OO 505 51O. 
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Ser Lys Ile Gly Glu Ile Val Ser Lieu. Asp Asp Glu Asn Asp Glin Lys 
515 52O 525 
Ile Asin Ser Phe Ser Phe Ile Pro His Glu Phe Phe Glu Asp Met Glu 
530 535 540 
Ser Lys Trp Lys Gly Arg Ile Lys Arg Ile His Ile Asp Asp Val Phe 
545 550 555 560 
Thr Ala Val Glu Lys Ala Ala Glu Ala Lieu. His Ile Ala Val Thr Glu 
565 570 575 
Asp Phe Val Pro Val Val Ser Arg Ile Lys Ala Ile Val Ala Pro Leu 
58O 585 59 O 
Gly Gly Pro Lys Gly Glu Ile Ser Tyr Ala Arg Glu Glin Glu Ala Wal 
595 600 605 
Trp Phe Lys Gly Lys Arg Phe Thr Pro Asn Leu Trp Ala Gly Ser Pro 
610 615 62O 
Gly Glu Glu Glin Ile Lys Glin Leu Arg His Ala Lieu. Asp Ser Lys Gly 
625 630 635 640 
Arg Llys Val Gly Glu Glu Trp Phe Thr Thr Pro Lys Val Glu Ala Ala 
645 650 655 
Lieu. Thir Arg Tyr His Glu Ala Asn Ala Lys Ala Lys Glu Arg Val Lieu 
660 665 67 O 
Glu Ile Leu Arg Gly Lieu Ala Ala Glu Lieu Glin Tyr Ser Ile Asn. Ile 
675 680 685 
Leu Val Phe Ser Ser Met Leu Lieu Val Ile Ala Lys Ala Lieu Phe Ala 
69 O. 695 7 OO 
His Ala Ser Glu Gly Arg Arg Arg Arg Trp Val Phe Pro Thr Leu Val 
705 710 715 720 
Glu Ser His Gly Phe Glu Asp Wall Lys Ser Lieu. Asp Lys Thr His Gly 
725 730 735 
Met Lys Ile Ser Gly Leu Leu Pro Tyr Trp Phe His Ile Ala Glu Gly 
740 745 750 
Val Val Arg Asn Asp Wall Asp Met Glin Ser Lieu Phe Leu Lieu. Thr Gly 
755 760 765 
Pro Asn Gly Gly Gly Lys Ser Ser Phe Leu Arg Ser Ile Cys Ala Ala 
770 775 78O 
Ala Lieu Lieu Gly Ile Cys Gly Lieu Met Val Pro Ala Glu Ser Ala Lieu 
785 790 795 8OO 
Ile Pro Tyr Phe Asp Ser Ile Thr Leu. His Met Lys Ser Tyr Asp Ser 
805 810 815 
Pro Ala Asp Llys Lys Ser Ser Phe Glin Val Glu Met Ser Glu Lieu Arg 
820 825 83O 
Ser Ile Ile Gly Gly Thr Thr Asn Arg Ser Lieu Val Lieu Val Asp Glu 
835 840 845 
Ile Cys Arg Gly Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser 
85 O 855 860 
Ile Ile Glu Thir Lieu. Asp Gly Ile Gly Cys Lieu Gly Ile Val Ser Thr 
865 870 875 88O 
His Lieu. His Gly Ile Phe Thr Lieu Pro Leu Asn Lys Lys Asn Thr Val 
885 890 895 
His Lys Ala Met Gly Thr Thr Ser Ile Asp Gly Glin Ile Met Pro Thr 
9 OO 905 910 
Trp Llys Lieu. Thir Asp Gly Val Cys Lys Glu Ser Leu Ala Phe Glu Thr 
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915 920 925 
Ala Lys Arg Glu Gly Ile Pro Glu His Ile Val Arg Arg Ala Glu Tyr 
930 935 940 
Leu Tyr Glin Leu Val Tyr Ala Lys Glu Met Leu Phe Ala Glu Asn. Phe 
945 950 955 96.O 
Pro Asn. Glu Glu Lys Phe Ser Thr Cys Ile Asn. Wall Asn. Asn Lieu. Asn 
965 970 975 
Gly Thr His Lieu. His Ser Lys Arg Phe Leu Ser Gly Ala Asn Gln Met 
98O 985 99 O 
Glu Val Leu Arg Glu Glu Val Glu Arg Ala Val Thr Val Ile Cys Glin 
995 10 OO 1005 
Asp His Ile Lys Asp Leu Lys Cys Lys Lys Ile Ala Leu Glu Lieu 
O 10 O15 O20 
Thr Glu Ile Lys Cys Leu Ile Ile Gly Thr Arg Glu Leu Pro Pro 
O25 O3O O35 
Pro Ser Val Val Gly Ser Ser Ser Val Tyr Val Met Phe Arg Pro 
O40 O45 O5 O 
Asp Llys Lys Lieu. Tyr Val Gly Glu Thir Asp Asp Leu Glu Gly Arg 
Val Arg Arg His Arg Lieu Lys Glu Gly Met His Asp Ala Ser Phe 
Leu Tyr Phe Leu Val Pro Gly Lys Ser Leu Ala Cys Glin Phe Glu 
Ser Lieu Lieu. Ile Asn Gln Leu Ser Gly Glin Gly Phe Glin Leu Ser 
1 OO 105 110 
Asn. Ile Ala Asp Gly Lys His Arg Asn. Phe Gly Thr Ser Asn Lieu 
115 120 125 
Tyr Thr 
130 
<210> SEQ ID NO 32 
&2 11s LENGTH 757 
&212> TYPE DNA 
<213> ORGANISM: Saccharum officinarum 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (512) . . (512) 
<223> OTHER INFORMATION: n is a c, g, or t 
<400 SEQUENCE: 32 
cc.gc.ctcitct cq.cccc.ccac titcccacgcc ccacgcc.gcc toccattcca gttccagogit 60 
ggacgcgacg ccggcgcgga gacgcggcgt citcgaag cac tag coccct g ttgttctitcc 120 
gc gcc.ggcgc gcc.ggcgc.ca tocaccgggit gctcgtgagc ticgctcqtgg cc.gc.cacgc.c 18O 
gc ggtggcto coccitc.gc.cg acticcatcct coggc gcc.gc cqc cogc gct gct coccitct 240 
toccatgctg. citatto gacc ggagg acttg gttccaagcca aggaaggtot cac gagg cat 3OO 
ttcagtggca totaggaaag citaacaaaca gggagaatat tdtgatgaaa goatgctato 360 
toatat catg togtggaaag agaaaatgga gaagtgcaga aaaccatcat citgtacagtt 420 
gacticagagg cittgttgtatt cqaatatatt agg gttggat cogaatttaa gaaatggaag 480 
cittgaaagat ggalacc ct ga acatggagat timtgctattt aaatcaaaat titccitcqtga 540 
ggttct actt togcagaaa.ca toc aggotta aattctottt gagggttgc gttctgacag 600 
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aatticcitaaa gotgggtgtc. cago.cggaat ttacggagac attggatgag ttgactic gat 660 
gtgg gaattic totgtgcaaa gtgaagaaat tacaggc.cga cccaag.ccct gcc.ccggaaa 720 
gtogattaat totggg catg cccatcctgg agcc.cta 757 
<210 SEQ ID NO 33 
&2 11s LENGTH 139 
&212> TYPE PRT 
<213> ORGANISM: Saccharum officinarum 
&220s FEATURE 
<221 NAME/KEY: misc feature 
<222> LOCATION: (125) . . (125) 
<223> OTHER INFORMATION: Xaa can be any naturally occurring amino acid 
<400 SEQUENCE: 33 
Met His Arg Val Leu Val Ser Ser Leu Val Ala Ala Thr Pro Arg Trp 
1 5 10 15 
Leu Pro Leu Ala Asp Ser Ile Leu Arg Arg Arg Arg Pro Arg Cys Ser 
2O 25 30 
Pro Leu Pro Met Leu Lleu Phe Asp Arg Arg Thr Trp Ser Lys Pro Arg 
35 40 45 
Lys Val Ser Arg Gly Ile Ser Val Ala Ser Arg Lys Ala Asn Lys Glin 
50 55 60 
Gly Glu Tyr Cys Asp Glu Ser Met Leu Ser His Ile Met Trp Trp Lys 
65 70 75 8O 
Glu Lys Met Glu Lys Cys Arg Llys Pro Ser Ser Val Glin Lieu. Thr Glin 
85 90 95 
Arg Lieu Val Tyr Ser Asn. Ile Leu Gly Lieu. Asp Pro Asn Lieu Arg Asn 
100 105 110 
Gly Ser Lieu Lys Asp Gly. Thir Lieu. Asn Met Glu Ile Xaa Lieu Phe Lys 
115 120 125 
Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg 
130 135 
<210> SEQ ID NO 34 
&2 11s LENGTH 504 
&212> TYPE DNA 
<213> ORGANISM: Saccharum officinarum 
<400 SEQUENCE: 34 
cacgtacctg. tcc toga attc ccc gaccgac ccatgcgtga gaacaagctt taattaaaac 60 
atacctaagt atcttctggg gtc.gc.cittca cqc coacaga ggggaggaag goatgcaaga 120 
tgctaccacc ctatacatct toggttcctgg caagagc gtt gcc toccago tagaaaccot 18O 
totcataaat cagottccitt citgagggctt Caagctdatc aacaaggtag acggaaag.ca 240 
taggaact to ggtatattitc gaatctotgg agaggcaatt gctactcaac taalactaatc 3OO 
acgtgaagat citaatttago tag acgacac tagtgagtct cattttggct act caatagg 360 
aggcaggagc taactgacac catgcc.gc.cc caatattgtt gaactgatag cqgagctago 420 
cittgaccata atacggg cat citttittcticg totaatgatg tagtacaatig caaatgatta 480 
gcaatgcaat gacactic gtt gtgc 504 
<210 SEQ ID NO 35 
&2 11s LENGTH 72 
&212> TYPE PRT 
<213> ORGANISM: Saccharum officinarum 
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SEQUENCE: 35 
Gly Arg Lieu. His Ala His Arg Gly Glu Glu Gly 
1 5 10 
Thr Leu Tyr Ile Leu Val Pro Gly Lys Ser Val 
2O 25 
Thr Lieu Lieu. Ile Asn Gln Leu Pro Ser Glu Gly 
35 40 
Lys Val Asp Gly Lys His Arg Asn. Phe Gly Ile 
50 55 




SEQ ID NO 36 
LENGTH 671 
TYPE DNA 
ORGANISM: Nicotiana tabacum. 
SEQUENCE: 36 
aacaattctt agccttctat gcttcagttt gtaaatgcta 
citatttacag citggtoaagt togcttgagtt gagggaggca 
aataaagaat gtgg to gatgaaatactgca gatgtacaga 
tittagagtca gCtgatggat CCtacttggg toggcaa.ccgg 
citctagtgaa togaatgtggg gagatttctg gtagaatcag 
gtgaaagtga toaaaagata agticcictato citatcatccc 
tggagtc.gcc atggaaaggit cqtgtcaaga ggatc cattt 
taga caaggc tigcagatgct ttatctttgg citgtgagtct 
atcc taatga tttacaagtt gtgcatctgt gtgcgctitta 
atatacattt gct gtaaagg cagtcagott ttcaacgtoc 
to cagtaata ttatctagga atttactgat cqatgaacaa 
aaataaacaa g 
<400 
SEQ ID NO 37 
LENGTH 488 
TYPE DNA 
ORGANISM: Lycopersicon esculentum 
SEQUENCE: 37 
gtttggtgaa gotggactitt totggggaga atgtaatgct 
tggcaatcct atc gatgagc titttgttcaa gqtaaaagag 
cattcc attc agaaatgtca citgttgtttc agaaaatagg 
aact gccaca caaattggtg citattocaac cqaagggatt 
gctitccitcct cattgcagtg gtctaccagt cotgtatatt 
accacccitat gagatttctt Cagacattca agagg catgc 
atgttcaatt cotgattitta cotgtattitc atctgcaaag 




Met Glin Asp 
Ala Cys Glin 
30 
Phe Lys Lieu 
45 










a tact cittitc 
agtaaaagct 
ttittggggta 
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gag cqg aag titt titt gcc aca acg goa aaa aaa citc aaa caa coa aaa 192 
Glu Arg Llys Phe Phe Ala Thir Thr Ala Lys Lys Lieu Lys Glin Pro Lys 
50 55 60 
agt att coa gag gala aaa gac tat gtt aat att atg togg tog aaa gag 240 
Ser Ile Pro Glu Glu Lys Asp Tyr Val Asn. Ile Met Trp Trp Lys Glu 
65 70 75 8O 
aga at g gala titc titg aga aag cott tot to C got citt citg got aag agg 288 
Arg Met Glu Phe Leu Arg Lys Pro Ser Ser Ala Lieu Lleu Ala Lys Arg 
85 90 95 
citt aca tat tdt aac ttg citg ggt gtg gat cog agt titg aga aat gga 336 
Lieu. Thir Tyr Cys Asn Lieu Lleu Gly Val Asp Pro Ser Lieu Arg Asn Gly 
100 105 110 
agt citt aaa gag gga aca citt aac to g gag atg ttg cag titc aag to a 384 
Ser Lieu Lys Glu Gly Thr Lieu. Asn. Ser Glu Met Leu Glin Phe Lys Ser 
115 120 125 
aaa titt coa cqt gaa gtt ttg ctic tot aga gta ggit gat ttt tat gala 432 
Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val Gly Asp Phe Tyr Glu 
130 135 1 4 0 
gct att gga titc gat gct tot att citt gtg gaa tat gct ggit tta aat 480 
Ala Ile Gly Phe Asp Ala Cys Ile Leu Val Glu Tyr Ala Gly Lieu. Asn 
145 15 O 55 160 
cca titt ggt ggc citg cac to a gat agt at a coa aaa got ggit tot coa 528 
Pro Phe Gly Gly Lieu. His Ser Asp Ser Ile Pro Lys Ala Gly Cys Pro 
1.65 170 175 
gtt gtgaat cita aga cag acg citt gat gat citc aca C gt aat ggt titc 576 
Val Val Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu. Thr Arg Asn Gly Phe 
18O 185 19 O 
tot gtg to C gttc gtg gag gala gtt cag ggit coa act caa got cqt gct 624 
Ser Val Cys Val Val Glu Glu Val Glin Gly Pro Thr Glin Ala Arg Ala 
195 200 2O5 
cgt aag agt cqa titt ata to a ggg cat go a cat coa ggc agt coc tat 672 
Arg Lys Ser Arg Phe Ile Ser Gly His Ala His Pro Gly Ser Pro Tyr 
210 215 220 
gtt titt ggc citt gtt gna gat gat caa gat citt gat titt coa gaa coa 720 
Val Phe Gly Lieu Val Xaa Asp Asp Glin Asp Lieu. Asp Phe Pro Glu Pro 
225 230 235 240 
atg cct gtt gtt goa ata toc cqt to a gog aag ggg tat toc att atc 768 
Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys Gly Tyr Cys Ile Ile 
245 250 255 
tot gtt tac gag act atg aag act tac tot gtg gaa gat ggc cta act 816 
Ser Val Tyr Glu Thr Met Lys Thr Tyr Ser Val Glu Asp Gly Leu Thr 
260 265 27 O 
gala gaa goc gta gtc. acc aaa citt cqt act tot cqa toc cat cat titt 864 
Glu Glu Ala Val Val Thr Lys Leu Arg Thr Cys Arg Cys His His Phe 
275 280 285 
titt ttg cat aat to a titg aag aac aat toc to a gga aca to g c gt tog 912 
Phe Lieu. His Asn. Ser Lieu Lys Asn. Asn. Ser Ser Gly Thr Ser Arg Trp 
29 O 295 3OO 
gga gag titt ggit gaa got goa citt ttg togg gga gaa tot aat gct aga 96.O 
Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly Glu Cys Asn Ala Arg 
305 310 315 320 
cag cag gala tog titg gat ggc aat cot atc gat gag citt ttg ttcaag 1008 
Glin Glin Glu Trp Lieu. Asp Gly Asn Pro Ile Asp Glu Lieu Lleu Phe Lys 
325 330 335 
gta aaa gag citt tat ggit citc aat gat gac att coa titc aga aat gtc 1056 
Wall Lys Glu Lieu. Tyr Gly Lieu. Asn Asp Asp Ile Pro Phe Arg Asn Val 
340 345 35 O 
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act gtt gtt to a gaa aat agg ccc cqt cott tta cac citt gga act gcc 104 
Thr Val Val Ser Glu Asn Arg Pro Arg Pro Leu. His Leu Gly Thr Ala 
355 360 365 
aca caa att ggit gct att coa acc gala ggg att coa tot ttg tta aag 152 
Thr Glin Ile Gly Ala Ile Pro Thr Glu Gly Ile Pro Cys Leu Leu Lys 
370 375 38O 
gtg ttg citt cot cott cat tdc agt ggit cita coa gtc. citg tat att agg 200 
Val Leu Leu Pro Pro His Cys Ser Gly Leu Pro Val Leu Tyr Ile Arg 
385 390 395 400 
gat citt citt tta aat coa coa goc tat gag att tot to a gac ata caa 248 
Asp Leu Lleu Lieu. Asn Pro Pro Ala Tyr Glu Ile Ser Ser Asp Ile Glin 
405 410 415 
gag goa toc aga citt atg atg agt gtc. aca tot toa att cot gat titt 296 
Glu Ala Cys Arg Leu Met Met Ser Val Thr Cys Ser Ile Pro Asp Phe 
420 425 43 O 
acc tot att to a tot gca aag ct g g to aag citg citt gag titg agg gag 344 
Thr Cys Ile Ser Ser Ala Lys Lieu Val Lys Lieu Lleu Glu Lieu Arg Glu 
435 4 40 4 45 
gca aat cac gtt gag titc toc aaa ata aag agc atg gtc. gala gag ata 392 
Ala Asn His Val Glu Phe Cys Lys Ile Lys Ser Met Val Glu Glu Ile 
450 455 460 
citg cag ttg tat aga aat to a gag citt cqt gct atw gta gag tta citg 4 40 
Leu Gln Leu Tyr Arg Asn. Ser Glu Lieu Arg Ala Xaa Val Glu Lieu Lieu 
465 470 475 480 
atg gat cott act togg gtg gca act ggg ttg aaa gtt gat titt gat aca 488 
Met Asp Pro Thr Trp Val Ala Thr Gly Leu Lys Val Asp Phe Asp Thr 
485 490 495 
cita gta aat gala tot goa aag att tot togt aga atc agt gala ata ata 536 
Leu Val Asn. Glu Cys Gly Lys Ile Ser Cys Arg Ile Ser Glu Ile Ile 
5 OO 505 51O. 
to C gta cat ggit gala aat gat caa aag att agt toc tat cot atc atc 584 
Ser Val His Gly Glu Asn Asp Gln Lys Ile Ser Ser Tyr Pro Ile Ile 
515 52O 525 
cca aat gat titc titt gaa gat at g gag ttg ttg tog aaa ggc cqt gtc 632 
Pro Asn Asp Phe Phe Glu Asp Met Glu Lieu Lleu Trp Lys Gly Arg Val 
530 535 540 
aag agg atc cat ttg gag gaa goa tat go a gaa gta gaa aag got gog 680 
Lys Arg Ile His Leu Glu Glu Ala Tyr Ala Glu Val Glu Lys Ala Ala 
545 550 555 560 
gat got tta tot tta gcc ata aca gaa gat titc cta cct att att to a 728 
Asp Ala Leu Ser Leu Ala Ile Thr Glu Asp Phe Leu Pro Ile Ile Ser 
565 570 575 
aga ata agg gcc acg atg gcc cca citt gga gga act aaa ggg gag att 776 
Arg Ile Arg Ala Thr Met Ala Pro Leu Gly Gly Thr Lys Gly Glu Ile 
58O 585 59 O 
ttg tat goc cqt gag cat gga got gta tog titt aag gga aag aga titt 824 
Leu Tyr Ala Arg Glu His Gly Ala Val Trp Phe Lys Gly Lys Arg Phe 
595 600 605 
gta coa act gtt togg gct gga acc gct gga gaa gaa caa att aag caa 872 
Val Pro Thr Val Trp Ala Gly. Thr Ala Gly Glu Glu Glin Ile Lys Glin 
610 615 62O 
citc aga cct gct cita gat toa aag ggg aag aag gtt goa gaa gaa togg 920 
Leu Arg Pro Ala Lieu. Asp Ser Lys Gly Lys Lys Val Gly Glu Glu Trp 
625 630 635 640 
titc act aca at g agg gtg gala gat gca at a got agg tat cac gag goa 968 
Phe Thr Thr Met Arg Val Glu Asp Ala Ile Ala Arg Tyr His Glu Ala 
645 650 655 





























